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Abstract
The Holy Grail of cancer research is to find effective treatments that can be
easily delivered to diseased cells with minimal collateral damage to healthy
tissue. In this context, recent developments in nanoparticle technology have
aroused considerable interest with the promise of multifunctional vectors
for both diagnostic and treatment of cancer.
Recently, new emphasis has been placed on hybrid nanoparticle (NP) sys-
tems, where combinations of different types of nanostructured materials
are used to create multimodal systems that exhibit the combined benefi-
cial properties of the component modules. In particular, nanorattles, which
are NPs with a core-shell structure containing a distinctive void separating
the core material from the shell, constitute promising launch platforms for
many biomedical applications.
Current hybrid NP systems tend to concentrate on adding extra properties
by increasing the number of modules and therefore, system complexity.
However, added complexity in itself does not guarantee higher effectiveness.
Therefore, in this thesis, a more holistic approach is proposed whereby
simplicity, efficiency and usefulness of the design are not overlooked.
The work presented here describes a gold-silica rattle-type particle, the
Quantum Rattle (QR), made of a hollow mesoporous silica shell (HS) host-
ing two classes of hydrophobic gold nanostructures: gold quantum dots
(AuQDs) and gold nanoparticles (AuNPs). The HS stabilises the gold
nanostructures, making them dispersible in water and thereby enables bio-
medical applications. It also allows passive targeting for the QR via the
enhanced permeability and retention (EPR) effect. The AuQDs absorb and
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emit light in the near-infrared (NIR) biological window where blood and
soft tissue are relatively transparent (650 nm - 900 nm). With their NIR
photonics, the AuQDs mediate both photothermal therapy (PPT) and live
infrared imaging. Finally, the hydrophobic AuNPs optimise the system’s
drug carrying performance by increasing the payload’s loading efficiency as
well as controlling its release profile. This thesis exhibits the first evidence
of the intrinsic and efficient therapeutic and diagnostic potential of this
new class of hybrid NP system and discusses how these results could have
a significant impact on the growing field of nanosystems used for cancer
treatment.
4
Preface
Author’s Declaration
This thesis is a record of the work carried out by me in the Department of
Materials and the Department of Bioengineering at Imperial College Lon-
don (London, UK) and the Laboratoire de Chimie de la Matière Condensée
de Paris at the Collège de France (Paris, France). The work described
herein is my own, unless otherwise stated.
Article in Preparation
Hembury M, Chiappini C, Bertazzo S, Drisko G, Hedegaard M, Gormley
A, Katla S, Kumar C, Ghandehari H, Porter A, Sanchez C, Boissière C,
Stevens M. (2012) Gold-Silica Quantum Rattles for Cancer Therapy and
Diagnosis. In preparation for submission to Nature Nanotechnology.
5

Acknowledgments
After four years, the time has finally come to submit my thesis. In doing
so I would like to express my sincere gratitude to all the people who helped
me complete this project. Without the continuous help and support of my
colleagues and friends, my research and resulting thesis would not have
come to fruition.
First, I would like to thank my two supervisors, Prof. Molly Stevens and
Dr. Alexandra Porter, for their support and guidance throughout all the
high spots as well as the trials and tribulations that marked the route to
the completion of my thesis. In particular, I would like to thank Molly for
believing in me and giving me the opportunity to realise the potential of
this project which has become such an important part of my life during
the last four years. Likewise my sincere thanks to Alex for her unremitting
advice and patience coupled with her contagious motivation.
I would also like to thank Prof. Clément Sanchez who generously offered me
the opportunity of being a guest researcher at his laboratory at the Collège
de France in Paris. His advice and unsurpassed knowledge of hybrid mater-
ials proved invaluable for the development of the Quantum Rattle system.
Likewise, my thanks to Dr. Cédric Boissière and Dr. Glenna Drisko, at
the Collège de France, for introducing me to the world of mesoporous silica
and for providing me with the competence and advice necessary to make
silica particles an essential ingredient in the Quantum Rattle system.
In addition, I would like to express my gratitude to Prof. Francesco Stellacci
for offering me the opportunity of visiting his research laboratory at MIT
in Boston, USA. The scientific discussions and the experience gained in his
group have been invaluable on both an academic and a personal level.
7
During the course of this research project, I also had the privilege to work,
and become friends with Dr. Ciro Chiappini and Dr. Sergio Bertazzo,
without whom this project would simply not have been realised in its ex-
isting form. Their enormous passion and creativity stimulated our many
discussions and elevated my work to a higher level than would otherwise
have been attained.
I am very grateful to all the great and interesting colleagues I worked
with in the Stevens group over the years. A special thank you goes to
Stu, Dave, Seth, John, James, Yann, Thomas, Heiko, Tommy, Nicolas,
Hélène, Jess, Amanda, Maria, Farina, Elsie, Lesley and Silvia for making
my time in London so enjoyable and memorable. Furthermore, I would like
to thank my friends back in Paris for their continuous support and interest
in my Quantum Rattle research. Of course, having received so much help
and support from so many people, it is inevitable that there will be some
important omissions in these acknowledgements. Nevertheless, you know
who you are and I am sure you will understand this lapse on my part.
Lastly, this thesis would not have been possible without the support and
encouragement of my family, especially my parents. In particular, a thank
you to my father for helping me break communications barriers and to my
mother for helping fix them afterwards. Thank you for always being there
for me. Finally, to Lise, a very special thank you for putting up with me
and being so supportive. You kept me on the straight and narrow especially
with regard to my logic. I do not believe I would have been able to finish
this PhD without your help and unrelenting optimism.
8
Contents
Abstract 3
Preface 5
Acknowledgments 7
Table of Contents 12
List of Figures 28
List of Movies 30
List of Tables 31
1 Introduction 33
1.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
1.1.1 Scope of the Thesis . . . . . . . . . . . . . . . . . . . 34
1.2 Nanotechnology . . . . . . . . . . . . . . . . . . . . . . . . . 35
1.2.1 Gold Nanoparticles . . . . . . . . . . . . . . . . . . . 37
1.2.2 Gold Quantum Dots . . . . . . . . . . . . . . . . . . 42
1.2.3 Multifunctional Hybrid Systems . . . . . . . . . . . . 46
1.3 Nanoparticles for Cancer Treatment . . . . . . . . . . . . . . 48
1.3.1 Diagnosis for Cancer Treatment . . . . . . . . . . . . 50
1.3.2 Photothermal Therapy . . . . . . . . . . . . . . . . . 56
1.3.3 Chemotherapy . . . . . . . . . . . . . . . . . . . . . . 59
2 Experimental Techniques 63
2.1 Microscopy . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
9
Contents
2.1.1 Transmission Electron Microscopy . . . . . . . . . . . 63
2.1.2 Laser Confocal Scanning Microscopy . . . . . . . . . 68
2.2 Spectrophotometry . . . . . . . . . . . . . . . . . . . . . . . 70
2.2.1 UV-Visible Spectroscopy . . . . . . . . . . . . . . . . 70
2.2.2 Steady-State Photoluminescence Spectroscopy . . . . 72
3 The Quantum Rattle System: Synthesis and Characterisa-
tion 75
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
3.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . 78
3.2.1 Hollow Mesoporous Silica Particles . . . . . . . . . . 78
3.2.2 Gold Synthesis . . . . . . . . . . . . . . . . . . . . . 79
3.2.3 Quantum Rattle Syntheses . . . . . . . . . . . . . . . 80
3.2.4 Particle Morphology and Composition . . . . . . . . 82
3.2.5 Photonic Characterisation . . . . . . . . . . . . . . . 85
3.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . 86
3.3.1 Hollow Mesoporous Silica Particles . . . . . . . . . . 86
3.3.2 Quantum Rattle . . . . . . . . . . . . . . . . . . . . 91
3.3.3 Quantum Rattle Photonic Properties . . . . . . . . . 101
3.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
4 Quantum Rattle Interactions with Cells 109
4.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
4.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . 111
4.2.1 Quantum Rattles Cytotoxicity . . . . . . . . . . . . . 112
4.2.2 Quantum Rattle Silica Shells Functionalisation . . . . 115
4.2.3 Microscopy . . . . . . . . . . . . . . . . . . . . . . . 115
4.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . 118
4.3.1 Quantum Rattles Cytotoxicity . . . . . . . . . . . . . 118
4.3.2 Quantum Rattles Internalisation . . . . . . . . . . . . 122
4.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
5 Quantum Rattles Mediate Hyperthermia In Vitro 133
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 133
10
Contents
5.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . 138
5.2.1 Photothermal Properties of the Quantum Rattles . . 138
5.2.2 In Vitro Assessment of the Quantum Rattles Photo-
thermal Properties . . . . . . . . . . . . . . . . . . . 139
5.2.3 Ex Vivo Assessment of the Quantum Rattles Photo-
thermal Properties . . . . . . . . . . . . . . . . . . . 144
5.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . 144
5.3.1 Photothermal Properties of the Quantum Rattles . . 144
5.3.2 In Vitro Assessment of the Quantum Rattles Photo-
thermal Properties . . . . . . . . . . . . . . . . . . . 150
5.3.3 Ex Vivo Assessment of the Quantum Rattles Photo-
thermal Properties . . . . . . . . . . . . . . . . . . . 157
5.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
6 Quantum Rattles for Drug Delivery 161
6.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . 161
6.2 Materials and Methods . . . . . . . . . . . . . . . . . . . . . 164
6.2.1 Drug Loading . . . . . . . . . . . . . . . . . . . . . . 164
6.2.2 Drug Release . . . . . . . . . . . . . . . . . . . . . . 165
6.3 Results and Discussion . . . . . . . . . . . . . . . . . . . . . 166
6.3.1 Drug Loading . . . . . . . . . . . . . . . . . . . . . . 166
6.3.2 Drug Release . . . . . . . . . . . . . . . . . . . . . . 169
6.4 Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . 171
7 Conclusions and Future Work 173
A Appendices 177
A.1 Photonic Properties of ‘Thick’ Quantum Rattles . . . . . . . 178
A.2 NIR Imaging Potential of the Quantum Rattles . . . . . . . 179
A.3 Magnetic Properties of the Quantum Rattles . . . . . . . . . 180
A.4 Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . . 180
A.4.1 In Vitro Cytotoxicity . . . . . . . . . . . . . . . . . . 181
A.4.2 LIVE/DEAD Quantification Study . . . . . . . . . . 187
11
Contents
A.4.3 Ex Vivo Assessment of the Quantum Rattles Photo-
thermal Properties Study . . . . . . . . . . . . . . . . 191
A.4.4 Drug Delivery Study . . . . . . . . . . . . . . . . . . 193
A.5 Thermal Camera Movies - Real-Time Temperature Acquisition196
A.6 LIVE/DEAD Assay Quantification - Killing Efficiency . . . 198
Bibliography 207
12
List of Figures
1.1 Scale comparing the dimensions of organic molecules and
biological entities with examples of nanomaterials. . . . . . 36
1.2 Schematics representing the syntheses of thiol-protected AuNPs
using (a) the Brust-Schiffrin reaction and (b) the Stucky re-
action. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
1.3 Schematic of plasmon oscillations of a metal nanosphere in
response to an incident electric field. Adapted from [1]. . . . 41
1.4 Crystal structure of a Au25(SR)18 gold quantum dot. Au25(SR)18
is based on a core-shell striker with (a) a centred icosahedral
Au13 core surrounded by (b) a Au12 exterior shell protec-
ted by (c) 18 thiolate ligands arranged in six ’staple’ motifs
-S-Au-S-Au-S-. Adapted from [2]. . . . . . . . . . . . . . . . 44
1.5 (a) Kohn-Sham orbital level diagram and (b) peak assign-
ment for the UV-Vis absorption spectrum of Au25(SR)18 gold
quantum dots. Adapted from [2]. . . . . . . . . . . . . . . . 45
1.6 Schematic illustrations of rattle-type particles with different
morphologies. Rattle-type particles with (a) a single core,
(b) multiple cores and (c) multiple shells. Adapted from [3]. 47
13
List of Figures
1.7 Schematic illustrations for preparing gold-silica rattle-type
particles employing (a) etching strategies and (b) soft tem-
plating methods. (c-d) Transmission electron microscopy
(TEM) images of Au@SiO2 nanorattles obtained through
etching with KCN at different concentrations, resulting in
varying gold core diameters. Scale bars: 200 nm. (e-f) TEM
images of Au@SiO2 nanorattles obtained through soft tem-
plating method using different concentrations of the initial
gold salt solution to vary the final gold loading. Scale bars:
20 nm. Adapted from [3–5]. . . . . . . . . . . . . . . . . . . 48
1.8 Enhanced permeability and retention (EPR) effect. (a) Vas-
culature in normal tissues is tight, preventing targeting nan-
oparticles from penetrating and extravasating. (b) Vascu-
lar walls in tumour tissue have multiple narrow slits and
are leaky and thus hyperpermeable to nanoparticles (60 nm
to 400 nm), which preferentially accumulate in the tumour.
Adapted from [6] . . . . . . . . . . . . . . . . . . . . . . . . 51
1.9 Advantages and limitations associated with different imaging
techniques. Adapted from [7]. . . . . . . . . . . . . . . . . . 52
1.10 Wavelength range of the near-infrared (NIR) tissue transmis-
sion window. Photothermal therapy and optical diagnostic
imaging are most efficient in the 650 nm to 900 nm spec-
tral range due to minimal light absorption by haemoglobin
(< 650 nm) and water (> 900 nm). Adapted from [8]. . . . . 54
1.11 Various types of nanoparticle-based systems used in biomed-
ical research and drug delivery.[9] . . . . . . . . . . . . . . . 60
2.1 Comparison between optical microscopy, transmission elec-
tron microscopy and scanning electron microscopy. Basic
set-ups of (a) an optical microscope, (b) a transmission elec-
tron microscope (TEM) and (c) a scanning electron micro-
scope (SEM). . . . . . . . . . . . . . . . . . . . . . . . . . . 64
14
List of Figures
2.2 Basic set-up of a confocal microscope. Light from the laser
(blue line) is scanned across the specimen by the scanning
mirrors. Optical sectioning occurs as the fluoresced light
(green line) passes through a pinhole before reaching the
detector. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
2.3 UV-Vis spectrophotometer basic set-up. . . . . . . . . . . . 71
2.4 Mechanism of photoluminescence. The horizontal lines in-
dicate quantum energy levels of the photoluminescent ob-
ject. When a photoluminescent object absorbs a photon, an
electron will be excited into a higher energy state. When it
returns to its ground state, a photon is emitted. . . . . . . . 73
3.1 The Quantum Rattle design specifications. The Quantum
Rattles are thin shells of mesoporous silica hosting gold nan-
oparticles within their core and gold quantum dots within
their mesopores. The biocompatible silica shell stabilises
the gold nanostructures inside it and has a diameter (< 400
nm) which sets well within the range to exploit the enhanced
permeability and retention (EPR) effect. The gold quantum
dots are photonically active in the near-infrared biological
window allowing both photothermal therapy and live fluor-
escent imaging. The gold nanoparticles enhance the meso-
porous silica shell as a drug vector by improving loading
efficiency and prolonging sustained release. . . . . . . . . . 77
3.2 Schematic of Quantum Rattle synthesis. (a) Chloro(tri-
phenylphosphine) gold (I) salt and 1-octanethiol are infused
into hollow mesoporous silica shells. (b) Nucleation and
formation of gold quantum dots inside the silica shell’s pores
and gold nanoparticles inside and outside the hollow shell
after the addition of the borane tert-butylamine complex
reducing agent. (c) Purification step separating Quantum
Rattles (QRs) from gold nanoparticles formed outside the
hollow silica shells. . . . . . . . . . . . . . . . . . . . . . . . 81
15
List of Figures
3.3 Morphology and size distribution of polystyrene particles
used in the hollow mesoporous silica synthesis as template
for the cavity. (a-c) Scanning electron microscopy images of
the polystyrene particle template showing a monodisperse
and spherical population at different magnifications. Scale
bars: 500 nm. . . . . . . . . . . . . . . . . . . . . . . . . . . 88
3.4 Morphology of hollow mesoporous silica particles. Bright
field transmission electron microscopy images of the (a-b)
thick and (c-d) thin hollow mesoporous silica particles (HSs).
Both type of HSs are monodisperse and spherical. The meso-
pores of both silica shells possess an ordered and radial or-
ganisation, starting from the core. Scale bars: 100 nm. . . . 90
3.5 Effect of the Quantum Rattle synthetic process on the meso-
porous silica shell. (a) Nitrogen adsorption and desorption
isotherm of thin (grey) and thick (black) and (b) small angle
x-ray scattering (SAXS) spectra of thin (grey) and thick
(black) Quantum Rattles (QRs, plain line) and hollow meso-
porous silica particles (HSs, dashed line) showing that the
QR synthetic pathway does not affect the integrity and pore
structure of the mesoporous silica shells. . . . . . . . . . . . 91
3.6 Attempted Quantum Rattle synthesis using gold (III) salt
as metallic precursor. (a) Bright field transmission electron
microscopy image showing hollow mesoporous silica particles
without any gold nanostructures inside the cavity. White
cross indicates where energy dispersive X-ray spectroscopy
(EDS) analysis was performed. Scale bar: 100 nm. (b)
Corresponding EDS spectra showing no elemental trace of
gold. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
16
List of Figures
3.7 Morphology of Quantum Rattles. Bright field transmission
electron micrographs of (a-b) thick and (c-d) thin Quantum
Rattles (QRs) showing gold nanostructures (yellow arrows)
inside hollow mesoporous silica particles (blue arrows). (a,c)
Ultrathin sections of resin-embedded QRs, obtained through
microtomy showing suprastructures formed of 5 nm to 10
nm gold nanoparticles; (b,d) Higher magnification of QRs
deposited on carbon coated TEM copper grid. Scale bars:
100 nm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
3.8 Quantum Rattle elemental analysis. (a) Bright field trans-
mission electron micrographs of thin Quantum Rattles (QR)
showing gold nanostructures (yellow arrows) inside hollow
mesoporous silica particles (blue arrows). White cross in-
dicates where energy dispersive X-ray spectroscopy (EDS)
analysis was performed. Scale bar: 100 nm. (b) Corres-
ponding EDS spectra of QR indicating the presence of silica
and gold. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
3.9 The Quantum Rattle system. Bright field high resolution
transmission electron micrographs (HRTEM) of thin Quant-
um Rattles (QRs). HRTEM images of (a) a QR showing
AuQDs (red arrow) within the mesoporous silica shell (blue
arrow) of the QR and AuNPs (yellow arrow) within the cav-
ity and (b) close-up on a QR silica shell. Scale bars: 20 nm.
(c) Zoom in on the AuNPs inside the QR cavity showing the
different crystal faces of the larger AuNPs. Scale bar: 5 nm. 98
3.10 The Quantum Rattle system. High angle annular dark field
scanning transmission electron micrographs (HAADF-STEM)
of thin Quantum Rattles (QRs). (a) HAADF-STEM images
of a QR highlighting the gold nanostructures of the QR:
AuQDs within the QR mesoporous silica shell and AuNPs
within the cavity. Scale bar: 50 nm. (b) Close-up on the
QRs mesoporous silica shell. Scale bar: 10 nm. . . . . . . . . 99
17
List of Figures
3.11 Monolayer protected gold nanoparticles. (a-b) Bright field
transmission electron micrographs of 1-octanethiol protec-
ted gold nanoparticles (OT AuNPs) synthesised using QR
process in the absence of hollow mesoporous silica shells at
different magnifications. The OT AuNPs are highly monod-
isperse 8 nm particles with a hexagonal packing on the TEM
copper grid. No AuQDs are visible. Scale bars: 20 nm. . . . 100
3.12 Extinction spectra of thin Quantum Rattles (QR, red) com-
pared to hollow mesoporous silica shells without gold (HS,
blue) and spherical gold nanoparticles synthesised using the
same method as the QR but in the absence of hollow silica
shells (AuNPs, black). Inset: zoomed in on the near in-
frared region of interest, showing an extinction peak centred
around 672 nm. . . . . . . . . . . . . . . . . . . . . . . . . . 102
3.13 Photoluminescence spectra of thin Quantum Rattles show-
ing an excitation peak centred at 672 nm and an emission
peak centred at 827 nm. Emission spectrum (λex = 672 nm,
red) and excitation spectrum (λem = 827 nm, grey). . . . . . 103
3.14 Photoluminescence spectra of (a) hollow mesoporous silica
particles (HS) and (b) spherical gold nanoparticles synthes-
ised using the same method as the QR but in the absence
of hollow silica shells (Free AuNPs). Both controls do not ex-
hibit the characteristic photoluminescent peaks of the Quant-
um Rattles. Emission spectra (λex = 672 nm) and excitation
spectra (λem = 827 nm). . . . . . . . . . . . . . . . . . . . . 104
3.15 Morphology of non-hollow Quantum Rattles. (a) Bright field
transmission electron micrograph of a non-hollow Quantum
Rattle (NQR) and (b) zoom in showing gold quantum dots
(AuQDs, red arrows) within the mesoporous silica shell of
the NQR. Scale bars: 50 nm. . . . . . . . . . . . . . . . . . . 105
18
List of Figures
3.16 Photonic properties of non-hollow Quantum Rattle: (a) Ex-
tinction spectra of non-hollow Quantum Rattles (NQRs, or-
ange) showing the same characteristic features as the Quan-
tum Rattles (QRs) extinction spectra. Inset: zoomed onto
the near infrared region of interest showing an extinction
peak centred around 673 nm. (b) Photoluminescence spec-
tra of NQRs showing an excitation peak centred at 673 nm
and an emission peak centred at 826 nm. Both emission
spectrum (λex = 673 nm, orange) and excitation spectrum
(λem = 826 nm, grey) are similar to the QRs photolumines-
cent spectra. . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.1 Functionalised Quantum Rattles cytocompatibility evaluated
by MTT assay. The different concentrations were obtained
by 10-fold dilutions of either 1011 particle.mL-1 dispersions
of fluorescently labelled particles or of media pre-soaked in
5 cm2.mL-1 of control material (from 100% to 0.1%). HeLa
cells after 1 day incubation in media containing different
concentrations (108 particle.mL-1 to 1011 particle.mL-1) of
fluorescein functionalised Quantum Rattles (fQR) or fluores-
cein functionalised hollow mesoporous silica particles (fHS),
do not show alterations of metabolic activity compared to
medical grade PVC (Negative Control). Organo-tin PVC
(Positive Control) shows expected cytotoxic effect on the cell
metabolic activity, proportional to the dilution factor of the
original organo-tin PVC solution. Results are normalised
to blank control (cells culture media without nanoparticles).
Error bars represent the standard deviations of triplicate ex-
periments. . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
19
List of Figures
4.2 Quantum Rattles cytocompatibility evaluated by MTT as-
say. HeLa cells after 1 day and 3 days incubation in media
containing either 1011 particle.mL-1 Quantum Rattles (QR,
red) or hollow mesoporous silica particles (HS, blue) do not
show alterations of metabolic activity compared to medical
grade PVC (Negative Control, white), whereas no metabolic
activity is measured with organo-tin PVC (Positive Control,
black). Results are normalised to blank control (cells cul-
ture media without nanoparticles). Error bars represent the
standard deviations of triplicate experiments. . . . . . . . . 121
4.3 Quantum Rattles cytocompatibility evaluated by total DNA
assay. HeLa cells after 1 day and 3 days incubation in media
containing either 1011 particle.mL-1 Quantum Rattles (QR,
red) or hollow mesoporous silica particles (HS, blue) do not
show alterations of cell proliferation compared to medical
grade PVC (Negative Control, white). Cell proliferation
and viability are significantly affected by organo-tin PVC
(Positive Control, black). Error bars represent the standard
deviations of triplicate experiments. . . . . . . . . . . . . . . 123
4.4 Quantum Rattle internalisation and near-infrared fluores-
cence. (a,b) Laser confocal scanning microscopy images of
HeLa cells incubated for 1 day with Quantum Rattles (QR),
which are imaged through their native fluorescence (red).
Cells are stained for F-actin (phalloidin AF488, green) and
nucleus (DAPI, blue). QRs are localised by their own pho-
toluminescence within the cells, accumulating in the peri-
nuclear region. (a) Cell overview and (b) close-up of on one
HeLa cell showing a QR aggregate in the perinuclear region.
Scale bars: 10 μm. . . . . . . . . . . . . . . . . . . . . . . . 125
20
List of Figures
4.5 Quantum Rattle silica shell functionalisation. Laser con-
focal scanning microscopy images of HeLa cells incubated
for 1 day with (a) fluorescein functionalised hollow meso-
porous silica particles (fHSs) or (b) fluorescein functional-
ised Quantum Rattles (fQR). Cells are stained for F-actin
(phalloidin AF569, red) and nucleus (DAPI, blue). Both
particles are localised by the fluorophore (fluorescein, green)
functionalised on their silica shells demonstrating the silane
functionalisation potential of the QRs. Scale bars: 10 μm. . . 127
4.6 Quantum Rattle internalisation. Transmission electron mi-
crographs of ultrathin sections of HeLa cells incubated with
Quantum Rattles (QRs) for 1 day, showing the co-internalisa-
tion and trafficking of the entire QR structure. (a-b) Cell
overview. Red arrows points at internalised QRs. Scale bar:
2 µm. (c-d) Close-ups of the QR cluster. Scale bar: 500 nm. 128
4.7 Quantum Rattle internalisation (a-c) Transmission electron
micrographs of ultrathin sections of HeLa cells incubated
with Quantum Rattles (QR) for 1 day showing the co-interna-
lisation and trafficking of the entire QR structure. (a) Cell
overview. Red arrow points at internalised QRs being traf-
ficked within a membranous vesicle. Scale bar: 2 µm. (b)
Close-up of the QR cluster inside the vesicle. Inset: Zoom in
on one QR. Scale bar: 100 nm. (c) Zoom in on several QRs,
where energy dispersive x-ray spectroscopy analysis was per-
formed. Scale bar: 100 nm. (d) EDS spectrum of the QR
region indicating the presence of silica and gold. . . . . . . . 129
4.8 Mapping Raman spectroscopy of Quantum Rattles (QR) in-
ternalised by HeLa cells. Each pixel represents a Raman
spectrum, which were categorised in 4 groups: nuclei (blue),
cytoplasm (green), gold (red) and gold with lipids (yellow).
Peaks originating from lipid molecules are clearly visible for
spectra around the QRs. Scale bar: 8 µm. . . . . . . . . . . 130
21
List of Figures
5.1 LIVE/DEAD assays quantification - irradiated cell popu-
lation (a-b) Representative merged fluorescent microscopy
image series of LIVE/DEAD assays performed on HeLa cells
(live cells in green, dead cells in red) incubated with Quantum
Rattles for 1 day and irradiated for 8 min with 671 nm laser
light (38 W.cm-2). The dashed surface represents the mask
applied to obtain the cropped image of the LIVE and DEAD
channels of (a) the irradiated cell population and (b) the cells
adjacent to the laser spot. Scale bars: 200 µm . . . . . . . . 141
5.2 LIVE/DEAD assays quantification - image segmentation.
Representative fluorescent microscopy image series of LIVE/
DEAD assays performed on HeLa cells (live cells in green,
dead cells in red) incubated with either cell media only, hol-
low silica shells (HS) or Quantum Rattles (QRs) for 1 day
and irradiated for either 0, 2, 5, 8, 10 or 15 min with 671
nm laser light (38 W.cm-2) showing their corresponding bin-
ary image series obtained after applying a segmentation al-
gorithm. The percentage cell death is calculated by calcu-
lating the sum of the binary image matrices and normalising
the DEAD channel value over the total of both LIVE and
DEAD channel values. . . . . . . . . . . . . . . . . . . . . . 143
5.3 Schematic of the experimental set-up used for the ex vivo
study of Quantum Rattles (QRs) NIR light absorption po-
tential. QRs were subcutaneously injected in chicken thighs,
which were subsequently treated with NIR light at 671 nm
(38 W.cm-2). Temperature profiles were monitored using a
thermocouple probe inserted under the skin of the chicken
thigh and recorded with a RTD thermometer. . . . . . . . . 145
22
List of Figures
5.4 Photothermal properties of Quantum Rattles. Temperature
profiles monitored with a thermal camera of hollow meso-
porous silica shells (HS, blue) and Quantum Rattles (QR,
red) dried on a glass slide showing a temperature increase
in the QR samples upon irradiation with a 671 nm laser (38
W.cm-2) compared to the HS control. . . . . . . . . . . . . 146
5.5 Photothermal properties of Quantum Rattles. Temperature
profiles monitored through a thermal camera of (a) hollow
mesoporous silica shells (HS, blue) and (b) Quantum Rattles
(QR, red) dried on a glass slide showing a temperature in-
crease in the QR samples upon irradiation with a 671 nm
laser (7 W.cm-2) compared to the HS control. The temper-
ature increase is lower than when the QR are irradiated at a
power density of 38 W.cm-2(Figure 5.4), demonstrating the
photothermal conversion is dependent on the incident laser
irradiation power. . . . . . . . . . . . . . . . . . . . . . . . . 147
5.6 Photothermal properties of Quantum Rattles. Temperature
profiles monitored through a thermocouple probe of (a) hol-
low mesoporous silica shells (HS, blue) and (b) Quantum
Rattles (QR, red) in solution showing a bulk increase in the
solvent temperature upon irradiation with a 671 nm laser
(38 W.cm-2) for the QRs compared to the HS control. . . . . 149
5.7 Effect of irradiation on the Quantum Rattles. Bright Field
high resolution transmission electron microscopy (HRTEM)
images of (a) overview and (b) close-up of a Quantum Rattle
after irradiation by a 671 nm laser (38 W.cm-2) for 15 min.
Scale bars: 50 nm. . . . . . . . . . . . . . . . . . . . . . . . 150
23
List of Figures
5.8 Quantum Rattles mediate hyperthermia in vitro. LIVE/
DEAD assays on HeLa cells (live cells in green, dead cells in
red) treated with 671 nm laser light (38 W.cm-2, spot size ~
1mm). Representative fluorescent microscopy images of (a-
f) cells incubated for 1 day with Quantum Rattles (QRs) and
irradiated for 0, 2, 5, 8, 10 and 15 min; (g) cells irradiated
for 15 min; (h) cells incubated with hollow mesoporous silica
shells (HS) for 1 day and irradiated for 15 min. Scale bars:
500 µm. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
5.9 Quantum Rattles mediate hyperthermia in vitro. LIVE/
DEAD assay quantification. Percentage of cell death inside
the laser spot saturates after 10 min of laser irradiation. The
hyperthermia and cell death caused by the QRs/laser light
combination is dose dependent (i.e. dependent on the energy
provided by the laser irradiation). Error bars represent the
standard deviations of quadruplicate experiments. . . . . . . 154
5.10 Quantum Rattles mediate hyperthermia in vitro. LIVE/
DEAD assay quantification. Percentage of cell death outside
the laser spot showing a linear trend (R2 = 0.97) between
cell death and irradiation time in the close proximity of the
laser spot. Error bars represent the standard deviations of
quadruplicate experiments. . . . . . . . . . . . . . . . . . . . 155
24
List of Figures
5.11 The photothermal potential of Quantum Rattles ex vivo.
Temperature profiles monitored through a thermocouple pro-
be inserted under the skin of a chicken thigh after (a) no in-
jection (Negative Control, grey), (b) phosphate buffer injec-
tion (PBS, grey) and (c) Quantum Rattles in PBS injection
(QR, red). (d) Maximum temperature increase recorded for
QRs in PBS injections (QR, red) compared to no injections
(Negative Control, grey) and PBS alone injections (PBS,
grey). A higher temperature increase is observed upon irra-
diation with a 671 nm laser (38 W.cm-2) for the QR injection
compared to the two controls, which show identical temper-
ature profiles. Error bars represent the standard deviations
of triplicate experiments. . . . . . . . . . . . . . . . . . . . . 158
6.1 Quantum Rattles loading efficiency of doxorubicin (DOX).
DOX loading efficiency of Quantum Rattles (QR, red) com-
pared to hollow mesoporous silica shells without gold (HS,
blue) and non-hollow Quantum Rattles (NQR, orange) show-
ing up to 9 and 5 fold increased loading efficiency for the QRs
compared to the HSs and NQRs, respectively. The higher
surface area and hydrophobic environment provided by the
gold nanoparticles inside the cavity of the silica shell drastic-
ally enhance the DOX loading efficiency of the system, start-
ing from concentrations as low of 31.3 µg.mL-1. Error bars
represent the standard deviation of triplicate experiments.
Inset: Transmission electron micrographs of QR, NQRs and
HS. Scale bars: 50 nm. . . . . . . . . . . . . . . . . . . . . . 167
25
List of Figures
6.2 Release of doxorubicin (DOX) from Quantum Rattles. Drug
release profile of Quantum Rattles (QR, red) compared to
hollow mesoporous silica shells without gold (HS, blue) and
non-hollow Quantum Rattles (NQR, orange) showing a 10
and 4 fold increase in the total DOX released compared to
the HSs and NQRs, respectively. The QRs appear to modu-
late the release kinetics providing prolonged release for up to
12 h compared to HSs where the DOX release plateaus after
4 h. Error bars represent the standard deviation of triplic-
ate experiments. Inset: Transmission electron micrographs
of QR, NQRs and HS. Scale bars: 50 nm. . . . . . . . . . . . 170
A.1 Photonic properties of thick Quantum Rattles (silica shell
thickness of ∼ 50 nm for a total diameter of ∼ 200 nm).
(a) Extinction spectra of thick Quantum Rattles (thick QR,
red) showing the same characteristic features as the thin
QRs extinction spectra. Inset: zoomed in on the near in-
frared region of interest showing an extinction peak centred
around 672 nm. (b) Photoluminescence spectra of thick QR
showing an excitation peak centred at 672 nm and an emis-
sion peak centred at 827 nm. Both emission spectrum (λex
= 672 nm, red) and excitation spectrum (λem = 827 nm,
grey) are identical to the thin QRs photoluminescent spectra. 178
26
List of Figures
A.2 NIR imaging of Quantum Rattles. DU145 bilateral prostate
tumours in NU/NU mice were injected with 500 µL of (a)
Quantum Rattles (QR, 20 mg.mL-1 in PBS) or (b) saline
solution. The mice were sacrificed 1 day after the intrat-
umoural injections and the excised tumours were fixed in
4% paraformaldehyde (PFA). QRs are localised by their own
photoluminescence within the tumours, accumulating in in-
tense epifluorescent spots, which are not observed in tumor-
ous tissue injected with saline solution. These results show
the great potential of the strong NIR absorption of the QRs
for selective photothermal tumour ablation. NIR imaging
set-up: λex = 675 nm and λem = 840 nm. . . . . . . . . . . . 179
A.3 Magnetic properties of the Quantum Rattle. Magnetisa-
tion curve of Quantum Rattles (QR, red dotted line) at 2 K
showing paramagnetic properties. These intrinsic QR para-
magnetic characteristics could enable efficient MRI imaging,
thereby providing another imaging modality to the QR system.180
A.4 Multicomparison test for the MTT assay of cells cultured in
the presence of fluorescein-functionalised Quantum Rattles. . 182
A.5 Multicomparison test for the MTT assay of cells cultured in
the presence of Quantum Rattles. . . . . . . . . . . . . . . . 184
A.6 Multicomparison test for the tDNA assay of cells cultured
in the presence of Quantum Rattles. . . . . . . . . . . . . . 186
A.7 Multicomparison test for the LIVE/DEAD study of the cell
population inside the laser spot, which has been incubated
with Quantum Rattles and treated with NIR light. . . . . . 188
A.8 Multicomparison test for the LIVE/DEAD study of the cell
population adjacent to the laser spot, which has been incub-
ated with Quantum Rattles and treated with NIR light. . . . 190
A.9 Multicomparison test for the ex vivo assessment of the Quantum
Rattles photothermal properties study. . . . . . . . . . . . . 192
A.10 Multicomparison test for the Quantum Rattles doxorubicin
loading efficiency study. . . . . . . . . . . . . . . . . . . . . 194
27
List of Figures
A.11 Multicomparison test for the Quantum Rattles doxorubicin
release study. . . . . . . . . . . . . . . . . . . . . . . . . . . 195
28
List of Movies
4.1 Quantum Rattle internalisation and near-infrared fluores-
cence. Three-dimensional reconstruction of laser confocal
scanning microscopy images of HeLa cells incubated for 1
day with Quantum Rattles (QR), which are imaged through
their native photoluminescence (red). Cells are stained for
F-actin (phalloidin AF488, green) and nucleus (DAPI, blue).
QRs are localised by their own fluorescence within the cells,
accumulating in the perinuclear region. (Click to play. Re-
quires Adobe Reader 8.× or higher) . . . . . . . . . . . . . . 124
5.1 Confocal time-lapse series of HeLa cells incubated with Quan-
tum Rattles for 1 day. (a-b) LIVE channel during laser
irradiation showing calcein (LIVE stain, green) disappear-
ing due to the loss of intracellular esterase activity with cell
death. (b) Zoomed-in view with bright field (inset) showing
cells bursting during death with cytoplasm leaking and, or-
ganelles and nuclei appearing. (c-d) LIVE and DEAD chan-
nels after laser irradiation of 2 and 5 min, showing DNA-
bound ethidium bromide homodimer-1 (DEAD stain, red)
appearing indicating the loss of plasma membrane integrity
(d) Zoomed-out view after laser irradiation showing laser
spot. (Click to play. Requires Adobe Reader 8.× or higher) . 156
29
List of Movies
A.1 Hollow mesoporous silica particles photothermal properties.
Movie showing the real-time acquisition by a thermal camera
of the temperature profile of a coverslip with hollow meso-
porous silica particles (HSs) drop-deposited on its surface.
No heat increase is observed when a 671 nm laser is irradi-
ated on the HS. (Click to play. Requires Adobe Reader 8.×
or higher) . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196
A.2 Quantum Rattles photothermal properties. Movie showing
the real-time acquisition by a thermal camera of the tem-
perature profile of a coverslip with Quantum Rattles (QRs)
drop-deposited on its surface. A temperature increase of ∼
1.5 °C is observed upon irradiation by a 671 nm laser of the
QR sample. (Click to play. Requires Adobe Reader 8.× or
higher) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 197
30
List of Tables
1.1 Detailed overview of gold-based platforms for cancer treat-
ment and diagnosis summarising the advantages and disad-
vantages of each system. . . . . . . . . . . . . . . . . . . . . 58
5.1 Detailed overview of gold-based platforms for cancer treat-
ment and diagnosis, summarising the advantages and disad-
vantages of each system compared to the Quantum Rattles. . 137
31

Chapter 1
Introduction
1.1 Introduction
Nanotechnology, in biology, focusses on the development of novel strategies
for diagnosis and therapy of disease as well as on exploring fundamental bio-
logical processes by exploiting the unique phenomena associated with ma-
terials of nanoscale dimensions. In order to tackle such biological problems,
nanotechnology-based approaches are often by necessity cross-disciplinary,
incorporating elements of chemistry, molecular biology, materials science,
physics and optics.
When material dimensions are reduced to the nanometer scale, new and
unique properties can emerge from the nanomaterial. For example, nan-
omaterials can exhibit advanced electronic, optical, magnetic, and mech-
anical properties compared to their bulk counterparts.[10–13] Nanotech-
nology, in its broadest sense, tries to combine and employ these unique
nanoscale properties for functional devices. The properties of the nano-
structured materials can resemble those of biomolecules and biomolecular
assemblies, such as proteins and nucleic acids.[14] Therefore, systems in-
corporating nanomaterials provide unique opportunities to investigate bio-
logical interactions and processes at the nanoscale. For example, the high
extinction and plasmonic optical properties exhibited by noble metal or
semiconductor NPs allows them to serve as powerful biological detection
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reagents.[15–20]
The unique properties of nanomaterials also show great potential for new
applications originating in the field of medical technology. Especially onco-
logy research has attracted a great deal of interest in nanotechnology.[21]
Despite allocations of huge research funds and resources towards cancer dia-
gnosis and therapy, cancer still remains one of the leading cause of death
worldwide.[22].
In the past decade, nanotechnology has already played a crucial role in the
development of more advanced cancer therapeutics.[23–28] By combining
nanomaterial-specific properties with environment-responsive and specific
bio-recognition motifs, new materials for use in oncology have been de-
veloped, including in vitro and in vivo imaging, drug delivery, diagnostics
and advanced therapeutic strategies.[29] An example that shows the po-
tential arising from the inherent interdisciplinary of nanotechnology ap-
proaches are biomolecule-nanoparticle formulations, which are capable of
simultaneously imaging and treating tumours in live mice.[30, 31] In con-
sideration of the numerous potential benefits of using nanotechnology in
cancer treatment, this thesis aims to develop an improved, simple and
multifunctional system to achieve simultaneous diagnosis and therapy of
cancer.
1.1.1 Scope of the Thesis
This thesis explores the use of gold and silica nanostructures to devise ad-
vanced approaches towards cancer diagnostics and therapy. To this end
a new straightforward synthesis has been developed to produce a novel,
synergistic gold-silica rattle-type system, the Quantum Rattle (QR). The
QR system is composed of a hollow mesoporous silica shell functionalised
with two distinct populations of gold nanostructures - gold quantum dots
(AuQDs) and gold nanoparticles (AuNPs). The overall aim of this project
is to develop a multifunctional system capable of both live imaging and
targeted, efficient therapy. Chapter 1 provides an overview of the emergent
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properties of AuNPs and AuQDs, and explores the use of nanotechno-
logy in cancer treatment, giving representative examples of nanomaterial
uses in cancer diagnosis and therapy. The chapter concludes on the use of
multifunctional composite nanosystems for use in oncology and, in partic-
ular, systems combining silica and gold in one treatment agent. Chapter
2 describes the main experimental techniques used to accomplish the work
presented in this thesis. Chapter 3 focuses on the synthesis and emergent
properties of the QR platform. After demonstrating the QR synthesis pro-
cess, the characterisation of the morphology and composition of the QR
and the promising properties of the QR with regards to cancer imaging an-
d/or therapy are described. Following from these results, chapter 4 focusses
on demonstrating the QR suitability for bioapplications and, in particular,
for NIR imaging. In parallel, chapter 5 explores the photothermal proper-
ties of the QRs and their potential use as photothermal anticancer agents.
Finally, chapter 6, investigates the QR potential use as drug delivery vec-
tor for hydrophobic cancer drugs. The outlook of this thesis is towards
a very promising candidate for highly efficient targeted cancer treatment,
which natively incorporates multimodal tools for both cancer imaging and
therapy.
1.2 Nanotechnology
Nanotechnology is a rapidly expanding field, encompassing the develop-
ment of man-made materials in the 5 nm to 200 nm size range. These
dimensions vastly exceeds that of standard organic molecules, but its lower
range approaches that of many proteins and biological macromolecules
(Figure 1.1).[9] When working with materials of nanoscale dimensions, of-
ten the properties of the nanomaterial are different to those of the bulk
material, whose characteristic length scale is bigger. As the size of the
materials tends towards the nanoscale, the percentage of atoms at the sur-
face increases and, consequently, the surface-to-volume ratio increases.[11]
Because the surface atoms are not subjected to the same environmental
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Figure 1.1: Scale comparing the dimensions of organic molecules and
biological entities with examples of nanomaterials.
stress as those in the core, the nanoparticle (NP) surface atoms tend to
express different physical properties. Where the composition of the core
determines many intrinsic material properties, such as plasticity, hardness
and conductivity, the atoms on the surface of nanomaterials have boundary
properties that are determined by the characteristics of the particle in isol-
ation plus properties arising from its interaction with other materials.[11]
Furthermore, the boundary properties may be amplified in any interaction
involving NPs, as the ratio of atoms on the surface to atoms in the bulk
becomes greater. This interesting physical behaviour can be ascribed to
quantum-mechanical rules, such as quantum confinement, superparamag-
netism and surface plasmon resonance.[10, 11]
In biology, the ability to exploit the phenomena associated with NPs re-
quires the functionalisation of the particles surfaces by either direct chem-
ical modification or by the association of molecular ligands.[9] For ex-
ample, biomolecule-metal or biomolecule-semiconductor NP hybrid sys-
tems combine the recognition and catalytic properties of biomolecules with
the distinctive electronic and optical properties of NPs.[14] Furthermore,
biomolecule-coupled NPs (metal or semi-conductor) are employed as nano
connectors that activate redox enzymes as well as optical or electrical labels
for biorecognition processes.[14] Next to that, peptide/protein-conjugated
AuNPs can be used to specifically target the cell nucleus using peptide se-
quences from various animal virus proteins.[32] Combining unique proper-
ties enables new possibilities for developing advanced electronic and optical
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biological targeted systems.
1.2.1 Gold Nanoparticles
With the emergence of nanoscience and nanotechnology, gold is increasingly
becoming a key material for use in NP systems due to a variety of highly
attractive properties.[11,23,33] AuNPs or gold colloids are the most stable
metal NPs and present fascinating properties, which offer researchers great
possibilities in the bottom-up approach for biology. For instance, AuNPs
exhibit useful optical properties and are used in sensors for detecting nu-
merous disease-related enzymes and proteins.[15,18,34] Furthermore, gold
is a reasonably inert material.[11, 35] It does not oxidise at temperatures
below its melting point and is not reactive with most chemicals or atmo-
spheric dioxygen.[35] These favourable properties facilitate easy handling
and manipulation of samples under atmospheric conditions, such as mi-
crofabrication and biology.[35] Besides, gold binds thiols with high affinity,
which is of practical convenience for the formation of self-assembled mono-
layers (SAMs).[35, 36] The simplicity of AuNPs synthesis[37–39] and the
ease with which their properties can be tailored, makes AuNPs highly at-
tractive in nanotechnology-based applications.[40]
Monolayer protected AuNPs are now routinely prepared by a wide variety
of colloidal methods, which provide the ability to readily functionalise the
gold with both hydrophobic and hydrophilic surface ligands. The prepar-
ation of AuNPs commonly involves the chemical reduction of gold salts in
aqueous, organic, or mixed solvent systems. However, as the gold surface
is extremely reactive under these conditions, aggregation occurs.[9] To cir-
cumvent this problem, AuNPs are regularly reduced in the presence of a
stabiliser, which binds to the surface and prevents aggregation via favour-
able cross-linking and charge properties.[9, 11, 41] Several capping ligands
exist for passivation of the AuNP surface, including thiols, amines, phos-
phines and a range of polymers or dendrimers.[11] Historically, AuNPs
were discovered by Faraday in the 19th century.[42] However, the simplest
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method of synthesising AuNPs, which involved the citrate reduction of gold
salt in water, was developed by Turkevich in 1951,[43] and updated by
Frens in 1973.[44] These AuNP synthesis methods provide approximately
spherical AuNPs with a size range of 10 nm to 100 nm and reasonably low
polydispersity.
An important advance in the fabrication of stable AuNPs was introduced by
Brust et al. in 1994,[38] who first synthesised stable alkanethiol-protected
AuNPs using a two-phase reaction process, which was later extended to a
single-phase system (Figure 1.2a).[45] By modifying this method, AuNPs
have been successfully synthesised using numerous biomolecular coatings.[37,
46, 47] More recently, Zheng et al.[48] introduced a one-phase synthesis
method for fabricating AuNPs using amine-borane complexes as redu-
cing agents (Figure 1.2b). Amine-borane complexes are weaker reductants
compared to conventional reducing agents, such as sodium borohydride
(NaBH4). By slowing down the reduction of gold cations, amine-borane
complexes enable greater control over the growth of the AuNP. Using this
method, Zheng et al. were able to synthesise different AuNPs with a size
range of 2 nm to 10 nm and narrow size distributions.[48] The strength of
all these gold synthesis techniques are:
• The synthetic processes are easily scalable;
• The mild synthetic conditions allow for a wide range of ligand func-
tionalities;
• Gold core dimensions can be tailored by varying the ratio between
the gold salt and the ligand ratios, reaction time and/or temperature.
One of the most commonly used properties of nanoscale gold is its in-
tense and environment-sensitive optical absorption, which allows AuNPs to
provide the basis for a wide range of applications. Well-dispersed AuNPs,
or other metal NPs (e.g. silver, copper), exhibit intense optical extinction
spectra due to localised surface plasmon resonance (LSPR). LSPR arises
due to coherent, collective dipolar oscillations of conduction band electrons
on the NP surface, induced by an irradiating electromagnetic wave, and res-
ults in an intense absorption band called the surface plasmon absorption
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Figure 1.2: Schematics representing the syntheses of thiol-protected
AuNPs using (a) the Brust-Schiffrin reaction and (b) the Stucky reaction.
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band (Figure 1.3). This phenomenon is the consequence of the quantum
size effect where the de Broglie wavelength of the valence electrons is of the
same order as the size of the particle itself.[11, 49,50]
The basis of the surface plasmon resonance band was first rationalised by
Mie in 1908.[51] Mie’s theory solves Maxwell’s equations for small spher-
ical particles assuming that the particles’s diameter, d, is significantly
lower than the wavelength of the incident light, λ (quasistatic approxima-
tion).[1, 41] It should be noted that Mie’s theory only explains the optical
behaviour of small particles with simple morphologies (e.g. spherical, rod-
like) of characteristic dimensions above 10 nm.[49,52] For smaller particles
other effects, such as quantum confinement effects, need to be taken in
account.[49,52] However, for these small objects, Mie’s solution provides a
relationship between the extinction cross-section, σ = σa + σs, (σa and σs
are the absorption and scattering cross-sections, respectively) as a summa-
tion over all electric and magnetic oscillations.[1, 41]
 σa =
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where εm and ε = ε1 + iε2 are the permittivity of the surrounding medium
and metal particle, respectively. Therefore, according to the quasistatic
approximation of Mie theory for small particles, the LSPR peak occurs
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Figure 1.3: Schematic of plasmon oscillations of a metal nanosphere in
response to an incident electric field. Adapted from [1].
when the NPs extinction cross-section is maximised. This condition is
satisfied when |ε+ 2εm| is minimised. The bulk plasmon resonance occurs
when the real component of the metal permittivity crosses zero. Thus,
the spectral properties of plasmonic NPs depend, very sensitively, on their
dielectric function.
All metals possess these optical characteristics but gold, silver and cop-
per have their LSPR absorption predominantly in the visible region of
the electromagnetic spectrum.[53] The intensity and wavelength of the ab-
sorption maximum is not only size dependent, but also depends on the
size distribution, the environment and the particle shape.[53–56] As the
surface plasmon is sensitive to its direct environment, it is also sensit-
ive to the SAM molecules capping the AuNP surface and, in particular,
their dielectric constant (as demonstrated in the previous paragraph). For
instance, electron-donating ligands, such as alkanethiols, induce a batho-
chromic shift of the plasmon band, whereas electron-accepting ligands, such
as phosphines, induce a hypsochromic shift.[12, 57] Therefore, absorbance
measurements of the surface plasmon resonance can be used to detect ag-
gregation or even size changes due to the conjugation of biomolecules to
the metal surface.[15,18,34,58]
Nevertheless, before being able to use the properties of inorganic AuNPs in
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any biological system, it is necessary to modify the gold surfaces with mo-
lecules that can act as a bridge between the inorganic and organic systems.
One way to functionalise AuNPs is by using so-called place-exchange re-
actions, as gold shows a strong affinity towards thiols, disulphides, amines
and phosphines.[11] Using derivatives of these ligands, a monolayer of con-
jugated functional ligands can be deposited onto a gold surface.[37, 46, 47]
The exact composition of the immobilised layers can be controlled by using
the natural equilibrium established between the ligands initially present on
the NP surface and those present in the surrounding medium.[37,59]
1.2.2 Gold Quantum Dots
While Mie’s theory explains the optical behaviour of metal NPs for particles
exceeding 10 nm in diameter, the photonic properties of NPs below that
size (metal QDs) are poorly understood.
In noble metal NPs (> 10 nm in diameter), the LSPR can largely be
described using a classical picture of electrons whereas in quantum dots
(QDs) the optical extinction and photoluminescence characteristics are gov-
erned by quantum confinement effects.[49,52] Experimental studies of metal
QDs are extremely challenging as optical detection is made difficult by the
AuQDs diminishing absorption and scattering intensities, which are pro-
portional to the third and sixth power of the particle’s radius, respectively
(c.f. equation 1.1).[1, 41] As a result, conflicting observations are reported
on metal QDs, showing either a decrease (blueshift) or an increase (redshift)
in the LSPR for reduced metal QD dimensions. While Genzel et al. repor-
ted a blueshift of approximately 15 nm for glass-embedded AgQDs with
diameters ranging from 10 nm to 2 nm,[60] Peng et al. reported a redshift
of approximately 43 nm for oleylamine-stabilised AgQDs with diameters
ranging from 18 nm to 2 nm.[61]
Due to the difficulties in experimentally exploring the photonic properties
of metal QDs, theoretical models were developed. Although computer-
assisted models, such as density functional theory (DFT), have been used
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to predict metal QDs properties,[2,62] these theoretical approaches are lim-
ited to particles smaller than 2 nm due to high computational demands.[49]
AuQDs of less than 2 nm exhibit discrete electronic structure and molecule-
like properties,[63] such as a HOMO-LUMO transition of one electron,
which is in contrast with the collective-electron plasmon excitation in larger
NPs. The free electron theory can be used to estimate at what size AuNPs
will exhibit distinct quantum effects. The average spacing, δ, between elec-
tronic energy levels roughly follows the following relation:[64]
δ =
Ef
N
where Ef is the Fermi energy and N is the number of gold atoms.
Therefore, assuming that the electronic energy quantisation becomes dis-
tinct for:
δ ≥ kBT
N ≥ Ef
kBT
(1.3)
At room temperature (∼ 298 K) and inputing the Ef of gold (5.5 eV), this
equates to a critical number of gold atoms Nmax of 300 atoms, which is
equivalent to roughly 2 nm in diameter.[52] This rationale demonstrates
that for AuNPs of less than 2 nm, the collective plasmon mode will not be
supported, as the electronic energy quantisation is not sufficiently import-
ant.
Whetten et al. were the first to isolate and characterise distinct popula-
tions of AuQDs ranging from 1 nm to 3.5 nm.[65,66] They observed critical
sizes with discrete core masses from 5 kDa to 93 kDa. The obtention of
truly monodisperse AuQDs (denoted AunRm, where n is the number of
gold atoms and m is the number of ligands) as well as the reliable de-
termination of the number of gold atoms composing the AuQD remains a
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Figure 1.4: Crystal structure of a Au25(SR)18 gold quantum dot.
Au25(SR)18 is based on a core-shell striker with (a) a centred icosahedral
Au13 core surrounded by (b) a Au12 exterior shell protected by (c) 18
thiolate ligands arranged in six ’staple’ motifs -S-Au-S-Au-S-. Adapted
from [2].
challenge.[2] For instance, Link et al. erroneously assigned Au25(SG)18to
Au28(SG)16 due to insufficient mass spectrometry resolution at the time
of the study.[67] Jin et al. were the first to report a kinetically controlled
method to obtain high purity Au25(SR)18 using a size-focusing method,
which proved to be be applicable to other AuQDs.[68–70] However, to date,
the most studied AuQDs remain Au25(SR)18. Zhu et al. used a combin-
ation of x-ray crystallography and DFT analysis to determine the crystal
structure of Au25(SR)18 (Figure 1.4). They showed that, compared to the
face-centred cubic (fcc) structure of bulk gold,[52] Au25(SR)18 is based on
a core-shell structure with a centred icosahedral Au13 core (Figure 1.4a),
which is capped by an Au12 exterior shell composed of six ‘staple’ motifs
of -S-Au-S-Au-S- (Figure 1.4b), while the whole cluster is encapsulated by
eighteen thiolate ligands (Figure 1.4c).[2]
The resolving of the crystal structure of Au25(SR)18 permitted the in-
depth investigation of the electronic structure and optical properties of
the AuQD by computational methods. Using DFT, the electronic struc-
ture of Au25(SR)18 was calculated (Figure 1.5a) and a theoretical absorp-
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Figure 1.5: (a) Kohn-Sham orbital level diagram and (b) peak
assignment for the UV-Vis absorption spectrum of Au25(SR)18 gold
quantum dots. Adapted from [2].
tion spectrum was predicted (Figure 1.5b), which correlated well with ex-
perimental observations.[69–73] The multiple absorption bands are due to
single-electron transitions between quantised electronic energy levels, which
is different in nature to the collective oscillation observed with the LSPR
of larger AuNPs.[49,52,74]
In addition to the absorption bands of AuQDs, their photoluminescent
properties have attracted a lot of attention, especially for application in
biology and sensing.[75] However, the origin of their luminescent nature is
still not clearly understood.[73, 76–78] Luminescence in AuQDs has been
shown to originate both from the gold core and the interactions between
the gold core and surface ligands.[77–79] Even less clearly understood is the
magnetic nature of some AuQDs, as many contradicting studies were re-
ported in the literature.[12] Compared to diamagnetic bulk gold, AuQDs of
different sizes and surface functionalisation can exhibit magnetic polarisa-
tion.[12] Most AuQDs characterisation has been undertaken using super-
conducting quantum interference device (SQUID) magnetometers.[12, 80]
These studies observed that the magnetic moment of AuQDs displays very
weak or no temperature dependence between 2 K and 400 K and the mag-
netisation curve shows either paramagnetic- or soft ferromagnetic-like be-
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haviours.[12] All these properties, if better understood and characterised,
could offer unprecedented opportunities for applications in biology, cata-
lysis and quantum optics.[49]
1.2.3 Multifunctional Hybrid Systems
Recently, new emphasis has been placed on composite NPs, where com-
binations of different types of nanostructured materials are used to create
multimodal systems that exhibit the beneficial properties of the compon-
ent modules.[81, 82] In particular, rattle-type NPs, which are NPs with a
core-shell structure containing a distinctive void that separates the core ma-
terial from the shell (Figure 1.6), have already been extensively investigated
for a variety of applications ranging from catalysis, lithium-ion batteries,
solar cells, drug delivery, biosensing and surface-enhanced Raman scatter-
ing (SERS).[83–88] Compared to core-shell particles, rattle-type NPs have
not only the advantage of a useable hollow cavity, but they also allow added
tailorability and functionality through the free floating core. More recently,
in the biomedical field, multifunctional NP systems have gained increasing
interest for targeting, imaging and drug delivery purposes.[33,86,89–92]
In 2003, Xia et al. were the first to demonstrate the synthesis of gold-
polymer rattle-type NPs[93] and, since then, the development of other
rattle-type systems has grown enormously, offering a wide variety of core
and shell compositions as well as a wide range of sizes, shapes and struc-
tures.[94,95] Different materials, including metal oxides, metals, silica, car-
bon and polymers, have been used both as core and shell material in rattle-
type systems.[84,86,93] Furthermore, rattle-type systems with multilayered
shells or multiple cores were developed (Figure 1.6b-c).[96,97] By synergist-
ically combining nanostructured materials, the resulting system not only
exhibits the linear combination of the components properties but also emer-
gent properties of its own.
Rattle-type systems can be prepared through a variety of different tech-
niques, including selective etching or dissolution, bottom-up approaches by
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Figure 1.6: Schematic illustrations of rattle-type particles with different
morphologies. Rattle-type particles with (a) a single core, (b) multiple
cores and (c) multiple shells. Adapted from [3].
soft templating assembly, ship-in-bottle methods, Ostwald ripening meth-
ods, galvanic replacement processes and Kirkendall effect based methods.[3]
The most commonly used methods are etching procedures[91, 98, 99] and
soft template approaches.[5,97] The selective etching process relies on coat-
ing pre-synthesised core materials with one or two layers of different ma-
terials before either removal of the sacrificial connecting layer or etch-
ing of the core by either dissolution or calcination (Figure 1.7a). This
method was used to create gold-silica rattle-type particles with spherical
(Figure 1.7c-d) and rod-like morphology for catalysis and cancer therapy,
respectively.[4, 91] However, these selective etching based methods usually
involve multiple complex steps, making the scaling-up of such processes
difficult. Furthermore, for biomedical applications, the thorough removal
of all traces of etchant can be challenging, but nevertheless critical con-
sidering the cytotoxicity of rattle-type systems produced through selective
etching processes.
The soft template methods can be easily scaled up and have been repor-
ted for the preparation of gold-silica rattle-type particles used in catalysis
(Figure 1.7e-f).[5] These methods rely on micelles, vesicles or microemul-
sions as soft-templates for the assembly of inorganic nanomaterials and
are useful for the preparation of rattle-type particles composed of porous
shells.[100,101] However, as for the etchant in the selective etching method,
all traces of the toxic surfactant need to be removed before any possible
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Figure 1.7: Schematic illustrations for preparing gold-silica rattle-type
particles employing (a) etching strategies and (b) soft templating
methods. (c-d) Transmission electron microscopy (TEM) images of
Au@SiO2 nanorattles obtained through etching with KCN at different
concentrations, resulting in varying gold core diameters. Scale bars:
200 nm. (e-f) TEM images of Au@SiO2 nanorattles obtained through soft
templating method using different concentrations of the initial gold salt
solution to vary the final gold loading. Scale bars: 20 nm. Adapted from
[3–5].
use of the produced system in biomedical applications.
1.3 Nanoparticles for Cancer Treatment
Although large amounts of funding is injected into cancer research, cancer
remains one of the leading causes of death worldwide.[22] Much promising
cancer research has been developed over recent years, however, transla-
tion of this laboratory knowledge to functional clinical technology remains
slow.[24] This translational clogging effect is mainly due to inadequacies
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in the ability to administer therapeutic agents so that they will selectively
reach the diseased tissue without causing negative side effects.[24,102,103]
To minimise the collateral damage induced by systemic therapeutics, drugs
can be administered in a specific and targeted manner.[104,105] In order to
improve the targeting potential and efficacy per dose of imaging or thera-
peutic agent, two main synergistic goals should be striven for:
• Increase the agent targeting selectivity;[106]
• Overcome the biological barriers of the body that prevent the agent
from reaching its target.[107]
The ideal therapeutic agent allows for efficient and specific targeting of
cells at an early stage of cancer development.[6, 7] To this end, nanotech-
nology offers many advantages that can contribute to improved targeting
as well as the development of tools to overcome the biological barriers pre-
venting efficient drug delivery.[6,108] In particular, NP-based systems have
been widely investigated for both active and passive targeting approaches
of cancer cells.[25,28,109–111] Active targeting depends on the integration
within the therapeutic system of recognition moieties, which have been
shown to target cancer-specific biomarkers.[25] Ligands that have been
functionalised to nanosystems for active tumour-targeting applications, in-
clude epidermal growth factor (EGF) receptors (EGFR), hypoxia-inducible
factor 1 alpha (HIF-1α) and αvβ3 and αvβ5 integrins.[25] However, these sur-
face modifications increase the overall complexity of the NP system.[112]
Passive targeting, on the other hand, relies on the agents physicochem-
ical properties to reach the tumours. By employing the enhanced per-
meability end retention (EPR) effect, size-dependent accumulation of NPs
can be achieved in cancer cells (Figure 1.8).[110, 111, 113] The EPR effect
happens because malignant cells replicate at a higher rate than healthy
cells[6, 25]. As the accelerated growth of the tumour leads to an increase
in nutrient demand, tumours develop their own vasculature (angiogenesis)
through which increasing amount of blood can be supplied.[6,25] However,
this accelerated angiogenesis is carried out in a highly disordered man-
ner, resulting in gaps in the endothelium that allow the preferential pen-
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etration and accumulation of nanosized objects with diameters between
60 nm and 400 nm.[25, 113, 114] Additionally, the diminished lymphatic
drainage is responsible for the retention of the nanosized objects in the tu-
mour.[6,25] Both active and passive targeting approaches have been shown
to successfully accumulate AuNPs in tumours, reaching NP concentrations
up to 13% and 5% by weight, respectively, after systemic injections in
vivo.[109–111] Since NPs have proven to be eligible for selective targeting,
a wide variety of NP systems have been explored for cancer diagnosis and
therapy.[7, 23, 28,115]
1.3.1 Diagnosis for Cancer Treatment
Early identification and localisation of cancerous tumours is critical to im-
prove the success of cancer therapy and patient survival rates.[115, 116]
Various imaging techniques have been developed to visualise tumours, in-
cluding nuclear imaging (positron emission tomography, PET), x-ray com-
puted tomography (CT), ultrasound imaging (US), magnetic resonance
imaging (MRI) and optical imaging.[117] Those five imaging techniques
can be separated into two categories: morphological imaging techniques,
characterised by high spatial resolution (CT, US and MRI); and molecu-
lar imaging, characterised by sensitive detection of molecular or cellular
changes (PET and optical imaging).[117, 118] These techniques have their
own inherent advantages and limitations (Figure 1.9), but all contribute
importantly to cancer diagnosis in the clinic. Nevertheless, in the past
few years, optical imaging has emerged as a promising non-invasive and
real-time modality for cancer detection.[115, 119, 120] Compared to other
imaging technologies, such as MRI, CT, PET and US,[121–124] optical
imaging is based on the detection of the luminescence of either specific in
vivo reactions or targeting probes. Due to its high sensitivity, multiplex de-
tection abilities and low equipment cost, optical imaging is highly suitable
for cancer diagnosis (Figure 1.9).[75,120]
To be more specific, optical imaging is an imaging technique that makes
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Figure 1.8: Enhanced permeability and retention (EPR) effect. (a)
Vasculature in normal tissues is tight, preventing targeting nanoparticles
from penetrating and extravasating. (b) Vascular walls in tumour tissue
have multiple narrow slits and are leaky and thus hyperpermeable to
nanoparticles (60 nm to 400 nm), which preferentially accumulate in the
tumour. Adapted from [6]
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Figure 1.9: Advantages and limitations associated with different imaging
techniques. Adapted from [7].
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use of electromagnetic light waves (visible, ultraviolet or infrared) to visu-
alise specific entities and can be categorised into bioluminescence imaging
and fluorescence imaging.[7] Bioluminescence imaging employs the light
emission generated by specific chemiluminescent enzyme reactions and has
been mainly applied to monitor events, such as transgene expression, trans-
plantation, toxicology, viral infections, and gene therapy.[125] Biolumines-
cence imaging allows real-time, rapid and easy simultaneous localisation
and quantification of biological processes in vivo.[126] Unlike biolumin-
escence imaging, fluorescence imaging relies on the detection of photon
emissions that are generated by fluorescent probes, which emit light at one
wavelength in response to excitation by light at a different wavelength.
This technique has been widely applied in the early detection of disease by
using fluorescent proteins possessing inherent multiplexing abilities, which
can be differentiated by colorimetry (i.e. different emission wavelength of
the proteins).[115,119,120,127,128]
The limitation of fluorescence imaging is the use of visible light as the
visualisation signal, which has especially low penetration depth due to the
high absorption of living tissues in the visible light range (Figure 1.10).
To circumvent this problem, more and more studies focus on the use of
near-infrared (NIR) imaging systems. Near-infrared (NIR) light and, in
particular, NIR light in the so-called ’bio-window’ (650 nm - 900 nm) is
minimally absorbed by biological tissues and physiological fluids (e.g. skin
and blood) (Figure 1.10).[6, 7, 23, 28, 115, 129] This lack of absorption in
the NIR bio-window enables NIR light to penetrate deeper into living tis-
sues compared to visible light.[6, 130] Lasers of microwatt power densit-
ies have been reported to penetrate almost 7 cm through muscle tissues
and 10 cm through breast tissue.[6, 130] Over the years, many different
types of fluorescent probes have been developed for the visualisation of
tumours.[131, 132] Conventionally, organic fluorophores are used as NIR
probes for fluorescent imaging.[116, 119, 133] However, these organic fluor-
escent probes have many drawbacks, such as low water solubility and low
chemical- and photostability, which makes them unsuitable for long-term
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Figure 1.10: Wavelength range of the near-infrared (NIR) tissue
transmission window. Photothermal therapy and optical diagnostic
imaging are most efficient in the 650 nm to 900 nm spectral range due to
minimal light absorption by haemoglobin (< 650 nm) and water
(> 900 nm). Adapted from [8].
molecular imaging.[115,133,134] Moreover, the fluorophore detection sens-
itivity is relatively low, and the cytotoxic effects of many fluorophores are
still unknown.[75]
Recently, a lot of emphasis has been placed on nanotechnology-based ap-
proaches to improve the detections limits and clinical efficiency of NIR
imaging.[7, 24] Moreover, the significant progress made in nanotechnology,
makes NP-based NIR probes promising agents for early diagnosis, therapy
and prevention of diseases.[7] NP probes are of particular interest for cancer
diagnosis, as the NPs can accumulate in the tumours by exploiting the en-
hanced permeability and retention (EPR) effect (passive targeting) or the
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specific binding between the tumour cell receptors and biofunctionalised
NPs (active targeting).[115] Many different kinds of nanostructures, such
as quantum dots (QDs) and gold-based NPs, have been designed and tuned
to enable NIR live imaging as well as targeting.[135, 136] Semiconductor
QDs have been extensively researched and are currently the fastest growing
imaging agent due to their highly attractive optical and structural prop-
erties.[75] In particular, semiconductor QDs possess high quantum yields
and photostability.[75] Multifunctional NPs, based on encapsulated semi-
conductor QDs inside triblock copolymers, have been developed for live
imaging and targeted (active) drug delivery applications.[135,137] However,
the inherent toxicity of semiconductor QDs still needs to be overcome be-
fore successful translation into clinical use.[138] By comparison, gold-based
nanostructures, such as nanorods and nanoshells, are attractive for op-
tical imaging due to their good biocompatibility, unique optical/electronic
properties and tuneable surface plasmon resonance in the NIR.[136, 139]
However, these gold-based probes depend on the functionalisation or associ-
ation to a fluorophore in order to enable fluorescence imaging. Noble metal
quantum dots (e.g. AuQDs, AgQDs), on the other hand, exhibit a native
photoluminescent emission in the NIR, which makes them a highly attract-
ive candidate for NIR fluorescent imaging.[75,140–142] Then again, AuQDs
are inherently unstable in biological environments and, therefore, require
stabilisers or carriers.[75, 142] The few studies that have explored the use
of AuQDs for cancer imaging applications, employ protein carriers to mod-
ulate the interaction of the AuQDs in vitro and in vivo, which can impair
their biocompatibility.[75, 142] Finally, AuQDs can also possess paramag-
netic properties, which, in combination with their NIR photoluminescence,
make them ideal systems for multimodal imaging applications.
Multimodal imaging offers the advantage of combining the advantages of
two or more imaging techniques, while diminishing each others limitations.
To tackle an issue as complex as the diagnosis of cancer, there is no single
technique available that provides all the answers. Therefore, merging to-
gether different imaging modalities might be a powerful strategy to improve
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imaging quality and efficiency as well as offering possibilities for early and
reliable cancer diagnosis. For example, the combination of magnetic and
optical imaging provides multimodal systems that possess the advantages
of both imaging modalities, such as high spatial and temporal resolution
(MRI) and high sensitivity (NIR fluorescence imaging).[136, 143] To date,
many nanocomposite systems combine gold and iron to create multimodal
imaging probes.[144] However, due to their different surface crystal struc-
tures these elements are not compatible with each other. Therefore, many
approaches employ a dielectric material as an intermediate (e.g. silica).[7]
Although multimodal MRI-optical imaging has been demonstrated to be
feasible,[136, 145–147] it is still challenging to engineer simple, robust and
reliable synthesis pathways that achieve high performance imaging sys-
tems.
1.3.2 Photothermal Therapy
Photothermal therapy (PTT) is a cancer treatment that relies on selective
targeting or increasing the sensitivity of cancer cells to cytotoxic damage
using heat.[6] PTT has become increasingly popular mainly due to the fact
that localised photoenergy is delivered directly to the tumour, resulting
in a less invasive alternative to conventional cancer therapies, such as sur-
gery and non-targeted chemotherapy.[92] PTT causes an increase in the
temperature of in vivo tissues, which can be used to selectively destroy
tumours because of their reduced heat tolerance compared to healthy tis-
sue.[6,148,149] By heating tissues to temperatures between 42 °C and 46 °C
(so-called hyperthermia),[150] the healthy tissue remains intact, whereas
the cancerous tissue is killed.[6, 148,149]
Gold nanoparticles have generated significant interest for their use as pho-
tothermal agents due to their high photostability and strong plasmonic
properties .[23, 54, 92] The AuNPs either absorb or scatter incoming light,
which can be harnessed to destroy tissue by local heating.[129] The surface
plasmon resonance of AuNPs exhibits a more sensitive response to environ-
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mental changes than traditional photothermal agents, like light-absorbing
dyes.[129, 148, 151] Such enhanced sensitivities make AuNPs particularly
useful as optical probes for PTT.
As mentioned before (c.f. section 1.3.1), only NIR light penetrates suf-
ficiently through blood and soft tissues.[6, 23, 28, 115, 129] AuNPs, how-
ever, mainly absorb light in the visible region of the electromagnetic spec-
trum.[28] In order to shift the AuNP plasmon resonance towards the NIR
bio-window, many NP systems have been developed, including gold nano-
shells, gold nanocages and gold nanorods.[109,139,152–157] Table 1.1 sum-
marises the advantages and limitations of these gold-based platforms for
cancer treatment.[109,139,153,156–160] By tailoring the composition, size
or shape of these NPs, absorbance in the NIR can be obtained.[152,153,161–
163] In particular, the elongated shape of gold nanorods offers very strong
absorption cross-sections and heats faster than gold (-silica) nanoshells or
nanocages.[10, 164–167] The recent advance to clinical trials of some gold-
based systems (Nanospectra Bioscience and CytImmune) shows the pro-
gress made in the exploitation of the plasmon resonance of AuNPs in pho-
tothermal therapeutic medicine and the great potential for gold NPs to
improve cancer treatment.[29,50]
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1.3.3 Chemotherapy
The treatment of cancer with drugs, chemotherapy, is one of the most
well-established cancer treatments available today, and is currently used
alongside radiotherapy and surgical ablations to treat most types of can-
cer.[7,144,168,169] However, all these treatments have inherent limitations
and are associated with negative side-effects, which significantly reduces
the quality of life of the patients.[25, 170] For example, most chemother-
apy drugs are injected systemically in the blood stream, which induces
collateral damage to healthy tissue.[23, 25, 170] Currently, at best 0.01%
of intravenously administered monoclonal antibodies reach their targets in
vivo.[171] The inherent lack of specificity of systemic chemotherapy not
only diminishes the efficacy of the treatment but also drastically reduces
the cost-effectiveness of the treatment.
The emergence of nanotechnology has played a crucial role in the de-
velopment of new cancer therapeutics.[7, 23–28] Nanotechnology has en-
abled passive or active targeting to be employed for selectively delivering
various drugs to tumours (c.f. section 1.3), thereby confining the treat-
ment to the tumour site.[25,28,109–111] Furthermore, the drug circulation
time can be increased by encapsulating the drug in a delivery vector (e.g.
mesoporous silica) or by coating the delivery vector (e.g. PEGylation on
AuNPs).[172]
A wide range of nanoparticles has been explored for drug delivery applic-
ations, including ceramics, liposomes, micelles and various types of inor-
ganic NPs (Figure 1.11). Polymeric NPs are one of the most established
nanomaterial drug delivery vectors due to the fact that they are biodegrad-
able, can be tailored through surface modifications, provide good pharma-
cokinetic control and can easily trap and delivery a wide range of antic-
ancer drugs.[9,21] Furthermore, polylactic acid- (PLA) and poly(lactic-co-
glycolic acid)- (PLGA) based NPs have been approved by the US Food
and Drug Administration (FDA) for use in humans. [9,21]. Liposomes and
micelles are composed of amphiphilic molecules, which self-assemble into
spherical structures. Liposomes are formed of concentric lipid bilayers that
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Figure 1.11: Various types of nanoparticle-based systems used in
biomedical research and drug delivery.[9]
can incorporate hydrophilic therapeutic agents in their internal spaces or
hydrophobic drugs within the bilayers.[173,174] Micelles are smaller (5 nm
- 10 nm) compared to liposomes (50 nm - 150 nm), but can incorporate
relatively larger amounts of poorly soluble hydrophobic anticancer drugs,
because their inner volume is composed of the hydrophobic tail of the sur-
factant constituent.[21] Drugs incorporated in liposomes or micelles have
the advantage that they can be slowly released in tumours, generating high
local dosages and, therefore, minimising side-effects.[173,174] The lipids of
the liposomes or micelles can then be readily dissociated and, subsequently,
harmlessly cleared by the body.[21, 173, 174] At the same time, the latter
advantage of these organic molecule drug delivery systems can also become
a drawback, as the liposome or micelle carrier might already be degraded
in vivo before reaching the tumour site.[9]
Mesoporous silica nanomaterials are showing great promise as potential
anticancer drug carriers due to their high surface area and tuneable size
and porosity, which offer a unique advantage for loading and releasing large
quantities of biomedical agents.[175–179] Furthermore, in contrast to or-
ganic drug vehicles, these NPs are not subjected to early enzymatic degrad-
ation.[9] The synthesis of mesoporous silica is based on sol-gel processes,
forming liquid-crystalline mesophases of amphiphilic molecules that serve
as templates for the condensation of orthosilic acid.[180] The synthesis can
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be performed in either acidic or basic conditions using different sources of
silica, such as sodium silicate or tetraethyl orthosilicate (TEOS).[180] Mo-
bile™ was the first to produce mesoporous silica particles with hexagonally
ordered mesopores (MCM-41) in 1992.[181] Since then, mesoporous silica
nanospheres (MSNs) have been highly attractive for drug delivery applic-
ations due to their low cytotoxicity and ease of surface modification for
improved internalisation.[182–184] In 2001, Vallet-Regi et al. showed that
MSNs could be used to deliver relatively large doses of drug in a controlled
manner.[185] More recently, Torney et al. developed responsive MSN-based
drug delivery vectors by using NPs caps or ‘gatekeepers’ (e.g. AuNPs,
Fe3O4 NPs oxide, semiconductor QDs) to trap drugs inside the silica pores.
Depending on the NP ‘gatekeepers’ used, the drug delivery system can be
tailored, and drug release can be triggered by changing the temperature, pH
or magnetic field.[186–188] Liu et al. reported on the use of multifunctional,
gold-coated, silica nanorattles for the combination of photothermal ther-
apy and chemotherapy.[189] This multimodal cancer treatment exhibited
enhanced overall therapeutic efficacy and reduced systemic toxicity.[189]
Such multifunctional nanostructured materials, which are able to combine
targeted diagnosis and therapy into one, integral system, can simultan-
eously image early tumour sites, deliver polyvalent payloads and kill cancer
cells in a controlled and verifiable manner.[30,91,190]
The nanoparticles used as examples in this introductory chapter, provide
just a glimpse of the huge potential hidden in the variable chemistry and
architecture of nanotechnology. This thesis goes on to develop and demon-
strate the flexibility and performance of a simple NP-based cancer treat-
ment approach that enables simultaneous imaging and multilayered ther-
apy. Yet, the details provided here only scratch the surface of what prom-
ises to be the beginning of a new era in the development of novel strategies
for combatting not only cancer, but many other diseases that aﬄict man-
kind.
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Chapter 2
Experimental Techniques
2.1 Microscopy
2.1.1 Transmission Electron Microscopy
Transmission Electron Microscopy (TEM) uses energetic electrons to provide
morphologic, compositional and crystallographic information of samples at
the nanoscale. A TEM functions under the same basic principles as an op-
tical microscope, however, in a TEM set-up, electrons replace photons, elec-
tromagnetic lenses replace glass lenses and images are viewed on a screen
rather than through an eyepiece (Figure 2.1).
The relatively large wavelength (400 nm to 700 nm) of light used to illu-
minate a sample in an optical microscope limits the ability to resolve detail
in that object. Theoretically, the maximum resolution, d, obtained through
a lens is proportional to the wavelength of the incident beam, λ, defined
by,
d =
λ
2n sinα
where n is the index of refraction of the medium and α is the half-angle of
the maximum cone of light that can enter or exit the lens.
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Figure 2.1: Comparison between optical microscopy, transmission
electron microscopy and scanning electron microscopy. Basic set-ups of
(a) an optical microscope, (b) a transmission electron microscope (TEM)
and (c) a scanning electron microscope (SEM).
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The idea of using electrons to magnify objects was realised after de Broglie
introduced particle-wave duality, showing that the wavelength of electrons
was many orders of magnitude smaller than that of light. De Broglie showed
that the wavelength of a particle and its momentum are inversely propor-
tional,
λ =
h
p
where p is the particle’s momentum and h is the Planck’s constant.
Furthermore, the momentum is by definition related to the kinetic energy
by,
p =
√
2m0E
where m0 is the rest mass of an electron and E the kinetic energy of the
accelerated electrons (E = eV , where e is the elementary charge and V is
the potential through which the electrons are accelerated)
Therefore, the wavelength of electrons in a TEM is related to the electrons
energy or the acceleration potential used to accelerate the electrons by,
λ =
h√
2m0eV
For particles travelling at speeds close of the speed of light in vacuum, c,
relativistic effects have to be accounted for. Then, the wavelength of the
electrons can be described by,[191]
λ =
h√
2m0eV (1 +
eV
2m0c2
)
(2.1)
In the TEM, electrons accelerated over a potential of 300 kV are travelling
at high velocities and, therefore, the relativistic wavelength becomes ∼
0.002 nm. During transmission, the velocity of electrons directly correlates
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to their wavelength. In other words, the faster electrons move, the shorter
the wavelength and the greater the resolution of the image. In TEM,
electrons typically have wavelengths over the range of 10-3 nm to 10-2 nm
(equation 2.1), which explains the much higher resolution obtained through
TEM compared to light microscopy.
Electrons are generated from either thermal sources or field emission sources.
Emitted electrons are accelerated through an electric field, typically between
80 kV and 300 kV. The higher the voltage, the better the theoretical resolu-
tion. The electron beam is initially focussed through a series of two or three
condenser lenses onto the sample. Subsequently, the forward scattered elec-
trons are focused by the objective lens onto the sample into a diffraction
pattern on the back focal plane of the TEM. After the back focal plane,
the first intermediate image is formed and the intermediate lens can be
used to form either an image or a diffraction pattern, depending on which
mode the TEM is set-up to operate, imaging mode or diffraction mode.
Finally, projection lenses are used to vary the magnification of the image
or diffraction pattern. The entire TEM column is kept under vacuum in
order to minimise interactions between the electrons and the gas molecules
in the column as well as to protect the electron source.
Contrast in the TEM image emerges from inhomogenous scattering of the
electrons by the sample and should not be confused with resolution. While
image resolution defines the ability to resolve adjacent features in an im-
age, the image contrast is defined by the difference in intensities between
these features. Different contrast mechanisms can contribute to the overall
contrast in an image, as scattering of the electrons can occur via different
processes. These processes are dependent on the atomic number, Z, the
density and the thickness of the sample. Consequently, three basic mechan-
isms contribute to contrast formation: mass-thickness contrast, phase con-
trast and diffraction contrast. Out of the three, mass-thickness contrast
is the most important when imaging biological samples. Mass-thickness
contrast appears when electrons are scattered off-axis by elastic scattering
events and reflects variations in the mass and the thickness of the sample.
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Areas of the samples that have a low mass-thickness scatter less strongly
and appear brighter in bright field TEM images.
In the case of scanning transmission electron microscopy (STEM) the in-
cident electron beam is focused into a spot, which is scanned over the
sample. Post-specimen detectors collect different scattered or unscattered
beams. The scattered or unscattered electrons are collected serially and the
image is displayed pixel by pixel. High angle annular dark field scanning
transmission electron microscopy (HAADF-STEM) only collects electrons
that are scattered to relatively high angles (e.g. 30 mrad) by Rutherford
scattering. At these angles the screening effect of the electron cloud can
be ignored.[191] The intensity in HAADF-STEM images is therefore de-
pendent on the square root of the atomic number of the sample, Z2. This
Z-contrast imaging is highly attractive for detecting gold nanoparticles and
heavy metal-stained organelles inside cells.
Additionally, in a TEM, the chemical composition of a sample can be de-
termined through energy dispersive X-ray spectroscopy (EDS). The prin-
ciple underlying the operation of EDS is the detection of X-rays that are
produced when the electron beam is accelerated onto the sample. The
electron beam excites the atoms in the sample that subsequently produce
X-rays with discrete energies that are different for every element and, there-
fore form a chemical fingerprint of the sample. The number and energy of
the X-rays emitted from the specimen are then measured by a detector re-
cording an energy spectrum of intensity versus energy. The characteristic
energy distribution in the spectrum provides information about the com-
position of the sample being studied, and the intensity of the peaks provides
information about the amount of each element present in the sample.
TEM and STEM images are used extensively in nanomedicine research as
they can provide visual evidence of the distribution and morphology of
assembled nanostructures inside biological entities. In this thesis, three
TEM microscopes were used to investigate the morphology and composi-
tion of the Quantum Rattles (QRs) as well as their internalisation in cells,
namely, a JEOL 2000 TEM, a JEOL 2010 TEM and a FEI TITAN 80/300
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Cs aberration corrected TEM/STEM.
2.1.2 Laser Confocal Scanning Microscopy
A confocal laser scanning microscope (CLSM) creates sharp, detailed 2D
images by incorporating two principal ideas: point-by-point illumination
of the sample and filtering of out-of-focus light.[192] In the set-up of the
confocal microscope (Figure 2.2), laser light is directed by a dichroic mir-
ror towards an assembly of horizontally and vertically scanning mirrors.
The motor-driven mirrors scan the laser through the microscope object-
ive across the sample, where the light excites the fluorescent sample. The
fluoresced light is de-scanned by the same mirrors used to scan the sample,
passes through the dichroic mirror and, finally, through a pinhole placed in
the conjugate focal plane of the sample. This pinhole filters all out-of-focus
light arriving from the sample, after which a detector, such as a photomul-
tiplier tube (PMT), collects the remaining focused light emerging from the
pinhole. By excluding the light that is not in the focal plane, sharper and
better-resolved images are obtained compared to conventional fluorescence
microscopy. As only one point of the sample is observed at any particular
instant, a computer is connected to the detector to reconstruct a 2D im-
age one pixel at a time. The resulting confocal 2D images represent thin
cross-sections through the sample. By assembling a series of these slices at
different depths, a 3D reconstruction of the sample can be built.
CLSM represented a revolution in numerous biological science disciplines,
from cell biology and genetics to microbiology and developmental biolo-
gy.[193, 194] The combination of confocal microscopy and fluorescent mo-
lecules allows visualisation of alive and fixed cells, thereby investigating,
for example, protein trafficking, cellular organisation, organelle dynamics,
apoptosis, membrane fluidity, and enzymatic activity. A great variety of
fluorescent probes are currently available, ranging from molecular dyes to
gold nanoparticles.[75,116] In this thesis, confocal microscopy was used for
the 2D and 3D mapping of the QR internalisation and dynamics in cells
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Figure 2.2: Basic set-up of a confocal microscope. Light from the laser
(blue line) is scanned across the specimen by the scanning mirrors.
Optical sectioning occurs as the fluoresced light (green line) passes
through a pinhole before reaching the detector.
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using a Leica SP5 MP/Flim inverted confocal microscope.
2.2 Spectrophotometry
2.2.1 UV-Visible Spectroscopy
UV-Visible spectroscopy measures the attenuation in intensity of incident
light, in the ultraviolet (UV) and visible ranges of the electromagnetic
spectrum, upon passing through a sample analyte relative to a reference.
This attenuation is due to the extinction of light by the sample arising from
electronic transitions to an excited state and scattering phenomena. The
UV-Vis spectrometer uses a light source to irradiate a solution of interest,
such as an incandescent bulb for the visible range and a deuterium arc lamp
for the UV region, and monitors the transmittance of the sample depending
on the incident wavelength, λ. The spectrometer uses a diffraction grating
or monochromater to separate the different wavelengths and directs them
at a photodiode or charge-coupled device (CCD) that detects the intensity
over the spectral range (Figure 2.3).
The transmittance, T (λ), is defined by,
T (λ) =
I(λ)
I0(λ)
where I(λ) is the intensity of the light transmitted through a sample as
a function of λ and I0(λ) is the intensity of light transmitted through a
reference as a function of λ.
For analytes, where scattering is negligible compared to absorption, the
absorption, A(λ), is defined by Beer-Lambert’s law,
A(λ) = log
(
1
T (λ)
)
= ε(λ)cl
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Figure 2.3: UV-Vis spectrophotometer basic set-up.
where ε(λ) is the molar extinction coefficient as a function of λ (M-1.cm-1),
c the molar concentration of the absorbing species (M), and l is the ab-
sorption pathlength (cm).
Therefore, UV-Vis spectroscopy enables the acquisition of the absorption
spectrum of analyte by monitoring the intensity of light transmitted through
a sample and a reference.
A(λ) = log
(
I0(λ)
I(λ)
)
(2.2)
For analytes with known molar extinction coefficients, the concentration
of a sample can also be determined by UV-Vis spectroscopy from Beer-
Lambert’s law. It should be noted that for species where the scattering is
not negligible compared to absorption, such as metal or silica NPs, the UV-
Vis spectrometer monitors the extinction spectrum (sum of the absorption
and scattering spectra) of the NPs and not the absorption alone. In this
thesis, UV-Vis spectroscopy was used to investigate the extinction spectra
of the QR system using a PerkinElmer Lambda 25 UV-Vis spectrophoto-
meter.
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2.2.2 Steady-State Photoluminescence Spectroscopy
Photoluminescence spectroscopy measures the intensity of photolumines-
cence (PL) of a sample analyte upon excitation with high-energy photons.
When photoluminescent species absorb a photon, electrons are excited into
a higher energy state. When the electrons return to their ground state, they
release energy in the form of a photon (Figure 2.4). A spectrofluorimeter
is capable of detecting and measuring the wavelength of that photon.
Light from an excitation source, such as a lasers, photodiodes or lamps
(e.g. xenon arcs and mercury-vapour lamp), are sent through a diffrac-
tion grating monochromator that isolates a single wavelength to irradiate
the sample. The incident light strikes the sample solution contained in a
quartz cuvette. The electrons of the sample absorb the incident light and
are excited. They release the energy in the form of emitted photons as the
excited electrons drop down to a lower energy state (Figure 2.4). Those
emitted photons pass through a second monochromator and into a photo
detector that can detect the emission spectrum. The photo detector is usu-
ally placed at a right angle to the incident light to minimise any erroneous
detection due to reflection or transmission of the incident light.
Quantum dots (QDs) absorb and emit photons in a very similar manner
to fluorescent molecules, as depicted in Figure 2.4. When QDs or fluor-
escent molecules absorb a photon, an electron-hole pair is created. When
the electron-hole pair recombines again, a photon is released at a discrete
energy equal to the band-gap energy that gives the fluorescent entity its
characteristic colour (if the emission wavelength is in the visible part of the
electromagnetic spectra).
The quantum yield, QY , of any photoluminescent object is defined as the
ratio of the number of photons emitted per photon absorbed.
QY =
photons emitted
photons absorbed
In this thesis, steady-state photoluminescence spectroscopy was employed
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Figure 2.4: Mechanism of photoluminescence. The horizontal lines
indicate quantum energy levels of the photoluminescent object. When a
photoluminescent object absorbs a photon, an electron will be excited
into a higher energy state. When it returns to its ground state, a photon
is emitted.
to investigate the photoluminescent properties of the QR system in the
near-infrared (NIR) region and to measure its quantum yield, using a
Horiba Scientific Fluorolog-3 (FL3-21) spectrophotometer.
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Chapter 3
The Quantum Rattle System:
Synthesis and Characterisation
3.1 Introduction
Recently, new emphasis has been placed on hybrid particle systems where
multiple nanostructured materials are combined to create multimodal sys-
tems possessing the properties of the component modules.[3, 82, 86, 90–92]
Such multifunctional systems have been extensively investigated for a vari-
ety of catalytic applications.[3, 83, 99, 185, 195–197] Likewise, in the bio-
medical field, multifunctional systems have been developed for targeting,
imaging and drug delivery purposes by adding together properties from dif-
ferent materials and bioconjugates.[33, 86, 89–92] In particular, rattle-type
particles, which are particles with a core-shell structure containing a dis-
tinctive void that separates the core material from the shell, are promising
platforms for many biomedical applications.[3, 23, 82,198]
Compromises are often made in order to synthesise multifunctional hy-
brid particles, as functionalities can be intrinsically difficult to combine.
For example, improving absorption for efficient photothermal conversion in
gold nanoparticles for photothermal therapy (PTT) can be detrimental to
generating intense emission from attached fluorescent dyes for live imaging.
Achieving the optimal efficiency for each functionality (i.e. efficiency of the
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best equivalent monofunctional systems) is very challenging, and currently
many studies concentrate on getting an optimal trade-off. Multiple step
processes are usually employed to accumulate different functionalities into
a hybrid system thereby adding complexity. In this thesis, a holistic ap-
proach is taken, whereby a simple multifunctional design induces emergent
properties and contributes to improved efficiency and versatility.
The overall aim of the project is to create a simple synthetic pathway,
which produces tailorable and multipurpose hybrid particles and, in par-
ticular, particles that combine multimodal therapy and diagnosis for cancer
treatment. The ideal system design for cancer treatment should have the
following emergent properties:
• Near-infrared (NIR) absorbance and photoluminescence for PTT and
live imaging;
• Biocompatibility and stability;
• Smart drug release;
• Targeting.
This chapter presents the synthesis and characterisation of a novel gold-
silica, rattle-type particle, the Quantum Rattle (QR), made of a hollow
mesoporous silica shell (HS) hosting two classes of hydrophobic gold nano-
structures: gold quantum dots (AuQDs) and gold nanoparticles (AuNPs)
(Figure 3.1). Each component of the QR synergistically combines to en-
dow the QR with emergent properties ideally suited for cancer treatment.
In addition to stabilising the gold nanostructures, making them dispers-
ible in water and thereby enabling biomedical applications, the HS can
leverage passive targeting for the QR via the enhanced permeability and
retention (EPR) effect.[25, 113, 114] The AuQDs absorb and emit light in
the near-infrared region (NIR) bio-window where blood and soft tissue are
relatively transparent (650 – 900 nm).[28,115,129] With their NIR photon-
ics, the AuQDs should allow the QR to mediate photothermal therapy (c.f.
Chapter 5) as well as live infrared imaging in vitro (c.f. Chapter 4). Finally,
the hydrophobic AuNPs can optimise the drug carrying performance of the
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Figure 3.1: The Quantum Rattle design specifications. The Quantum
Rattles are thin shells of mesoporous silica hosting gold nanoparticles
within their core and gold quantum dots within their mesopores. The
biocompatible silica shell stabilises the gold nanostructures inside it and
has a diameter (< 400 nm) which sets well within the range to exploit the
enhanced permeability and retention (EPR) effect. The gold quantum
dots are photonically active in the near-infrared biological window
allowing both photothermal therapy and live fluorescent imaging. The
gold nanoparticles enhance the mesoporous silica shell as a drug vector by
improving loading efficiency and prolonging sustained release.
system by increasing the payload’s loading efficiency inside the particle as
well as controlling its release profile (c.f. Chapter 6).
Rattle-type systems can be prepared through a variety of different tech-
niques, including: selective etching or dissolution;[91,98,99] bottom-up ap-
proaches by soft templating assembly;[5,97] and ship-in-bottle methods.[3]
In this study, a ship-in-bottle approach was used to synthesis the QRs us-
ing hollow containments. First, hollow mesoporous silica particles (HS)
were synthesised using a previously published co-templating method.[199]
Secondly, the QRs were obtained by infusing and nucleating gold precurs-
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ors inside the pores and cavity of the silica shells. This chapter describes
the synthesis and morphological and physicochemical characterisation of
this novel QR design.
3.2 Materials and Methods
The hollow mesoporous silica shells syntheses were performed both at Im-
perial College London and at the Collège de France in Professor Clément
Sanchez’s group with the help of Dr. Glenna Drisko. The characterisation
of the hollow mesoporous silica shells with small angle x-ray scattering and
nitrogen physisorption as well as the synthesis of the non-hollow mesopor-
ous Stöber silica particles were performed at the Collège de France by Dr.
Glenna Drisko in Professor Clément Sanchez’s group. The ultramicrotomy
images were acquired with the help of Dr. Ciro Chiappini. The transmis-
sion and scanning electron microscopy images were acquired with the help
of Dr. Sergio Bertazzo.
Materials : Chloro(triphenylphosphine) gold (I) salt, 1-octanethiol (OT),
borane tert-butylamine complex, gold (III) chloride (HAuCl4), sodium boro-
hydride (NaBH4), sodium citrate, styrene, dihexylsulfosuccinate sodium
salt, sodium bicarbonate, potassium persulfate (KPS), hexadecyltrimethyl-
ammonium bromide (CTAB), tetraethyl orthosilicate (TEOS), potassium
hydroxide (KOH) and ammonia solution (28%) were purchased from Sigma-
Aldrich, UK. Solvents and acids, such as chloroform, absolute ethanol, di-
ethyl ether or nitric acid, were purchased from VWR, UK. Carbon coated
copper TEM grids (300 mesh) were purchased from Agar Scientific, UK.
3.2.1 Hollow Mesoporous Silica Particles
Polystyrene Particle Synthesis : Polystyrene particles were prepared using
an emulsion polymerisation with an anionic initiator, potassium persulfate
(KPS). Dihexylsulfosuccinate sodium salt (2.6 g), MilliQ H2O (206 mL),
sodium bicarbonate (0.43 g) and styrene (30.2 g) were mixed in a round
78
3.2 Materials and Methods
bottom flask. The solution was degassed over 30 min by bubbling with
argon. The solution was then added to a pre-heated 90 °C oil bath. As
styrene can autoinitiate at this temperature, the initiator, KPS (0.43 g) in
MilliQ H2O (14.9 mL) was promptly added to the hot solution via syringe.
The reaction was performed under a slight positive pressure of argon. After
6 h the reaction was complete. The particles were dialysed over one week
producing an 8.9 wt% polystyrene dispersion.
Hollow Mesoporous Silica Shell Synthesis : Mesoporous silica was grown on
the polystyrene particles to produce a core cavity. The surfactant (CTAB,
3.2 g) was dissolved in MilliQ H2O (100 mL) at 35 °C. The polystyrene
particles (17.5 g or 5 g for thin and thick shell particles respectively) were
diluted with 500 mL MilliQ H2O, 200 mL of ethanol and basified with 7.5 g
of ammonia. The CTAB/H2O was added to the polystyrene dispersion and
allowed to equilibrate for 45 min. TEOS (5.4 g) was added drop-wise to
the solution, which was subsequently allowed to react for 1 day. To collect
the particles, the solution was centrifuged at 8000 rpm.min-1 for 1 h. The
resulting material was calcined using the following program: 25 to 250 °C
at a rate of 5 °C min-1, held at 250 °C for 2 h, 250 to 550 °C at a rate of 2
°C min-1, held at 550 °C for 5 h.
3.2.2 Gold Synthesis
All glassware were pre-washed in aqua regia (1:3 HNO3:HCl) and left in
saturated ethanolic KOH overnight before any synthesis.
Monolayer Protected Gold Nanoparticle Synthesis : Gold NPs were synthes-
ised following a slightly modified one-step, one-phase Stucky method[48]
using gold (I) salt as metallic precursor, thiol ligand as capping agent and
a borane complex as reducing agent in a ratio of 1:2:10. Chloro(triphenyl-
phosphine) gold (I) salt (222.6 mg) and 1-octanethiol (156.2 μL) were dis-
solved in chloroform (30 mL) and left to mix for 20 min. A solution of
borane tert-butylamine complex (391.4 mg) was then prepared in chloro-
form (10 mL) and added to the gold-thiol solution while mixing in a round
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bottom flask. The reaction vessel was equipped with a condensation column
and transferred to a pre-heated 55 °C oil bath. The solution was left to
react for 1 h. After cooling the solution to room temperature, ethanol (250
mL) was added and the particles were left to settle overnight at 4 °C. The
supernatant was removed and the particles were washed and centrifuged 3
times at 4000 rpm.min-1 for 8 min in ethanol before leaving to dry at room
temperature.
3.2.3 Quantum Rattle Syntheses
The QRs were obtained by infusing hollow mesoporous silica shells (HSs,
c.f. section 3.2.1) with gold precursors and generating nucleation anchors
both inside the pores and cavity of the HS using a one-step, one-phase
method (Figure 3.2).
Chloro(triphenylphosphine) gold (I) salt (222.6 mg) and HSs (100 mg) were
suspended in chloroform (25 mL) and left to mix overnight (> 12 h) at
room temperature. The next day, 1-octanethiol (156.2 μL) was added to
the gold-silica suspension and left to mix for 20 min. A solution of borane
tert-butylamine complex (391.4 mg) was then prepared in chloroform (15
mL) and added to the gold-silica-thiol solution while mixing in a round
bottom flask. The reaction vessel was then equipped with a condensation
column and transferred to a pre-heated 55 °C oil bath. The solution was
left to react for 1h. After cooling the solution to room temperature, diethyl
ether (250 mL) was added and the particles were left to settle overnight
at 4 °C. The supernatant was removed and the particles were washed and
centrifuged 3 times at 1500 rpm.min-1 for 8 min in diethyl ether and 2 times
at 6500 rpm.min-1 for 20 min in 0.5 mL EtOH and 10 mL chloroform before
leaving to dry at room temperature.
Non-hollow Quantum Rattles (NQRs) were synthesised to deconvolve the
role of the AuQDs from the AuNPs in the photonic properties of the QRs.
The same protocol used for the QRs was used for the NQRs with the ex-
ceptions that non-hollow Stöber mesoporous silica particles with the same
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Figure 3.2: Schematic of Quantum Rattle synthesis. (a)
Chloro(triphenylphosphine) gold (I) salt and 1-octanethiol are infused
into hollow mesoporous silica shells. (b) Nucleation and formation of gold
quantum dots inside the silica shell’s pores and gold nanoparticles inside
and outside the hollow shell after the addition of the borane
tert-butylamine complex reducing agent. (c) Purification step separating
Quantum Rattles (QRs) from gold nanoparticles formed outside the
hollow silica shells.
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pore size as the HS were used instead of HSs.
Citrate protected gold NP synthesis was also tried in the presence of HS.
Gold (III) chloride (1.7 mg) and HSs (100 mg) were suspended in MilliQ
H2O (20 mL) and left to mix overnight at room temperature. The next day,
sodium citrate (7.35 mg) was dissolved in MilliQ H2O (1mL) and 10 μL
was added to the gold-silica suspension which was left to mix for 20 min. A
solution of sodium borohydride (3.78 mg) was then prepared in MilliQ H2O
(1 mL) and 600 μL was added drop-wise to the gold-silica-citrate solution
while mixing in a round bottom flask at room temperature. The solution
was left to react until it turned a ruby red colour and the particles were
then left to settle overnight at 4 °C. The supernatant was removed and the
particles were washed and centrifuged 3 times at 1500 rpm.min-1 for 8 min
in MilliQ H2O.
3.2.4 Particle Morphology and Composition
Small angle x-ray scattering (SAXS) was collected on a Rigaku S-Max
3000 equipped with a microfocus source of 20 μm x 20 μm. The radi-
ation wavelength (Kα) used was 0.154 nm. A 2D Gabriel type detector
was placed 1469 mm from the sample. Diffraction patterns were analysed
using SAXGUI V2.04.05 software. Bragg’s law was used to calculate the
d-spacing, d, from the SAXS data:
nλ = 2d sin θq = 4Π sin θ
λ
⇒ d = 2Πn
q
(3.1)
where n is an integer describing the order, λ is the wavelength, θ is the
scattering angle and q is the magnitude of the scattering vector.
The nitrogen physisorption method was used to determine the effect of the
QR synthesis on the integrity of the silica shell of the QR. The nitrogen
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adsorption and desorption curves were obtained on a BELSORP-max (BEL
Japan) instrument. The samples were degassed at 80 °C at a pressure of
10-2 kPa for 1 day prior to analysis using a BELPREP-vacII (BEL Japan)
pretreatment instrument.
Electron Microscopy
Scanning electron microscopy was used to assess the morphology and size
distribution of the polystyrene particles used as templates for the core of the
HS. SEM images were acquired using a Leo 1525 Gemini scanning electron
microscope (SEM) operated at an accelerating voltage of 5 kV.
Transmission electron microscopy (TEM) was used to determine the mor-
phology and size distribution of the QRs. TEM images of the particles
were acquired using a JEOL 2010 TEM equipped with an energy dispers-
ive x-ray spectroscopy (EDS) detector (Carl Zeiss SMT Ltd.) operated
at an accelerating voltage of 200 kV. Samples were dissolved in EtOH (1
mg.ml-1) and drop-deposited on TEM grids prior to analysis.
EDS analysis was used to quantify the chemical composition of the QRs.
X-ray counts were recorded over five separate areas per specimen (in trip-
licate) during a 1 minute period at 10 kV and analysed using INCA Energy
3000 software (Oxford Instruments).
The contribution of each component of the QR (SiO2 shell, AuQD and
AuNP) to the total mass of one QR was calculated using the EDS data
and the following set of equations.
From geometrical considerations, the mass of the silica shell of the QR,
mSiO2 , and the mass of the AuNPs inside the cavity of the QR, mAuNP ,
were calculated using:
mSiO2 =
4
3
pi(r3SiO2outer − r3SiO2inner) · dSiO2
mAuNP =
4
3
pir3AuNP · dAu
where dSiO2 and dAu are the densities of mesoporous silica (1.8 g.cm-3) and
gold (19.3 g.cm-3), respectively. rSiO2outer and rSiO2inner are the outer and
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inner radius of the silica shell (75 nm and 50 nm, respectively, as determined
from TEM analysis). rAuNP is the radius of the entire aggregate of AuNPs
inside the cavity, assuming they aggregate in a spherical structure (15 nm,
as determined from TEM analysis).
From the mass percentage of silica composing a QR obtained from the EDS
data, xEDS(SiO2), the total mass of AuQDs per QR,mAuQD, was evaluated
using:
 mQR = mSiO2 +mAuNP +mAuQDmSiO2
mQR
= xEDS(SiO2)
100
(3.2)
⇒ mAuQD = ( 100
xEDS(SiO2)
− 1) ·mSiO2 −mAuNP (3.3)
By re-inputing mAuQD into the first equation of 3.2, the mass of one QR,
mQR, was obtained. The mass percentage of AuQDs and AuNPs was then
calculated using:
 xcalculated(AuQD) =
mAuQD
mQR
xcalculated(AuNP ) =
mAuNP
mQR
(3.4)
The number of AuQDs per QR, nAuQD was then induced from the mass of
AuQDs per QR, mAuQD, using:
 mAunQD = n ·
MAu
Na
nAuQD =
mAuQD
mAunQD
⇒ nAuQD = mAuQD ·Na
n ·MAu (3.5)
where mAunQD is the mass of one AuQD composed of n gold atoms. Na
and MAu are Avogadro’s number (6.02×1023 mol-1) and the molar mass of
gold (196.96 g.mol-1), respectively.
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Ultramicrotomy was used to assess the inner structure of the QRs. The QRs
(1 mg) were embedded through a graded Epon812/Araldite resin:acetone
series (1:2, 2:1, 1:0 v/v), transferred to fresh pure Epon812/Araldite and
polymerised at 60 °C for 1 day. Ultrathin sections of approximately 100
nm were cut on a Power Tome XL ultramicrotome (RMC Products, USA)
using a 35° diamond knife and transferred to a TEM copper grid. TEM
images were acquired using a JEOL 2000 TEM operated at 120 kV.
High resolution transmission electron microscopy (HRTEM) and high angle
annular dark field scanning transmission electron microscopy (HAADF-
STEM) was used to resolve and image gold inside of the QRs pores. HRTEM
and HAADF-STEM images of the particles were acquired using FEI TI-
TAN 80/300 STEM/TEM operated at an accelerating voltage of 200 kV.
Samples were dissolved in EtOH (1 mg.ml-1) and drop-deposited on TEM
grids prior to analysis.
3.2.5 Photonic Characterisation
The photonic properties of the QRs and in particular the extinction and
photoluminescent properties were assessed by UV-Vis and Fluorescent spec-
troscopy. UV-Vis measurements were collected using a 1 cm path-length
quartz cuvette using a PerkinElmer Lambda 25 UV-Vis spectrophotometer
at a scanning rate of 480 nm.min-1 from 400 nm to 1000 nm with 0.2 nm
resolution. Spectra were normalised to the peak maximum intensity at 672
nm. Samples were dispersed in EtOH (1 mg.ml-1) and sonicated for 5 min
prior to analysis.
Steady-state photoluminescence measurements were collected using a 1 cm
path-length quartz cuvette using a Horiba Scientific Fluorolog-3 (FL3-21)
spectrophotometer with an integration time of 1 s and 12 nm slits for the
QRs and 5 nm for the controls. Emission spectra were collected from 700
nm to 900 nm with an excitation at 672 nm and 673 nm for the QRs and
NQRs, respectively. Excitation spectra were collected from 550 nm to 800
nm by acquiring the emission intensity at 827 nm and 826 nm for the QRs
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and NQRs, respectively. The acquired spectra were corrected for variations
in lamp and detector efficiency and normalised to either the peak maximum
for the QRs and NQRs or the maximum in the range scanned for the con-
trols. Each emission peak observed was confirmed to be a photoluminescent
peak or a Raman peak by acquiring a new emission measurement at an ex-
citation wavelength 20 nm lower than the original. If the wavelength of the
emission peak maximum was independent from the excitation wavelength
(i.e. the peak did not shift between the two measurements) then the peak
was confirmed to be a photoluminescent peak. QR samples were dispersed
in EtOH (1 mg.ml-1) and sonicated for 5 min prior to analysis.
The quantum yield (QY) of the QRs was calculated relative to adsorption-
matched dilutions of Qdot 705 ITK (Molecular Probes, UK) organic quan-
tum dots (QY = 0.63) in hexane. The extinction E of both the reference
Qdot 705 and the QRs was adjusted to be below 0.2 optical density at
the excitation wavelength (672 nm) for the QRs and at the adsorption
maximum of the Qdot (450 nm) for the reference Qdot in order to minimise
luminescence quenching due to internal reabsorption. The final QY of the
QRs was calculated according to:
QY = QYref
I
Iref
n2
n2ref
(1− 10−Eref )
(1− 10−E) (3.6)
where I is the integrated luminescence intensity and ref denotes the ref-
erence sample (the Qdot in this study).
3.3 Results and Discussion
3.3.1 Hollow Mesoporous Silica Particles
The QR synthetic pathway uses a ship-in-bottle method to combine hollow
mesoporous silica particles (HSs) with gold nanostructures. The HSs were
obtained by means of a a dual-template approach.[199] Briefly, polystyrene
particles with anionic surface charges acted as core template, while CTAB
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served as a co-template to structure the mesopores formation during TEOS
hydrolysis/condensation. This dual templating approach using a soft core
and surfactant as co-template has been shown to provide a better control on
the ordering of the mesopores inside the silica shell.[199] The surfactant acts
as a structuring agent for the pore formation during the sol-gel condens-
ation of the silica precursor (TEOS).[200–202] However, soft-templating
approaches tend to lack in particle dispersity, control of particle dimen-
sions, independent tuning of hollow cavity diameter and shell thickness or
mesopores ordering and orientation. To circumvent such problems, hard
core templates, and in particular polymer dispersions, combined with a sur-
factant co-template seem to be a preferable choice for more reliable dual-
templating syntheses of hierarchically structured silica particles.[203, 204]
However, the use of a polymer dispersion template and a surfactant co-
template to assist in the silica formation can lead to various morphologies
depending on the reaction parameters. The dual-template protocol used
here produced monodisperse spherical hollow particles with ordered meso-
porous silica shells.
Polystyrene Particle Synthesis - Core Template for Hollow
Mesoporous Silica Particle Synthesis
The first step in obtaining the HSs, is the synthesis of polystyrene beads
which serve as templates for the growth of mesoporous silica and create
the cavity after removal by calcination. Being the template on which the
silica shell of the HS is grown, the morphology and size distribution of
the polystyrene beads is crucial to the final dimension of the HSs. The
polystyrene bead size should be large enough to create a cavity in the HS
(after calcination) that can accommodate several AuNPs in the range of 5
to 10 nm in diameter. Furthermore, the polystyrene particles should allow
the growth of an intact mesoporous silica shell (i.e. thicker than 5 nm[199])
to enable controlled gold salt diffusion. Finally, the total dimensions of the
resulting HS particle (cavity + silica shell) should not exceed 400 nm in
diameter in order to accumulate inside the tumorous tissue by means of
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Figure 3.3: Morphology and size distribution of polystyrene particles
used in the hollow mesoporous silica synthesis as template for the cavity.
(a-c) Scanning electron microscopy images of the polystyrene particle
template showing a monodisperse and spherical population at different
magnifications. Scale bars: 500 nm.
the EPR effect (c.f. Chapter 1).[25, 113,114]
Using an anionic precursor (KPS), highly monodisperse and spherical poly-
styrene beads, with diameters varying between 110 nm and 120 nm (n =
10) were formed (Figure 3.3). These beads have an optimal size specific-
ations for hosting small AuNPs and growing a robust silica shell, whilst
staying within the size range for the EPR (60 nm - 400 nm).
Hollow Mesoporous Silica Shell Synthesis
The next step in the QR synthesis process is the formation of mesoporous
silica on the polystyrene particle surface. The hydrolysis-condensation of
TEOS in the presence of CTAB micelles was performed using two different
amounts of polystyrene beads. A decrease in the ratio of silica precursor
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to polystyrene bead resulted in the formation of thicker silica shells. After
calcination of the polystyrene filling, the two type of HSs were characterised
by TEM (Figure 3.4). Both thin and thick HSs are monodisperse in size
(around 150 nm and 200 nm, respectively) and perfectly spherical. The
silica shells of both thin and thick HSs are uniform in thickness (around 25
nm and 50 nm, respectively) and exhibit highly ordered mesopores perpen-
dicularly oriented to the core of the HS particle. The HSs mesostructure
was further investigated by SAXS (Figure 3.5b). The sharp SAXS peaks
confirm the mesopore ordering in the shell of both HSs. Furthermore, the
d-spacing, calculated by inputing the q values corresponding to the diffrac-
tion peaks of both HSs into equation 3.1, decreases with increasing shell
thickness (6.0 nm and 4.6 nm for the thin and thick HS, respectively). The
d-spacing is in good agreement with those of common mesoporous silica
powders prepared in basic media.[205]
As can be seen on the TEM images, the average diameter of both thin and
thick HSs hollow core (around 100 nm) is slightly lower than the polystyrene
beads diameter. This might be due to a constriction phenomenon occurring
during the calcination step.[199] However, the calcination process does not
affect the particle stability as the silica shell remains intact with a perfectly
spherical hollow core.
The highly ordered and radial organisation of the mesopores and the integ-
rity of the silica shells are the predominant characteristics to consider before
attempting the synthesis of QRs. The mesopore organisation is important
in order to get the most controlled and consistent diffusion process of mo-
lecules inside the HS particles, in particular of gold salts for the synthesis
of QRs. The integrity of the silica shells is critical in order to obtain hollow
mesoporous particles with cavities sealed off from the external environment
that are only reachable through the mesopores. Creating an independent
space sealed off from the external environment is crucial in the application
of the QRs, where a hydrophobic environment contained inside the shells
is beneficial to drug loading and release kinetics (c.f. Chapters 6).
To conclude, compared to synthetic pathways described in the literature,
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Figure 3.4: Morphology of hollow mesoporous silica particles. Bright
field transmission electron microscopy images of the (a-b) thick and (c-d)
thin hollow mesoporous silica particles (HSs). Both type of HSs are
monodisperse and spherical. The mesopores of both silica shells possess
an ordered and radial organisation, starting from the core. Scale bars:
100 nm.
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Figure 3.5: Effect of the Quantum Rattle synthetic process on the
mesoporous silica shell. (a) Nitrogen adsorption and desorption isotherm
of thin (grey) and thick (black) and (b) small angle x-ray scattering
(SAXS) spectra of thin (grey) and thick (black) Quantum Rattles (QRs,
plain line) and hollow mesoporous silica particles (HSs, dashed line)
showing that the QR synthetic pathway does not affect the integrity and
pore structure of the mesoporous silica shells.
where the inhomogenous morphology of both particles and pores could
be an issue for the QR synthesis,[195, 206, 207] the method used here to
synthesise HSs produces highly monodisperse hollow particles with silica
shells of controlled thickness containing radially oriented mesopores.
3.3.2 Quantum Rattle
Quantum Rattle Synthesis
Once monodisperse, spherical hollow mesoporous silica shells with radially
oriented mesopores were obtained, Au@Si rattle-type particles (Quantum
Rattles, QRs) could be synthesised. Two types of monodisperse QRs were
synthesised by nucleating gold into thin and thick HSs by means of a one-
step, one-phase synthesis (c.f. section 3.2.3).
Briefly, chloro(triphenylphosphine) gold (I) was left to infuse into the HSs
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pores and cavity overnight (> 12 h). The next day, a thiol ligand (1-
octanethiol) was added before the gold nucleation was triggered using bor-
ane tert-butylamine complex as reducing agent. Compared to the more
commonly used gold (III) salt[38,43], the QR synthesis uses a gold (I) salt
as the gold precursor. The nature of the gold salt is crucial to the QR
synthesis as adaptations of methods using gold (III) chloride (HAuCl4) as
metallic precursor to the QR process do not induce gold nucleation inside
the QRs silica shells (Figure 3.6). TEM images do not show any denser
particles inside the cavity of the QRs silica shell (Figure 3.6a) and EDS
analysis show no trace of gold in the samples (Figure 3.6b) confirming that
gold does not nucleate inside the HSs while using gold (III) precursor in
the QR synthesis.
Chloro(triphenylphosphine) gold (I) has been used in many studies as a
metallic precursor to synthesise of < 2 nm AuQDs.[72,208–210] The more
commonly used gold (III) precursor, HAuCl4, however, first forms an inter-
mediate Au(I):SR complex (where R can be alkyl- or arythiols) before full
gold reduction.[68–70,73,211] Previous studies have shown that this inter-
mediate Au(I):SR forms structures larger than 100 nm. This can explain
the failure of QR synthesis using gold (III) precursors, as such complexes
will not be able to diffuse in HSs to create gold particles inside the cavity.
Another factor that could influence the formation of gold nanostructures
within the HS is the reducing ability of the reductant. Borane complexes
have a weaker reducing ability than more commonly used reducing agents,
such as sodium or lithium borohydride, which can slow the reducing rate
of gold cations and, therefore, allow for a better diffusion of the reducing
agent inside the HSs. Upon the addition of strong reductants, gold cations
are reduced rapidly, resulting in an immediate colour change of the reac-
tion mixture from colourless or yellow to dark red.[38,48] With the use of a
weaker reductants, such as borane complexes, a much slower but continu-
ous colour change from colourless to yellow to brown, and finally to deep
red/purple is observed, which indicates a relatively slow reducing rate of
gold (I). In the QR synthesis, where the diffusion kinetics of the reducing
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Figure 3.6: Attempted Quantum Rattle synthesis using gold (III) salt as
metallic precursor. (a) Bright field transmission electron microscopy
image showing hollow mesoporous silica particles without any gold
nanostructures inside the cavity. White cross indicates where energy
dispersive X-ray spectroscopy (EDS) analysis was performed. Scale bar:
100 nm. (b) Corresponding EDS spectra showing no elemental trace of
gold.
agent inside the silica shells is crucial, a rapid reducing rate could prevent
nucleation of gold inside the HSs.
Moreover, the borane complex reducing agent allows the integrity of the
silica shell to be preserved without evident signs of erosion or perforations
(Figures 3.5 and 3.7). The nitrogen adsorption and desorption isotherms of
both thick and thin QRs are type IV isotherms characteristic of mesoporous
materials.[199,212] The large box-like hysteresis observed in the isotherms
shows that the QR synthetic pathway does not affect the integrity of the
silica shells (Figure 3.5a).
The pore structure and organisation within the silica shells of the QRs
is confirmed by small angle x-ray scattering (SAXS, Figure 3.5b). The d-
spacing, calculated by inputing the q values corresponding to the diffraction
peaks of both QRs into equation 3.1, is 4.9 nm and 4.3 nm for the thin and
thick QRs, respectively and is slightly lower than the d-spacing observed
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for the HS (6.0 nm and 4.6 nm for thin and thick, respectively). The QR
synthesis alters the pore distribution slightly, which is to be expected by
the addition of AuQDs inside the pore structure of the QR silica shells.
Furthermore, the intensity of the diffraction peak of the QRs is higher
compared to the signal observed for the HS, indicating the addition of a
denser material than silica, such as gold, into the HS system.
The hydrophobic ligand in the QR synthesis was chosen to simplify the
purification process of the QRs from the external AuNPs (Figure 3.2c)
by precipitation of the hydrophilic silica shells from the free hydrophobic
AuNPs. In addition, the ligand was also chosen as it can contribute to the
emergent QR properties in two ways:
• The hydrophobic surface of the thiol-protected AuNPs create an hy-
drophobic environment inside the QR cavity, favourable for the load-
ing of cancer drugs[91,213] (c.f. Chapter 6);
• The thiol ligand plays a critical role in the AuQDs photonic properties
and therefore the QRs photonic properties.[52, 71,77,214]
By changing the functional group of the thiol-ligand capping the AuQDs,
the photonic properties of the AuQDs can be adapted[77, 79] and, in the
future, different type of thiol-ligands could be used to tailor the photonic
properties of the QRs (c.f. Chapter 7).
Quantum Rattle Morphology and Composition
Transmission electron microscopy (TEM) was used to investigate the mor-
phology and composition of both type of QRs. Ultrathin sections (100 nm)
of resin-embedded QRs obtained through ultramicrotomy in combination
with drop-deposited QRs on carbon coated TEM grids show that the QRs
are well-defined monodisperse particles (approximately 150 nm and 200
nm total diameter for the thin and thick QRs, respectively) composed of
mesoporous silica shells (approximately 25 nm and 50 nm thickness for the
thin and thick QRs, respectively) with AuNPs of 5 nm to 10 nm diameter
inside the cavity of the QRs (Figure 3.7). The composition of the QR was
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confirmed by EDS analysis, where both silica and gold peaks are present
(Figure 3.8). The other peaks can be attributed to the carbon and copper
of the TEM grids used.
The images obtained through ultramicrotomy (Figure 3.7a and c) show
that the AuNPs are present in the cavity of nearly all QRs (thin and thick)
and, in dry conditions, tend to assemble into suprastructures of around 30
nm for both thin and thick QRs. The quantity of AuNPs is not only similar
for all the QRs in the thin or thick groups, but also similar when the two
groups are compared to each other. This difference in AuNP amount is
not expected, as the diffusion of the borane complex reducing agent, which
is the key step in the QR synthesis, should be slower for the thick silica
shell compared to the thin one. A slower diffusion was thought to lead to
less AuNPs overall, but larger and more polydisperse in size. However, the
similarity in AuNP formation for both thin and thick QRs may be due to
the difference in thickness being too little to influence the AuNPs synthesis.
The higher magnification TEM images of the drop-deposited QR on TEM
grids show radially oriented mesopore channels visible in both type of QRs
(Figure 3.7b and d), confirming in addition to the SAXS data (Figure 3.5b)
that the mesostructure of the silica shell is not affected by the process of
QR synthesis.
The proposed QR system composed of only AuNPs of more than 5 nm
diameter inside a silica shell does not explain the photonic properties ob-
served for the QRs (c.f. next section 3.3.3), which indicates that smaller
gold structures must be present in the system.[52,67–74,79] High-resolution
transmission electron microscopy (HRTEM) was used to characterise the
thin QRs morphology and composition in more detail (Figure 3.9), while
high angle annular dark field scanning transmission electron microscopy
(HAADF-STEM) was used to complement the HRTEM study, highlight-
ing all gold nanostructures present in the QRs (Figure 3.10). The thin QRs
are well-defined monodisperse particles (around 150 nm diameter) with a
mesoporous silica shell (around 25 nm thickness) hosting both AuQDs (<
2 nm diameter) and AuNPs (5 - 10 nm diameter) (Figure 3.9a-b). The crys-
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Figure 3.7: Morphology of Quantum Rattles. Bright field transmission
electron micrographs of (a-b) thick and (c-d) thin Quantum Rattles (QRs)
showing gold nanostructures (yellow arrows) inside hollow mesoporous
silica particles (blue arrows). (a,c) Ultrathin sections of resin-embedded
QRs, obtained through microtomy showing suprastructures formed of 5
nm to 10 nm gold nanoparticles; (b,d) Higher magnification of QRs
deposited on carbon coated TEM copper grid. Scale bars: 100 nm.
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Figure 3.8: Quantum Rattle elemental analysis. (a) Bright field
transmission electron micrographs of thin Quantum Rattles (QR) showing
gold nanostructures (yellow arrows) inside hollow mesoporous silica
particles (blue arrows). White cross indicates where energy dispersive
X-ray spectroscopy (EDS) analysis was performed. Scale bar: 100 nm.
(b) Corresponding EDS spectra of QR indicating the presence of silica
and gold.
tal faces of the larger AuNPs can be clearly identified through the silica
shell on high magnification HRTEM images (Figure 3.9d). The HAADF-
STEM images of the QRs highlight the complete loading of the silica shell
with AuQDs (Figure 3.10). The AuQDs are confined within the pores of
the silica shells and give the QRs their photonic properties.[52,79] EDS ana-
lysis demonstrated that the silica shell and the gold nanostructures of the
QR accounted for 73% and 27% of the total mass of the QR, respectively.
The mass percentages attributable to AuQDs and AuNPs were calculated
using equation 3.4 and were found to be 18% and 9% of the total mass
of the QR for AuQDs and AuNPs, respectively. Finally, by inputing the
mass of AuQDs per QR calculated using equation 3.3 into equation 3.5 and
assuming that the AuQDs are composed by 25 gold atoms, the number of
AuQDs per QR was calculated to be approximately 7.104.
In parallel to the QR synthesis, OT protected AuNPs were synthesised
using the QR process in the absence of HSs (Figure 3.11). The synthesised
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Figure 3.9: The Quantum Rattle system. Bright field high resolution
transmission electron micrographs (HRTEM) of thin Quantum Rattles
(QRs). HRTEM images of (a) a QR showing AuQDs (red arrow) within
the mesoporous silica shell (blue arrow) of the QR and AuNPs (yellow
arrow) within the cavity and (b) close-up on a QR silica shell. Scale bars:
20 nm. (c) Zoom in on the AuNPs inside the QR cavity showing the
different crystal faces of the larger AuNPs. Scale bar: 5 nm.
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Figure 3.10: The Quantum Rattle system. High angle annular dark field
scanning transmission electron micrographs (HAADF-STEM) of thin
Quantum Rattles (QRs). (a) HAADF-STEM images of a QR highlighting
the gold nanostructures of the QR: AuQDs within the QR mesoporous
silica shell and AuNPs within the cavity. Scale bar: 50 nm. (b) Close-up
on the QRs mesoporous silica shell. Scale bar: 10 nm.
AuNPs were then employed as a control to assess both the importance of the
silica as a template for AuQD formation and the influence of hollow silica
shells on the polydispersity of the AuNPs inside the cavity. The pores of the
silica shells appear to be crucial in the formation of the AuQDs, anchoring
the gold salt to promote nucleation sites and, at the same time, spatially
restraining the growth of the gold structures by their inherent size. Finally,
the particles synthesised within the QRs cavities (Figure 3.9) are clearly
less spherical and more polydisperse than the OT protected AuNPs formed
in the absence of HSs (Figure 3.11). This can be explained by the diffusion
barrier imposed by the silica shells on the reducing agent. Furthermore, it
was found that the silica shell does not allow homogeneous stirring inside
the cavity. Therefore, the nucleation inside the cavity is expected to be
less homogeneous resulting in polydisperse and less spherical gold particles
than the particles obtained in the absence of HS.
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Figure 3.11: Monolayer protected gold nanoparticles. (a-b) Bright field
transmission electron micrographs of 1-octanethiol protected gold
nanoparticles (OT AuNPs) synthesised using QR process in the absence
of hollow mesoporous silica shells at different magnifications. The OT
AuNPs are highly monodisperse 8 nm particles with a hexagonal packing
on the TEM copper grid. No AuQDs are visible. Scale bars: 20 nm.
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3.3.3 Quantum Rattle Photonic Properties
The QRs were designed to be photonically active in the NIR to exploit
the biological window (c.f. Chapter 1 section 1.3.1) and mediate light-
induced therapeutic processes. The QRs show distinct extinction peaks
at 411 nm and 672 nm, which can be attributed to the stable AuQDs
trapped within the silica shell’s mesopores. Such peaks are absent from
the HS or the AuNPs synthesised using the same protocol in the absence
of HS (free AuNPs) (Figure 3.12). Compared to free AuNPs, where the
plasmon peak hardly goes above 600 nm for gold particles > 100 nm[54], the
AuQDs place the quantum plasmon peak of the QRs1 in the NIR (672 nm),
thereby enabling their effective use for PTT. Other research groups have
studied the optical absorption spectrum of AuQDs by performing density
functional theory (DFT) calculations.[2, 215] The calculated spectrum of
stable AuQDs consisting of 25 atoms (Au25(SR)18) show similar extinction
spectra to that of the QRs while larger AuQDs do not.[2, 52, 215] Zhu et
al.[2] stated that the 670 nm peak corresponds to the LUMO ← HOMO
transition, which is essentially an intraband (sp ← sp) transition. The 411
nm peak is harder to assign as the DFT calculations report peaks at 400 nm
and 450 nm. Although there is a shoulder around 450 nm in the extinction
spectrum of the QRs, the only distinct peak appears at 411 nm. The lack
of peaks could be the result of the interference from the plasmon resonance
of the larger AuNPs inside the QRs silica shells which probably red shifts
the 400 nm and attenuates the 450 nm peaks. On the other hand, another
study on 11 atoms AuQDs (Au11C12)[79] shows identical extinction spectra
which seems to imply that the QRs could also be populated by 11 atoms
AuQDs.
The extinction peak at 672 nm excites a photoluminescent emission peak
at 827 nm, which also sits in the bio-window (650 nm - 900 nm) and is
suitable for live imaging applications (Figure 3.13). The photoluminescent
1The results presented in this section are obtained using thin QR samples. The thick
QR samples present identical photonic properties and the results are presented in
the Appendices (Figure A.1).
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Figure 3.12: Extinction spectra of thin Quantum Rattles (QR, red)
compared to hollow mesoporous silica shells without gold (HS, blue) and
spherical gold nanoparticles synthesised using the same method as the
QR but in the absence of hollow silica shells (AuNPs, black). Inset:
zoomed in on the near infrared region of interest, showing an extinction
peak centred around 672 nm.
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Figure 3.13: Photoluminescence spectra of thin Quantum Rattles
showing an excitation peak centred at 672 nm and an emission peak
centred at 827 nm. Emission spectrum (λex = 672 nm, red) and
excitation spectrum (λem = 827 nm, grey).
spectra of HS and AuNPs when synthesised using the same protocol and
in the absence of HS (free AuNPs), were also acquired in the same NIR
region of interest. Neither of the controls exhibited any peaks at 411 nm or
672 nm, demonstrating that the QR emergent photoluminescent properties
arise from the QR synthetic process, supporting AuQD formation in the
mesopores of the silica shell. (Figure 3.14).
The QRs have a quantum yield of 2.10-4 (calculated using equation 3.6),
which is comparable to the quantum yield of other free gold QDs repor-
ted in the literature.[71] The attainment of a similar quantum efficiency
to that of the best performing AuQDs reported in contemporary stud-
ies,[71] can be attributed to the high density of AuQDs per QR (> 6.104)
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Figure 3.14: Photoluminescence spectra of (a) hollow mesoporous silica
particles (HS) and (b) spherical gold nanoparticles synthesised using the
same method as the QR but in the absence of hollow silica shells (Free
AuNPs). Both controls do not exhibit the characteristic photoluminescent
peaks of the Quantum Rattles. Emission spectra (λex = 672 nm) and
excitation spectra (λem = 827 nm).
and the highly controlled organisation inside the mesopores of the QRs
silica shells. Importantly, other reported AuQDs systems with comparable
performance,[67, 71, 216] are not natively water soluble, which makes the
water soluble QRs a highly attractive NIR dye for bio-applications. In ad-
dition to the high photostability of AuQDs,[75] the large stokes shift of the
QRs also provides a lower background signal with more flexible excitation
options, resulting in an improved signal-to-noise ratio over standard NIR
fluorophores.[133]
To further clarify the photonic role of the AuQDs trapped within the meso-
pores, non-hollow QRs (NQRs) were synthesised in order to obtain particles
with only AuQDs (i.e. without AuNPs), which allowed the roles of the
AuQDs and AuNPs to be deconvolved. The NQRs were synthesised using
the same strategy as the one used for QRs, except that the HSs were re-
placed by non-hollow mesoporous silica particles with the same pore size
and dimensions as the HSs. HRTEM confirmed the presence of AuQDs
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Figure 3.15: Morphology of non-hollow Quantum Rattles. (a) Bright
field transmission electron micrograph of a non-hollow Quantum Rattle
(NQR) and (b) zoom in showing gold quantum dots (AuQDs, red arrows)
within the mesoporous silica shell of the NQR. Scale bars: 50 nm.
within the mesopores of NQRs (Figure 3.15). Furthermore, the NQRs
present the same extinction peaks at 411 nm and 673 nm and fluorescent
emission at 826 nm as the QRs (Figure 3.16). This supports the attribution
of the photonic properties of the QRs to AuQDs trapped within their silica
shell. This data is confirmed by several other studies where AuQDs of less
than 25 atoms, capped with alkanethiol ligands, possess similar photonics
to the QRs.[52,67,71,79] From the photonic properties and HRTEM we can
infer that the QRs host a population of AuQDs of less than 25 atoms.
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Figure 3.16: Photonic properties of non-hollow Quantum Rattle: (a)
Extinction spectra of non-hollow Quantum Rattles (NQRs, orange)
showing the same characteristic features as the Quantum Rattles (QRs)
extinction spectra. Inset: zoomed onto the near infrared region of interest
showing an extinction peak centred around 673 nm. (b)
Photoluminescence spectra of NQRs showing an excitation peak centred
at 673 nm and an emission peak centred at 826 nm. Both emission
spectrum (λex = 673 nm, orange) and excitation spectrum (λem = 826
nm, grey) are similar to the QRs photoluminescent spectra.
106
3.4 Conclusions
3.4 Conclusions
To conclude, two types of Quantum Rattles (QRs) were successfully syn-
thesised using a ship-in-bottle approach. Starting from a hollow mesopor-
ous silica particle (HSs), gold (I) salt was infiltrated inside the HSs cavities
before the gold reduction was initiated. The nucleation of gold was achieved
both in the cavity and in the mesopores of the silica shell, which, by impos-
ing a spatial constraint on the gold formation, resulted in the formation of
two distinct populations: 5 nm - 10 nm diameter AuNPs inside the cavity
and < 2 nm AuQDs inside the mesopores of the QRs silica shell.
Each component of the QR system works synergistically to create emergent
properties ideally suited for cancer treatment:
• The AuQDs absorb and emit light in the NIR bio-window where
blood and soft tissue are relatively transparent (650 – 900 nm).[6,23,
28,115,129] With their NIR photonics, the AuQDs mediate PTT (c.f.
Chapter 5) as well as live infrared imaging in vitro (c.f. Chapter 4);
• The hydrophobic AuNPs can optimise the drug carrying performance
of the system by increasing the loading efficiency of the payload within
the QR particle as well as controlling its release profile (c.f. Chapter
6);
• The hydrophilic mesoporous silica shell of the QR not only stabilises
the gold nanostructures, making them dispersible in aqueous solu-
tions, but also acts as a protecting barrier between the system’s pay-
load and the external environment. Furthermore, the QRs silica shell
dimensions are in the range suitable to exploit the EPR effect (60
- 400 nm) allowing passive targeting through the tumour-associated
leaky vasculature.[25, 113, 114] Finally, the HS structure is fully bio-
degradable into harmless intermediates and end products[217], which
are highly abundant in the body, while the AuQDs small size allows
for rapid renal clearance.[218]
Compared to other methods used to obtain rattle-type particles [3,5,21,23,
82,91,97–99], the QRs synthesis is simple and natively ’bio-friendly’. Fur-
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thermore, the morphology and composition of the QRs is more controlled
than other rattle-type particles where monodispersity, shell integrity, meso-
structure and gold core functionalisation are subject to design compromises.
Finally, the QR is the first system to include AuQDs in a mesoporous shell
structure.
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Quantum Rattle Interactions
with Cells
4.1 Introduction
Early identification and localisation of cancerous tumours is critical to im-
prove the success of cancer therapy and patient survival rates.[115,116] In
the past few years, fluorescence imaging approaches have emerged as prom-
ising non-invasive, real-time modalities for cancer detection.[115, 119, 120]
Compared to other imaging technologies, such as magnetic resonance ima-
ging, x-ray, positron emission tomography (PET), and ultrasound,[121–124]
fluorescence imaging is highly suitable for cancer diagnosis due to its high
sensitivity, multiplex detection abilities and low equipment cost.[75,120]
In vivo fluorescence imaging is based on the detection of photon emissions
from within living tissues, generated by fluorescent probes which emit light
at a predetermined wavelength in response to excitation by light of a dif-
ferent wavelength. Most of the in vivo fluorescence imaging systems were
first developed for imaging in the visible region of the spectrum.[119] Al-
though, most in vivo fluorescence imaging systems were first developed
for imaging in the visible region of the spectrum,[119] more and more
studies now concentrate on the use of near-infrared (NIR) imaging sys-
tems. The advantage of NIR imaging is that biological tissues show very
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low absorption and autofluorescence in the NIR bio-window (650 nm -
900 nm).[6, 23, 28, 115, 129] The most conventional NIR probes for fluor-
escent imaging are organic fluorophores, the most common being poly-
methines (e.g. indocyanine green).[116, 119, 133] However, these organic
fluorescent compounds suffer from several limitations, including low water
solubility and low chemical- and photostability.[115] Furthermore, the de-
tection sensitivity is relatively low because only a limited number of fluoro-
phores can be conjugated per tumour targeting ligand.[115,133] Addition-
ally, conventional fluorophores undergo rapid photobleaching, which is not
a feature suitable for long-term molecular imaging.[115, 133, 134] Finally,
the cytotoxicity of many fluorophores is still currently unknown.[75]
Recently, the emergence of nanomedicine has led to the development of
nanoparticle (NP) probes for in vivo cancer imaging. By exploiting the
enhanced permeability and retention (EPR) effect (passive targeting) or the
specific binding between the tumour cell receptors and biofunctionalised NP
(active targeting), these probes can be made to accumulate at tumour sites.
Both passive and active targeting of tumours by NP-based probes offer the
promise of detecting cancers at an earlier stage of development compared
to more conventional organic fluorophores dyes.[115] NIR semiconductor
quantum dots (QDs) have gained increasing interest for in vivo imaging
and are, currently, the fastest growing imaging agents due to their high
quantum yield and photostability.[75] Although QDs have been used in
small animal models of human cancer,[219,220] their inherent toxicity is still
a main issue, which will have to be efficiently tackled before any successful
translation into clinical use.[138]
On the other hand, noble metal quantum dots (e.g. AuQDs, AgQDs)
are highly attractive for biomedical purposes due to their low toxicity as
well as their photonic and magnetic properties.[12, 140, 141] Noble metal
QDs of less than 10 nm exhibit emerging properties derived from the
quantum nature of their valence electrons,[49] such as NIR photolumin-
escence[75, 142] and paramagnetism,[12, 52, 80] yet they are rarely used
in cancer imaging applications. Such lack of interest is often due to the
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AuQDs unfavourable biointeraction (e.g. poor dispersibility), with the res-
ult that protein carriers are usually necessary to modulate their interac-
tion in biological systems.[75, 142] The Quantum Rattle (QR) system in
this thesis, however, is designed to have the AuQDs trapped within a silica
shell, allowing the AuQDs to maintain their photonic properties in aqueous
environment without any protein carrier.
The aim of this chapter is to demonstrate the QR suitability for bioap-
plications and, in particular, for fluorescence live imaging. The QRs are
designed for photothermal therapy (PTT) and, therefore, to selectively kill
cancer cells when subjected to NIR irradiation. However, until the QRs are
triggered to kill cancerous cells, the particles should be biocompatible and
accumulate at tumour sites for in vivo cancer imaging detection. The first
part of the chapter focuses on investigating the in vitro cytotoxicity of the
QRs. Cervical cancer cells (HeLa) were incubated with cell culture media
containing QRs, either with or without a fluorescent dye conjugated to the
silica shells, to evaluate the effect of QRs and their functionalisation on
cell viability and proliferation. The second part of the chapter investigates
the internalisation process of the QRs into cells, thereby, evaluating the
fate of QRs in vitro and demonstrating the potential of the QRs for NIR
live imaging of tumour sites in vivo. To this end, the QR cellular inter-
nalisation was characterised using multiple techniques, including mapping
Raman spectroscopy, transmission electron microscopy (TEM) and laser
confocal scanning microscopy.
4.2 Materials and Methods
The ultrathin sectioning was performed by Dr. Ciro Chiappini. The trans-
mission electron microscopy images and the confocal images were acquired
with the help of Dr. Ciro Chiappini. The Raman spectra acquisition and
analysis were performed by Dr. Martin Hedegaard.
Materials : Paraformaldehyde (PFA), glutaraldehyde, cacodylate buffer, 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), ethyle-
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nediaminetetraacetic acid (EDTA), cystein-HCl, papain from papaya latex
(P3125) , osmium tetroxide, NHS-fluorescein, (3-Aminopropyl)triethoxy-
silane (APTES), potassium ferrocyanide, Epon 812 and Araldite were pur-
chased from Sigma-Aldrich, UK. Solvents such as absolute ethanol, acetone
and dimethyl sulfoxide (DMSO) were purchased from VWR, UK. Quant-iT
PicoGreen dsDNA assay kit (tDNA assay), Dulbecco’s modified eagle me-
dium (DMEM), foetal bovine serum (FBS), Antibiotic-Antimycotic (A/A),
AlexaFluor 568 (AF568) phalloidin, AlexaFluor 488 (AF488) phalloidin,
4’,6-diamidino-2- phenylindole (DAPI), trypsin-EDTA, phosphate buffer
(PBS, pH 7.4), were purchased from Invitrogen, UK. Magnesium fluoride
(MgF2) coverslips were purchased from Global Optics, UK. Carbon coated
copper TEM grids (300 mesh) were purchased from Agar Scientific, UK.
4.2.1 Quantum Rattles Cytotoxicity
Cell Culture
The human cervical cancer HeLa cells used in this study were obtained
from European Collection of Cell Cultures (ECACC, UK). This immortal
cell line is the oldest and most commonly used cancer cell line.[221] The
cells were maintained in an incubator at a temperature of 37 °C, regulated
with 5% CO2, 95% air, and a saturated humidity. DMEM medium sup-
plemented with 10% (v/v) FBS and 1% (v/v) A/A was used as the cell
culture medium. Cell media was changed every 2-4 days and the cells were
passed using trypsin-EDTA upon reaching 80% confluency.
Particle Sterilisation
Prior to cell seeding, all the particles were sterilised by ethanol washing
steps. Samples were dispersed in 70% ethanol and left for 2 h before be-
ing washed twice in ethanol, twice in PBS and twice in medium at 14000
rpm.min-1 for 5 min. The samples were then diluted to the appropriate
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concentration for the different assays. The samples were all used the same
day because, once in saline solution, the silica shells start degrading.[217]
MTT Assay
The influence of QRs and HSs on cell metabolic activity was assayed against
cervical HeLa cells using a MTT assay. This colorimetric assay measures
the enzymatic reduction of the yellow tetrazolium salt MTT by mitochon-
dria in living cells. Within active mitochondria, dehydrogenases split tet-
razolium rings into blue-violet, alcohol-soluble formazans. HeLa cells were
cultured as previously described (c.f. section 4.2.1) before being seeded
in a 48-well plates at a density of 2.104 cells.cm-2 and incubated in 5%
CO2 at 37 °C for 1 day. Cell culture media was replaced with media con-
taining particles at concentrations ranging from 108 particle.mL-1 to 1011
particle.mL-1. The cells were then incubated in the same conditions for
another 1 day or 3 days. At the end of the incubation, the media contain-
ing the particles was removed, and 300 μL of MTT salt solution (diluted
in a culture media without red-phenol and with a final concentration of
0.5 mg.mL-1) was added and incubated for another 2 h. The media was
replaced with 300 μL of DMSO per well, and the absorbance was monitored
using a microplate reader (SpectraMax M5) at the wavelength of 570 nm
with a reference wavelength at 650 nm. Formazan solution absorbs light at
550 nm to 570 nm, and the amount of absorbance is directly proportional
to the number of viable cells and their metabolic activity.[222] The cyto-
toxicity was expressed as the percentage of cell viability compared to each
time points respective untreated cell controls. The experiment was run in
triplicate and the results are presented as percentage averages ± standard
deviation. Statistical significance is determined using MatLab (Appendix
A.4.1) and is assessed for each time point assayed.
The negative and positive controls were medical grade PVC and organo-tin
PVC respectively, which were used in ISO 10993-5 cytotoxicity tests.[223]
Both plastic materials were left in 70% ethanol for 2 h and thoroughly
washed in PBS and media. Media (0.2 mL.cm-2of plastic control material)
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was added to dry samples of both control materials and left in the incubator
for 1 day. The media obtained was then used in the same way as the particle
containing sample media.
Total DNA Assay
The influence of QRs and HSs on cell proliferation was assayed against
cervical HeLa cells using a tDNA assay. This quantitative fluorescent as-
say is based on an ultrasensitive fluorescent nucleic acid stain which binds
to double-stranded DNA. HeLa cells were cultured as previously described
(c.f. section 4.2.1) before being seeded in a 48-well plates at a density of
2.104 cells.cm-2 and incubated in 5% CO2 at 37 °C for 1 day. Cell culture
media was replaced with media containing particles at a concentration of
1011 particle.mL-1. The cells were then incubated in the same conditions for
another 1 day or 3 days. At the end of the incubation, DNA was extracted
from the cells lysed by incubating them in papain digest (5 mM Cystein-
HCl, 5 mM EDTA, 1 - 2 units.mL-1 of papain in PBS) for 2 h in 5% CO2 at
60 °C. A 20 fold dilution of the TE buffer (10 nM Tris-HCl, 1 mM EDTA)
from the tDNA assay kit was prepared to make the working solution of Pi-
coGreen reagent (200 fold dilution in TE). The working reagent was added
to the lysate and allowed to react for 5 min in the dark. The fluorescence
emission was monitored at 535 nm with an excitation wavelength set at
480 nm using a microplate reader (SpectraMax M5). The cytotoxicity was
expressed as concentration of double stranded DNA which was calculated
subtracting the values obtained for DNA cell-free controls against a DNA
standard curve constructed from known DNA concentrations. The DNA
samples for the standard curve were obtained by diluting the DNA solution
provided in the tDNA kit (100 µg.mL-1bacteriophage lambda DNA) to con-
centrations varying from 1 µg.mL-1to 1 ng.mL-1, in 1 order of magnitude
steps. The negative and positive controls are identical to the controls pre-
pared for the MTT assay (c.f. section 4.2.1). The experiment was run in
triplicate and the results are presented as percentage averages ± standard
deviation. Statistical significance is determined using MatLab (Appendix
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A.4.1) and is assessed for each time point assayed.
Statistical Analysis
The statistical analysis was performed using MatLab R2012a (MathWorks).
To statistically assess differences in cytotoxicity between the QRs, HSs and
controls, a one-way ANOVA and Tukey’s honestly significant difference
criterion was used in the multiple comparison tests. These differences were
then deemed significant if the probability of the results occurring by random
chance was less than 5% (p < 0.05). The MatLab scripts and the results
from the multiple comparison tests are presented in Appendix A.4.1.
4.2.2 Quantum Rattle Silica Shells Functionalisation
The functionalisation potential of the QR silica shells was investigated by
functionalising the QR or HS silica shells with a fluorophore. QRs or HSs
(1 mg.mL-1) were left to incubate for 2 h in a 2% (v/v) APTES solution
in ethanol. The samples were then washed 3 times in MilliQ H2O by
centrifugation at 14000 rpm.min-1 for 2 min. Next the particles were left to
react with NHS-fluorescein in DMSO (1 mg.mL-1) for 15 min while stirring,
before being washed 3 more times in MilliQ H2O by centrifugation at 14000
rpm.min-1. The particles were then sterilised in the same way as QRs and
HSs (c.f. section 4.2.1) and always used the same day.
4.2.3 Microscopy
Laser Confocal Scanning Microscopy
Confocal Microscopy for Particle Internalisation Study: HeLa cells were
cultured as previously described (c.f. section 4.2.1) in 8-well glass cham-
ber slides (Lab-Tek®). Briefly, the cells were seeded at a density of 2.104
cells.cm-2 and cultured for 1 day before they were incubated with particles
at a concentration of 1011 particle.mL-1. After the medium was removed,
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the cells were washed 3 times with PBS and fixed with 4% (v/v) par-
aformaldehyde (PFA) in PBS. The cells F-actin and nuclei were stained
respectively with phalloidin, AF488 phalloidin and DAPI using established
methods. The cells were first permeabilised using 0.1% (v/v) Triton X in
PBS for 5 min. The cell samples were then blocked with 1% (w/v) BSA
in PBS for 30 min. The phalloidin and DAPI solutions were added under
dark conditions for 30 min and 5 min, respectively. In between each step
the samples were washed twice with PBS. The QRs were observed using
a multiphoton NIR laser set at 710 nm1. The glass slides were visualised
under a confocal microscope (Leica SP5 MP/Flim inverted) and the images
were analysed with Volocity 6.0 (PerkinElmer) and Amira 3D visualisation
software (Mercury Computer Systems). Finally, the 3D confocal internal-
isation movie was edited using iMovie (Apple).
Confocal Microscopy for QRs Silica Shell Functionalisation Study: HeLa
cells were cultured and stained as previously described (c.f. section 4.2.3)
in 8-well glass chamber slides (Lab-Tek®), with the exceptions that AF568
phalloidin was used to replace AF488 phalloidin to prevent the fluorescein
emission (518 nm) from overlapping with the phalloidin and that the fluor-
escein conjugated QRs and HSs were used (c.f. section 4.2.2). The glass
slides were visualised under a confocal microscope (Leica SP5 MP/Flim in-
verted) and the images were analysed with Volocity 6.0 (PerkinElmer).
Transmission Electron Microscopy
Transmission Electron Microscopy for Particle Internalisation Study : HeLa
cells were cultured as previously described (c.f. section 4.2.1) in 24-well
plates. Briefly, the cells were seeded at a density of 2.104 cells.cm-2 and
cultured for 1 day before they were incubated with particles at a concentra-
tion of 1011 particle.mL-1. After the medium was removed, the cells were
1Although the NIR multiphoton laser range is from 690 nm to 1020 nm, 710 nm was
chosen because the power attenuation below it was too strong. At 710 nm the
effective power of the multiphoton laser was 500 mW compared to < 200 mW at 690
nm.
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detached by incubation with 0.25% (v/v) trypsin-EDTA for 5 min. The cell
suspension was centrifuged at 1200 rpm.min-1 for 5 min. The supernatant
was removed and the cells were fixed on ice by 2.5% (v/v) glutaraldehyde,
0.1 M cacodylate buffer in MilliQ water for 30 min. Further fixation with
2% (w/v) osmium tetroxide, 2% (w/v) potassium ferrocyanide in 0.1 M
cacodylade buffer also provided heavy metal contrast staining for electron
microscopy visualisation of cells. The cells were dehydrated through a
graded ethanol series and then washed twice in 100% acetone. The em-
bedding was performed through a graded Epon812/Araldite resin:acetone
series (1:2, 2:1, 1:0 v/v), transferred to fresh pure Epon812/Araldite and
polymerised at 60 °C for 1 day. Ultrathin sections of approximately 100
nm were cut on a Power Tome XL ultramicrotome (RMC Products, USA)
using a 35° diamond knife and transferred to a TEM copper grid. Transmis-
sion electron microscopy (TEM) images of more than 30 different cells were
acquired using a JEOL 2000 TEM equipped with EDS detector, operated
at 120 kV.
Mapping Raman Spectroscopy
Mapping Raman Spectroscopy for Particle Internalisation Study : HeLa
cells were cultured as previously described (c.f. section 4.2.1) on 1 mm
x 1 mm MgF2 slides. The MgF2 slides were sterilised by incubating them
in 70% ethanol for 2 h before thoroughly washing them with PBS and me-
dia. The cells were seeded at a density of 2.104 cells.cm-2 and cultured
for 1 day before they were incubated with particles at a concentration of
1011 particle.mL-1. After the medium was removed, the cells were washed 3
times with PBS and fixed with 4% (v/v) paraformaldehyde (PFA) in PBS.
The QRs were observed using a Renishaw RM2000 Raman spectrometer
connected to a Leica microscope and equipped with a 600l grating. Raman
images were collected with 0.8 µm resolution using 60X, NA = 1.0, Nikon
objective. Acquisition time for individual spectra were 1 second and collec-
ted in the region of 400 cm-1 to 3100 cm-1. MatLab R2012a (MathWorks)
was used to process the Raman images by implementing in-house written
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scripts employing the N-FINDR algorithm with 4 endmembers.[224] Briefly,
the N-FINDR algorithm works by finding the most dissimilar spectra from
the entire data set of images and defining as endmembers. Each pixel of the
mapped sample is then described as a linear combination of the resulting
endmember spectra.
4.3 Results and Discussion
4.3.1 Quantum Rattles Cytotoxicity
Although a good indication of the favourable toxicology of QRs can be in-
ferred by the nature of their components, which are either biodegradable
(HS), clearable (AuQDs) or highly biocompatible (AuNPs), it is still im-
portant to show that their assembly does not impart cytotoxic properties.
Therefore, assessing the cytocompatibility of the QRs is key in evaluating
the QR suitability for cancer treatment.
Cell Metabolic Activity
The QRs cell metabolic activity in vitro was evaluated using a MTT assay
over a period of 3 days. This time frame is longer than the time period of a
typical photothermal therapeutic intervention in vivo using the EPR effect
to accumulate the photothermal agent at the tumour site.[113, 146, 225]
Based on previous studies demonstrating the use of NPs as photothermal
agents in both in vitro and in vivo environments,[29, 113] HeLa cells were
incubated for 1 day with QR and HS concentrations varying from 108
particle.mL-1 to 1011 particle.mL-1. Functionalised particles are more likely
to exhibit cytotoxic effects compared to non-functionalised particles be-
cause they require additional chemical treatments. Therefore, the meta-
bolic activity of fluorescein-functionalised QRs (fQRs) and HSs (fHSs) was
first evaluated for the above mentioned various concentrations. The MTT
assays (Figure 4.1) show similar cellular responses to all concentrations of
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fQRs, fHSs and the dilution series of the negative, medical grade PVC con-
trol, with no statistical differences observed in the dilution series of each
group (Appendix Figure A.4). The dilution effect of the positive, organo-tin
PVC control on cell metabolic activity is also clearly visible, demonstrating
that the HeLa cells response to toxic materials is normal.
After observing that fluorescein-functionalised QRs did not affect cell meta-
bolic activity, the cytotoxic behaviour over time of the as synthesised QRs
was examined. HeLa cells were incubated for up to 3 days with either QRs
or HSs at a concentration of 1011 particle.mL-1. The MTT assays (Figure
4.2) show similar cellular responses to QRs, HSs and the negative, medical
grade PVC control, with no significant statistical differences between the
groups (Appendix Figure A.5). These assays demonstrate that both QRs
and HSs do not interfere with cell metabolism or the cell cycle. Only the
positive, organo-tin PVC control shows significant statistical differences
from all the other groups, demonstrating that the HeLa cells response to
toxic materials is normal. These cell studies demonstrate the suitability of
the QRs, employed at a high concentration[146], for PTT treatment as the
QRs do not affect cell metabolic activity over the time period of a typical
therapeutic intervention in vivo.[113,146,225]
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Figure 4.1: Functionalised Quantum Rattles cytocompatibility evaluated
by MTT assay. The different concentrations were obtained by 10-fold
dilutions of either 1011 particle.mL-1 dispersions of fluorescently labelled
particles or of media pre-soaked in 5 cm2.mL-1 of control material (from
100% to 0.1%). HeLa cells after 1 day incubation in media containing
different concentrations (108 particle.mL-1 to 1011 particle.mL-1) of
fluorescein functionalised Quantum Rattles (fQR) or fluorescein
functionalised hollow mesoporous silica particles (fHS), do not show
alterations of metabolic activity compared to medical grade PVC
(Negative Control). Organo-tin PVC (Positive Control) shows expected
cytotoxic effect on the cell metabolic activity, proportional to the dilution
factor of the original organo-tin PVC solution. Results are normalised to
blank control (cells culture media without nanoparticles). Error bars
represent the standard deviations of triplicate experiments.
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Figure 4.2: Quantum Rattles cytocompatibility evaluated by MTT
assay. HeLa cells after 1 day and 3 days incubation in media containing
either 1011 particle.mL-1 Quantum Rattles (QR, red) or hollow
mesoporous silica particles (HS, blue) do not show alterations of
metabolic activity compared to medical grade PVC (Negative Control,
white), whereas no metabolic activity is measured with organo-tin PVC
(Positive Control, black). Results are normalised to blank control (cells
culture media without nanoparticles). Error bars represent the standard
deviations of triplicate experiments.
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Cell Proliferation
PicoGreen total DNA assays were performed on QR-incubated HeLa cells,
to further evaluate the QRs cell viability and proliferation in vitro (Figure
4.3). The same incubation times and particle concentration used in the
MTT assays (up to 3 days at 1011 particle.mL-1) were employed in the
tDNA assay. As with the MTT assay, the tDNA assay shows similar cell
responses to QR, HS and the negative, medical grade PVC control. The
results show a general increase in double-stranded DNA content, which
correlates to the amount of viable cells. Cell proliferation is neither up-
regulated nor down-regulated by the presence of QR particles as there is
no significant statistical difference observed between cells cultured with
QR or with the negative, medical grade PVC control. (Appendix Figure
A.6). As expected, cell proliferation is impeded by the positive, organo-tin
control, which shows significant statistical differences with all other groups.
These cell proliferation results confirm the MTT cell viability results, and
prove again the potential of the QR system for PTT.
4.3.2 Quantum Rattles Internalisation
The processes and mechanisms of internalisation, alongside the QRs loc-
alisation, are critical to establish the QRs performance for PTT, chemo-
therapy and imaging. Cell internalisation of the QRs into isolated com-
partments is necessary for accurate live imaging as it ensures that the QR
components are trafficked together for the course of a typical PTT treat-
ment.[113, 146, 225] The QRs cellular internalisation process was investig-
ated by laser confocal scanning microscopy, TEM of ultrathin sections and
mapping Raman spectroscopy.
For the confocal microscopy study, HeLa cells were incubated with QRs for
1 day and stained for fluorescence microscopy. The QRs native NIR photo-
luminescence enabled facile luminescent imaging by means of a multiphoton
NIR laser, thereby demonstrating the QRs potential for live imaging (Fig-
ure 4.4 and Movie 4.1). The luminescent images and reconstructed 3D
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Figure 4.3: Quantum Rattles cytocompatibility evaluated by total DNA
assay. HeLa cells after 1 day and 3 days incubation in media containing
either 1011 particle.mL-1 Quantum Rattles (QR, red) or hollow
mesoporous silica particles (HS, blue) do not show alterations of cell
proliferation compared to medical grade PVC (Negative Control, white).
Cell proliferation and viability are significantly affected by organo-tin
PVC (Positive Control, black). Error bars represent the standard
deviations of triplicate experiments.
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Movie 4.1: Quantum Rattle internalisation and near-infrared
fluorescence. Three-dimensional reconstruction of laser confocal scanning
microscopy images of HeLa cells incubated for 1 day with Quantum
Rattles (QR), which are imaged through their native photoluminescence
(red). Cells are stained for F-actin (phalloidin AF488, green) and nucleus
(DAPI, blue). QRs are localised by their own fluorescence within the
cells, accumulating in the perinuclear region. (Click to play. Requires
Adobe Reader 8.× or higher)
movie show QRs localised within the cells cytoplasm and accumulating in
the perinuclear region. This is compatible with endocytotic processes that
internalise particles, traffic them through the endolysosomal system to fi-
nally accumulate in the perinuclear area. The QRs PTT performance could
take advantage of this perinuclear localisation, which sensitises cells to heat
shock. Other QRs are localised within actin-rich cups at the cell membrane,
a further indication in support of cell-mediated endocytosis processes for
internalisation.
Another approach, based on conjugating fluorescent dyes to the QRs and
HSs, was used in this study to follow the internalisation process of the
QRs. In this way, the potential of QR silane functionalisation could also
be investigated. A fluorophore (fluorescein) was conjugated to the silica
shells of HSs (fHSs) and QRs (fQRs), and internalised particles were now
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imaged using the fluorescence of the functionalised dye instead of the native
QR photoluminescence. HeLa cells were incubated with dye-conjugated
particles for 1 day and stained for fluorescence microscopy. Both fHSs and
fQRs are clearly visible using the fluorescence of the fluorophore. This
simple, yet effective functionalisation process opens the door to a more
advanced QR system, including active targeting ability, improved stability,
triggered drug delivery, etc.
In addition to the fluorescent confocal microscopy results, TEM of ultrathin
sections provided further insight into the localisation and trafficking of the
QRs (Figures 4.6 and 4.7). The TEM images show that the QRs are intern-
alised by HeLa cells without affecting the cell structure or cell morphology
(Figure 4.6). In some cells, the QRs are localised in large groups within
membranous vesicles inside the cytoplasm (Figure 4.7). Furthermore, the
QR clusters inside the vesicle clearly show AuNPs surrounded by silica
shells (Figure 4.7c). The smaller, darker spots most probably represent the
AuQDs. EDS analysis confirmed the presence of both gold and silica inside
the vesicles (Figure 4.7d), supporting cellular internalisation of the QRs.
Finally, HeLa cells, incubated with QRs for 1 day at a concentration of 1011
particle.mL-1, were also examined using Raman mapping spectroscopy. The
Raman results detected the presence of amino acids and DNA molecules
of the nuclei, proteins of the cytoplasm, gold and lipids. In particular,
the Raman mapping showed that lipids tend to surround gold (as seen in
the gold with lipid spectra between 2800 cm-1 and 3000 cm-1) within the
cell cytoplasm. The intracellular membranes encapsulating the QRs, as
observed with TEM, can be attributed to these lipid vesicles.
It has been reported in many studies that the particle size is a key factor
in the process of particle internalisation.[226–228] Other research groups
showed internalisation of nanoparticles smaller than 200 nm mainly in-
volved clathrin-mediated endocytosis (CME).[229] By means of this CME
pathway, NPs are directed in clathrin-coated vesicles of around 120 nm to-
wards lysosomes.[229] The QR-surrounding vesicles observed in the TEM
images, however, appeared to have sizes varying from 300 nm to 1 µm, con-
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Figure 4.6: Quantum Rattle internalisation. Transmission electron
micrographs of ultrathin sections of HeLa cells incubated with Quantum
Rattles (QRs) for 1 day, showing the co-internalisation and trafficking of
the entire QR structure. (a-b) Cell overview. Red arrows points at
internalised QRs. Scale bar: 2 µm. (c-d) Close-ups of the QR cluster.
Scale bar: 500 nm.
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Figure 4.7: Quantum Rattle internalisation (a-c) Transmission electron
micrographs of ultrathin sections of HeLa cells incubated with Quantum
Rattles (QR) for 1 day showing the co-internalisation and trafficking of
the entire QR structure. (a) Cell overview. Red arrow points at
internalised QRs being trafficked within a membranous vesicle. Scale bar:
2 µm. (b) Close-up of the QR cluster inside the vesicle. Inset: Zoom in on
one QR. Scale bar: 100 nm. (c) Zoom in on several QRs, where energy
dispersive x-ray spectroscopy analysis was performed. Scale bar: 100 nm.
(d) EDS spectrum of the QR region indicating the presence of silica and
gold.
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Figure 4.8: Mapping Raman spectroscopy of Quantum Rattles (QR)
internalised by HeLa cells. Each pixel represents a Raman spectrum,
which were categorised in 4 groups: nuclei (blue), cytoplasm (green), gold
(red) and gold with lipids (yellow). Peaks originating from lipid molecules
are clearly visible for spectra around the QRs. Scale bar: 8 µm.
taining mostly clusters of QRs. This suggests the QRs are taken up by the
cells through a clathrin-independent macropinocytosis mechanism. During
macropinocytosis cell-surface protrusions collapse onto the foreign material,
in this case the QRs, and fuse with the plasma membrane to generate large
endocytotic vesicles (0.5 µm - 10 µm).[227] When the QRs are internalised
via this non-specific pathway, the vesicles deliver the QRs into other, non-
lysosomal compartments.[230] The bypass of the acidic and harmful milieu
via the macropinocytotic pathway might be a major advantage of the QR
system for drug delivery applications.[227,228]
4.4 Conclusions
The aim of this chapter was to demonstrate the biocompatibility of the
QRs as well as their internalisation process. The QRs non-cytotoxic effect is
crucial before looking at their PTT potential as the QRs need to selectively
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kill cancer cells, but only in a controlled manner once they are triggered
by NIR light. The first part of the chapter demonstrated that the QRs,
employed at a high concentration,[146] are well tolerated by cells over the
few days of a typical therapeutic intervention in vivo.[113,146,225]
The second part of the chapter focused on the internalisation process of
the QRs to investigate both the intracellular fate of the QRs as well as
their potential for fluorescent live imaging. The QRs internalisation was
verified by three complementary techniques that suggested QR trafficking
via endocytotic pathways to the perinuclear region. The internalised QRs
can be imaged in the NIR through both their native fluorescence and con-
jugated fluorescent dyes, proving their use for cancer detection. Moreover,
the simple functionalisation procedure demonstrated in this study, shows
great possibilities for designing a more advanced QR system with improved
or added properties.
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Chapter 5
Quantum Rattles Mediate
Hyperthermia In Vitro
5.1 Introduction
Despite years of research and drug development for cancer treatment, can-
cer still remains one of the leading cause of death worldwide.[22] Tradition-
ally, chemotherapy, radiotherapy and surgical ablation of tumours have
been used, in combination, to treat many cancers,[7,144,168,169] however
all these methods have limitations.[25,170] Anticancer drug treatments may
exhibit limited efficacy while causing high morbidity due to unwanted side
effects.[23,25,170] At the same time, radiotherapy can be very demanding
on a patient’s body, causing significant collateral damage to healthy tissue
and resulting in additional morbidity.[231, 232] Likewise, surgery is highly
invasive, requires long convalescence periods and cannot be undertaken for
the treatment of metastatic cancers or tumours that are not easily access-
ible.[170]
Over the past years, new technologies have attempted to address the lim-
itations of conventional cancer treatments by:
• Identifying specific early biomarkers with a view to developing reliable
tools for early cancer detection and to monitor cancer recurrence;
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• Developing cost-effective, fast and non-invasive screening techniques
for clinical implementation;
• Developing diagnostic tools capable of imaging tumours throughout
the entire body;
• Engineering hybrid materials with powerful therapeutic activity, highly
specific and selective tumour targeting and significantly lower associ-
ated side effects.
In particular, nanotechnology has played a crucial role in the develop-
ment of new cancer therapeutics.[7, 23–28] Recently, cancer nanomedicine
research has focused on systems that can improve diagnostic and thera-
peutic capabilities, by enhancing efficacy, reducing side effects, targeting
and translocating across biological barriers, improving biodistribution and
combining therapies.[23,28,81,91,198] Among the advanced nanomaterials
that hold the greatest promise for new cancer treatments, silica and gold
nanostructures are of particular interest and stand at the core of simple, yet
efficient nanotechnologies.[190, 233] For example, mesoporous silica nano-
materials are effective drug carriers due to their large specific surface area
and pore volume, favourable biocompatibility and ease of functionalisa-
tion through silane chemistry.[175–177] Likewise, gold nanostructures are
promising candidates for cancer treatments, in particular as photothermal
therapy (PTT) agents due to their optical absorbance in the visible and
near-infrared (NIR).[23, 25,28,50,92,148]
While Chapter 6 focuses on the drug delivery application of the QRs, this
chapter investigates the potential of QR-mediated PTT. Like chemother-
apy, PTT is a cancer treatment that relies on selective targeting and the
increased sensitivity of cancer cells to cytotoxic damage.[6] However, in-
stead of using drugs to kill cancerous cells, PTT generates heat to destroy
the tumour. The direct delivery of localised photoenergy to the tumour,
makes PTT a less invasive alternative to conventional cancer therapies.[92]
Depending on the temperature increase achieved in vivo by PTT, either
hyperthermia or thermal ablation occurs.[92] Hyperthermia is defined as
the heating of tissues to temperatures between 42 °C and 46 °C,[150] while
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thermal ablation is defined as irreversible PTT-induced necrosis.[234] Pre-
vious studies demonstrated that, by comparison with healthy tissue, tu-
mours are selectively destroyed when subjected to temperature increases
in the range of 42 °C to 46 °C.[6, 148, 149] Such selective destruction of
tumour tissue is caused by reduced heat tolerance which, in turn, is mainly
due to inferior vascularisation.[6, 148, 149] The rate of heat dissipation by
blood flow in tumours is slower than that in normal tissues, and thus the
higher temperature in the tumour is sustained longer compared to normal
tissue.[235, 236] Furthermore, upon heating, the intratumorous environ-
ment becomes even more acidic, hypoxic, and nutritionally deprived.[236]
Such a suboptimal environment in the heated tumours potentiates the re-
sponse of tumour cells to hyperthermia and inhibits the repair of thermal
damage.[149,235,236]
The strong plasmonic properties of gold nanoparticles (NPs) make them at-
tractive candidates for PTT.[23,54,92] In 2003, Hirsch and co-workers were
the first to demonstrate the use of gold NPs as a photothermal agent.[29]
Compared to traditional photothermal agents, such as light-absorbing dyes,
gold NPs exhibit enhanced optical cross-sections (up to 5 orders of mag-
nitude stronger) and higher photostability.[129, 148, 151] In addition, gold
NPs have a strong surface plasmon resonance that can easily be tailored by
varying the composition, size or shape of the NPs. The gold NP plasmon
resonance can either radiate (Mie scattering) or can be converted to heat
(absorption).[129] Although spherical gold NPs have been investigated as
photothermal agents,[158, 159] they mainly absorb light in the visible re-
gion (around 530 nm),[28] which has a shallow penetration depth in tissue
compared to the NIR ’bio-window’ (650 nm and 900 nm), where blood and
soft tissue are relatively transparent.[6, 23,28,115,129] In order to circum-
vent this major drawback, NPs can be aggregated or clustered to shift the
absorbance away from the visible spectrum and towards the NIR.[55,237]
Other strategies have been developed in order to attain a shift in the gold
NP plasmon resonance towards the NIR (Table 5.1). NP systems, consist-
ing of gold nanoshells formed around a dielectric silica core, were shown to
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have a resonance span from the visible to the NIR, depending on the silica
core dimension and gold shell thickness.[152,153] Likewise, by tailoring the
dimensions of hollow gold nanoshells[109, 154, 161, 162] and gold nanoc-
ages,[155, 156, 163] absorbance in the NIR can be obtained. Furthermore,
gold nanorods can easily be tuned to absorb light in the NIR.[139, 157]
Their elongated shape offer a stronger absorption cross-section and they
heat faster than gold (-silica) nanoshells or nanocages.[10, 164–167] The
gold NP systems, pointed out above and in Table 5.1, with absorbance in
the NIR bio-window, are highly promising for PTT. Also, the hollow core
of the nanoshells and nanocages can additionally be used as a vector for
delivering therapeutic agents.[238] Finally, the advance to clinical trials of
some gold-based systems (e.g. Nanospectra Bioscience and CytImmune)
for PTT and drug/gene delivery further indicates the great potential of
gold NPs to improve cancer treatment.[29,50]
The aim of this chapter is to examine the potential of QR-mediated PTT.
By demonstrating the QRs photothermal ability, in addition to the their
native photoluminescence (Chapter 3) and use for in vitro NIR live imaging
(Chapter 3), the QRs would prove to be an advanced, natively multimodal
system compared to existing NPs for PTT (the QRs potential for drug
delivery will be examined in Chapter 6). To date, the optical properties
of AuQDs have never been used for PTT applications (Table 5.1). It is
hypothesised that the AuQDs in the silica shells of the QRs, having an
extinction peak in the NIR at 672 nm (Chapter 3), will generate heat upon
laser irradiation, thereby causing cell death in cancerous tissue. First,
the NIR photothermal conversion ability of the QR system is explored
on dry surfaces and in solution by measuring temperature changes upon
laser irradiation. Next, QR-incubated HeLa cells are subjected to NIR
irradiation to investigate the potential of the QR system to induce cell
death in vitro. Lastly, ex vivo characterisation of the PTT potential of the
QRs is investigated as a final step towards a future study using an animal
model.
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5.2 Materials and Methods
Mr. Ji Qi from Dr. Daniel Elson’s group at Imperial College London helped
with the set up and use of the thermal camera employed in the assessment
of the QRs photothermal potential experiment and provided us with the
57 mW, 671 nm diode laser (DreamLaser, China). The 300 mW, 671 nm
diode laser (DreamLaser, China) was provided by Prof. Søren Hassing
at the University of Southern Denmark, Denmark. The high resolution
transmission electron microscopy images were acquired with the help of
Dr. Sergio Bertazzo.
Materials : Solvents, such as absolute ethanol, were purchased from VWR,
UK. LIVE/DEAD® Viability/Cytotoxicity Kit (L-3224), Dulbecco’s mod-
ified eagle medium (DMEM), trypsin-EDTA, foetal bovine serum (FBS),
Antibiotic-Antimycotic (A/A), phosphate buffer (PBS, pH 7.4), were pur-
chased from Invitrogen, UK. The chicken thighs for the ex vivo study were
purchased from Waitrose, UK.
5.2.1 Photothermal Properties of the Quantum
Rattles
Temperature Measurement of Dry Quantum Rattles : To assess the NIR
photothermal properties of the QRs on dried surfaces, QR and HS suspen-
sions (2 mg.mL-1) were first prepared in ethanol. A drop of the suspensions
was then deposited on borosilicate coverslips and left to dry. The process
was repeated 3 times. The dry coverslips were mounted in the path of 300
mW and 57 mW, 671 nm diode lasers (38 W.cm-2, and 7 W.cm-2, respect-
ively) and the temperature data was recorded through a thermal camera.
Data were logged for more than 10 min, with 10 sec interval collected prior
to the laser being turned on and 1 min interval between 5 min and 4 min
acquisition times with the laser turned on. The maximum temperature in
a 1.5 mm diameter disk area centred on the laser spot was recorded for
each sample. The experiments were repeated three times.
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Temperature Measurement of Quantum Rattles in Solution: To assess the
NIR photothermal properties of QRs and HSs in solutions, QR and HS
suspensions (2 mg.mL-1) were prepared in MilliQ H2O. A quartz cuvette
containing 1 mL of suspension was placed in the path of a 300 mW, 671 nm
diode laser (38 W.cm-2), while the temperature profile of the solution was
recorded using a mini-hypodermic probe, type T thermocouple (Omega,
UK) and a RTD thermometer (Omega, UK). The mini-hypodermic probe
was placed at the top of the quartz cuvette with its active extremity in the
QR dispersion, whereas the laser was shone upon the QR dispersion at the
bottom of the cuvette. This ensured that any heating recorded was not due
to the laser/probe interaction. Data was logged until no further increase in
temperature was recorded. The experiments were repeated three times.
Laser Irradiation Effect on QRs Morphology : High resolution transmis-
sion electron microscopy (HRTEM) was used to determine the morphology
of the QRs after NIR irradiation. HRTEM images of the particles were
acquired using a FEI TITAN 80/300 STEM/TEM operating at an acceler-
ating voltage of 200 kV. Samples were dissolved in EtOH (1 mg.ml-1) and
drop-deposited on TEM grids. The TEM grids were placed under the path
of a 30 mW, 671 nm laser (38 W.cm-2) for 15 min prior to analysis.
5.2.2 In Vitro Assessment of the Quantum Rattles
Photothermal Properties
LIVE/DEAD Assay
The QRs potential to mediate controlled cell death upon NIR light ac-
tivation was investigated in vitro by assaying cell viability against HeLa
cells using a LIVE/DEAD assay after NIR irradiation. Cells incubated
with either media with no particles or containing HS were used as controls.
This two-colour assay determines viability in a cell population based on
plasma membrane integrity and esterase activity. Membrane-permeant cal-
cein AM (LIVE stain) is cleaved by esterases in live cells to yield cytoplas-
mic green fluorescence, and membrane-impermeant ethidium homodimer-1
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labels nucleic acids of membrane-compromised cells with red fluorescence.
HeLa cells were cultured as previously described (c.f. section 4.2.1) in 6-
well plates at a density of 2.104 cells.cm-2 and cultured in 5% CO2 at 37 °C
for 1 day. The QRs and HSs sterilisation was performed identically to the
in vitro studies performed in chapter 4 (c.f. section 4.2.1). Cell culture
media was replaced with media containing particles at a concentration of
1011 particle.mL-1. The cells were then incubated under the same condi-
tions for another period of 1 day. At the end of the incubation period,
samples were irradiated with a 300 mW, 671 nm laser (38 W.cm-2) for 0
min, 2 min, 5 min, 8 min, 10 min and 15 min. The total amount of time
outside the incubator for any sample was 15 min. Afterwards, the media
containing the particles was removed, and 1 mL of LIVE/DEAD solution
(2 µM calcein AM, 2 µM ethidium homodimer-1 in PBS) was added. The
samples were incubated for another 45 min at 37 °C before being imaged
using a Leica epifluorescent inverted microscope. The ’LIVE’ green and
’DEAD’ red images were merged using Photoshop CS5 (Adobe) to obtain
the LIVE/DEAD images used to quantify cell death. The experiment was
performed four times.
LIVE/DEAD Assay Quantification
Image processing and segmentation algorithms were used to quantify the
QR-mediated cell death. Masks were applied to the fluorescent microscopy
images in Photoshop CS5 (Adobe) to obtain the exact areas of the irra-
diated cell population (Figure 5.1a) and of the cell population adjacent
to the irradiated surface (Figure 5.1b). The masks were the inverse of a
1 mm disk centred on the laser spot (Figure 5.1a) for the irradiated cell
population and the inverse of a 0.3 mm thick ring around the laser spot
(Figure 5.1b) for the adjacent cell population.
The images of both LIVE and DEAD channels were then segmented us-
ing MatLab R2012a (MathWorks) to obtain binary images representing
the surface of live and dead cells, respectively (Figure 5.2). The Mat-
Lab script used to obtain the binary images is described in the Appendices
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Figure 5.1: LIVE/DEAD assays quantification - irradiated cell
population (a-b) Representative merged fluorescent microscopy image
series of LIVE/DEAD assays performed on HeLa cells (live cells in green,
dead cells in red) incubated with Quantum Rattles for 1 day and
irradiated for 8 min with 671 nm laser light (38 W.cm-2). The dashed
surface represents the mask applied to obtain the cropped image of the
LIVE and DEAD channels of (a) the irradiated cell population and (b)
the cells adjacent to the laser spot. Scale bars: 200 µm
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(script A.9). The percentage cell death was obtained by calculating the sum
of the binary image matrices and normalising the DEAD channel value over
the total of both LIVE and DEAD channel values.
LIVE/DEAD Assay - Time-Lapse Confocal Microscopy
Time-lapse confocal microscopy was used to follow the real-time cell vi-
ability of HeLa cells incubated with QRs. HeLa cells were cultured as
previously described (c.f. section 5.2.2) in 8-well glass chamber slides (Lab-
Tek®). Briefly, the cells were seeded at a density of 2.104 cells.cm-2 and
cultured for 1 day before they were incubated with QRs at a concentration
of 1011 particle.mL-1. After the medium was removed, the cells were washed
3 times with PBS and 1 mL of LIVE/DEAD solution (2 µM calcein AM,
2 µM ethidium homodimer-1 in PBS) was added. The QR-incubated cells
were observed under a confocal microscope (Leica SP5 MP/Flim inverted)
equipped with an environmental chamber. The QR-incubated cells were
irradiated using a multiphoton NIR laser at 710 nm.1 LIVE and DEAD
channels were defined as the emission window of calcein (494 nm - 517 nm)
and DNA-bound ethidium homodimer-1 (528 nm - 617 nm), respectively.
Bright-field and LIVE channels were recorded during laser treatments of 2
or 5 min after which the laser treatment was stopped and the DEAD chan-
nel was recorded in addition to the LIVE channel for a further 40 min.2
The movie clips were created using Fiji (National Institutes of Health) and
assembled in iMovie (Apple).
1Although the NIR multiphoton laser range is from 690 nm to 1100 nm, 710 nm was
chosen because the power attenuation below this wavelength was too strong. At 710
nm the effective power of the multiphoton laser was 500 mW compared to < 200
mW at 690 nm.
2The DEAD channel could not be recorded at the same time because the laser treat-
ment as the wavelength used to treat the cells (710 nm) and the emission wavelength
window of DNA-bound ethidium homodimer-1 were too close, resulting in saturation
of the DEAD channel while treating the cells with NIR light.
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5.2.3 Ex Vivo Assessment of the Quantum Rattles
Photothermal Properties
The QRs photothermal potential in tissue upon NIR irradiation was in-
vestigated ex vivo using chicken muscles from the thigh (Figure 5.3). QR
suspension (2 mg.mL-1) was prepared in PBS and approximately 500 µL
was subcutaneously injected in the chicken thighs. Chicken tissue injected
with PBS (without any QRs) and untreated chicken tissue served as con-
trols. The chicken thighs were placed under the path of a 300 mW, 671 nm
diode laser (38 W.cm-2) and the tissue temperature profiles were recorded
using a mini-hypodermic probe, type T thermocouple (Omega, UK) and a
RTD thermometer (Omega, UK). The mini-hypodermic probe was inserted
1 to 3 mm under the skin of the chicken thigh and the temperature pro-
file was recorded before and after NIR irradiation. The experiments were
repeated 3 times.
5.3 Results and Discussion
5.3.1 Photothermal Properties of the Quantum
Rattles
Dried Quantum Rattles
The NIR extinction peak of the QRs at 672 nm (c.f. Chapter 3) could be
used for QR-mediated PTT, if the photothermal conversion of the QRs is
high enough to induce hyperthermia. The QRs photothermal conversion
efficiency of NIR light to heat was investigated using a thermal camera,
while using a 671 nm laser (38 W.cm-2) to irradiate QRs deposited on a
borosilicate glass surface (Figure 5.4). During the first minute of laser ir-
radiation, the QRs induce a rapid temperature increase of approximately 6
°C, whereas the HS control did not record any heat increase. The temper-
ature stabilises after the first minute of laser irradiation and rapidly drops
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Figure 5.3: Schematic of the experimental set-up used for the ex vivo
study of Quantum Rattles (QRs) NIR light absorption potential. QRs
were subcutaneously injected in chicken thighs, which were subsequently
treated with NIR light at 671 nm (38 W.cm-2). Temperature profiles were
monitored using a thermocouple probe inserted under the skin of the
chicken thigh and recorded with a RTD thermometer.
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Figure 5.4: Photothermal properties of Quantum Rattles. Temperature
profiles monitored with a thermal camera of hollow mesoporous silica
shells (HS, blue) and Quantum Rattles (QR, red) dried on a glass slide
showing a temperature increase in the QR samples upon irradiation with
a 671 nm laser (38 W.cm-2) compared to the HS control.
to the initial value after closing the laser shutter. The reproducibility of the
QR-induced heating phenomenon was tested by reopening the laser shut-
ter after one minute. Subjecting the QRs to the laser light again induces
the same temperature profile as in the first experiment, indicating that the
heating of the QRs does not alter their photothermal ability.
The same photothermal efficiency experiment was performed on the QRs
and HSs at a lower power density (7 W.cm-2) using a less powerful 57 mW,
671 nm diode laser (Figure 5.5). Movies of the temperature acquisition by
the thermal camera and real-time heating of the QRs are viewable in the
Appendices (Movies A.1 and A.2). Although the lower power density laser
irradiation (7 W.cm-2) causes heating of the QRs, the measured increase
in temperature is just 1.5 °C compared to 6 °C for QRs irradiated at a
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Figure 5.5: Photothermal properties of Quantum Rattles. Temperature
profiles monitored through a thermal camera of (a) hollow mesoporous
silica shells (HS, blue) and (b) Quantum Rattles (QR, red) dried on a
glass slide showing a temperature increase in the QR samples upon
irradiation with a 671 nm laser (7 W.cm-2) compared to the HS control.
The temperature increase is lower than when the QR are irradiated at a
power density of 38 W.cm-2(Figure 5.4), demonstrating the photothermal
conversion is dependent on the incident laser irradiation power.
higher power density of NIR laser light (38 W.cm-2). Hence, the observed
temperature increase is dependent on the power of the incident irradiation.
This NIR light dose dependency needs to be taken into account in order to
modulate the QRs efficiency when mediating hyperthermia in tumours.
Quantum Rattles in Solution
After assessing the photothermal conversion efficiency of QRs in a dry state
on a surface, QRs were dispersed in water to investigate their ability to heat
a bulk volume of solvent (Figure 5.6). Upon irradiation with a 671 nm laser
(38 W.cm-2), the QRs induce an increase of 3 °C in temperature of the sur-
rounding water (1 mL) within a time period of 5 - 10 min, whereas the HS
control do not generate any heat. Compared to the QRs irradiated in a
dry environment, the QRs in solution cause a slower and lower temperature
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increase. However, this lower heat increase is to be expected as the tem-
perature probe was placed outside the laser spot to demonstrate that an
entire volume of water can be heated by a localised application of NIR light
and, at the same time, ensure that any temperature increase is not due to
probe/laser interaction. This bulk heating of a macroscopic volume of wa-
ter shows great promise for in vivo QR-mediated PTT application, where
the whole tumour needs to be heated homogeneously over the treatment
period.
Compared to other NP systems that possess very high absorbance cross-
sections, such as gold nanorods, the QRs quantum plasmon peak at 672 nm
is different in nature to the local surface plasmon peak.[6,28] In the case of
AuQDs incorporated in the QR shell, quantum confinement effects govern
the optical absorption, whereas the local surface plasmon exhibited by gold
nanorods arises from coherent, collective dipolar oscillations of conduction
band electrons. This difference in physical phenomena causing the extinc-
tion peak of the QRs compared to other NP systems might lead to different
approaches and uses of the QRs for PTT. It is important to note that the
NIR extinction peak (at 672 nm) of the QRs is utilised for exploiting both
the imaging and therapeutic properties of the QR system. Therefore, an
unavoidable trade-off exists between the amount of absorbed incident NIR
light converted to photoluminescent emission (used to image the QR) and
the amount of absorbed light converted to heat (used to mediate hyperther-
mia). Nevertheless, combining tumour imaging and hyperthermia within
one sole agent guarantees distinct therapeutic targeting on the imaged area
only.
Effect of Laser Irradiation on Quantum Rattle Morphology
In order to assess the effect of laser irradiation on the QRs morphology
and structure, QRs that underwent laser irradiation (671 nm, 38 W.cm-2)
for 15 min were analysed by HRTEM (Figure 5.7). When compared to the
HRTEM images of the non-irradiated QRs (c.f. Figure 3.9), the HRTEM
images of the irradiated QRs show that the laser does not influence the
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Figure 5.6: Photothermal properties of Quantum Rattles. Temperature
profiles monitored through a thermocouple probe of (a) hollow
mesoporous silica shells (HS, blue) and (b) Quantum Rattles (QR, red) in
solution showing a bulk increase in the solvent temperature upon
irradiation with a 671 nm laser (38 W.cm-2) for the QRs compared to the
HS control.
morphology of the silica shell. Furthermore, the AuQDs are still present in
the QR silica shell after laser irradiation. The mesopores in the silica shell,
encapsulating the AuQDs, appear to stabilise the structure of the AuQDs
and preserve them from alterations caused by the heating process. This
is an important feature of the QRs, as laser irradiation of gold NPs have
been reported to lead to fragmentation of the NPs.[239,240] The slow heat
release of the deposited laser energy into the surrounding environment by
the gold NPs, can result in the melting and even vaporisation of the gold
atoms.[89] As the gold NPs cannot cool down as fast as they are heated,
they fragment into smaller nanodots.[89] In addition, gold nanostructures
for PTT that have high photothermal conversion efficiency, such as gold
nanorods, have also been reported to change shape under the influence of
laser light.[89, 164, 241] However, previous studies have also demonstrated
that the addition of a silica layer around gold nanorods can prevent the
morphological change of the gold due to the laser light,[241] which can
be an explanation for the preserved AuQDs in the QR silica shell. This
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Figure 5.7: Effect of irradiation on the Quantum Rattles. Bright Field
high resolution transmission electron microscopy (HRTEM) images of (a)
overview and (b) close-up of a Quantum Rattle after irradiation by a 671
nm laser (38 W.cm-2) for 15 min. Scale bars: 50 nm.
non-destructive character of the QR upon laser irradiation shows again the
great potential of the QR system for PTT purposes.
5.3.2 In Vitro Assessment of the Quantum Rattles
Photothermal Properties
The QRs temperature profiles monitored on a surface or in solution upon
laser irradiation, show the potential of the QRs for inducing hyperthermia
in cells by means of AuQD-mediated heat generation. The next step in this
study, was to try and induce localised cell death in vitro using the novel
QR system. HeLa cells were incubated with QRs for 1 day and irradiated
with a 671 nm laser (38 W.cm-2) to establish the QRs efficiency at inducing
cell death (Figure 5.8). LIVE/DEAD assays were used to determine the
performance of the QRs at inducing localised cell death. Cells incubated
with either no particles or HSs were used as controls. All QR-incubated
cells remain viable below 2 min of irradiation (Figure 5.8a-b). After this
threshold of 2 min of laser light, circular regions of cell death are seen in the
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LIVE/DEAD fluorescence microscopy images (Figure 5.8c-f). The amount
of cell death in and around the area of the laser spot is irradiation-time
dependent. On the other hand, laser irradiation on cells incubated with no
particles or HSs do not induce any cell death, demonstrating the need of
QRs for NIR laser-triggered cell death and, therefore, the QRs potential
for PTT (Figure 5.8g-h). Although cell death clearly occurs in the centre
of the laser treatment area, cells also die in close proximity of the laser
spot. This result can be explained by heat diffusing from the irradiated
QRs inside the laser spot to the cells outside the beam area.
Image processing and segmentation algorithms of the LIVE/DEAD assays
provided quantification of QR-mediated cell death by computing the per-
centage of cell death. Cell death within the laser spot is proportional to
irradiation times between 2 and 10 min and then saturates reaching 97%
cell death (Figures 5.9). Cells outside the laser beam are indirectly affected
by the laser irradiation. Quantifications of the cell death in the cell popu-
lation adjacent to the laser beam show that the percentage of cell death in
this region is linearly proportional to the irradiation time, with a squared
correlation coefficient R2 value of 0.97 (Figures 5.10). After 15 min of laser
irradiation, the percentage of cell death reaches 84% in close proximity to
the laser beam.
Previous in vitro studies of gold nanosystems-mediated cell death do not
report on the evolution of cell death depending on irradiation time and,
therefore, the question of the fate of the cells adjacent to the laser beam
remains unclear.[29,136,153] The in vitro QR-mediated PTT experiments
demonstrate the importance of a trade-off between the time or dose of a
treatment, the amount of cell death in the laser treatment area and the
amount of collateral damage outside the treatment area. However, in vitro
studies do not allow the differentiation of NP-induced photothermal effects
between cancerous cells and healthy cells. Nevertheless, for in vivo NP-
mediated PTT applications, other parameters besides the NIR irradiation
area prevent damage to healthy cells, such as targeting (passive or active)
and the lower sensitivity of healthy cells to heat damage compared to cancer
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cells.
Cell death was followed by time-lapse confocal microscopy on HeLa cells
incubated with QRs, in order to gain a further understanding of the un-
derlying process involved in QR-mediated cell death (Movie 5.1). In the
time-lapse sequence the LIVE stain (calcein) rapidly disappeared (within
2 min) from most cells under NIR laser irradiation, indicating comprom-
ised cell viability by the quick loss of intracellular esterase activity (Movie
5.1a). The DEAD stain (DNA-bound ethidium homodimer-1) appears af-
terwards proving the loss of plasma membrane integrity and, ultimately,
cell death (Movie 5.1c-d). Finally, cell death only occurs within the limits
of the irradiated area, indicating an efficient localisation for QR-mediated
hyperthermia for a short treatment time (Figure 5.8, Movie 5.1d). Previ-
ous studies on hyperthermic effects at the cellular level show changes to
the cytoskeletal structure, cell membrane rupture, protein denaturation,
impairment of DNA and RNA synthesis and programmed apoptosis occur
as a result of the heat increase in living tissue.[28] Movie 5.1 shows changes
in cell structure and cell membrane rupturing take place upon laser ir-
radiation. However, as no temperature profile of the cells was recorded
during laser treatment, it cannot be stated yet if these effects are induced
by hyperthermia.
The first published results[29] on gold nanoshell-mediated PTT led to the
commercialisation of the AuroLase system (NanoSpectra), which is cur-
rently undergoing clinical trials. In this study, gold nanoshell-mediated
cell death was investigated in vitro on human breast epithelial carcinoma
SK-BR-3 cells. The QR performance on HeLa cells is comparable to that
of the gold nanoshells, where cell death occurred upon laser treatment of
7 min at 820 nm (35 W.cm-2).[29] This result provides encouraging sup-
port for the use of QR-mediated cancer therapy through PTT. Moreover,
in contrast to the gold nanoshells, the QRs native properties offer potential
for not only PTT but also NIR live imaging (c.f. Chapter 4) and combined
therapy through targeted drug delivery (c.f. Chapter 6).
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Figure 5.9: Quantum Rattles mediate hyperthermia in vitro.
LIVE/DEAD assay quantification. Percentage of cell death inside the
laser spot saturates after 10 min of laser irradiation. The hyperthermia
and cell death caused by the QRs/laser light combination is dose
dependent (i.e. dependent on the energy provided by the laser
irradiation). Error bars represent the standard deviations of
quadruplicate experiments.
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Figure 5.10: Quantum Rattles mediate hyperthermia in vitro.
LIVE/DEAD assay quantification. Percentage of cell death outside the
laser spot showing a linear trend (R2 = 0.97) between cell death and
irradiation time in the close proximity of the laser spot. Error bars
represent the standard deviations of quadruplicate experiments.
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Movie 5.1: Confocal time-lapse series of HeLa cells incubated with
Quantum Rattles for 1 day. (a-b) LIVE channel during laser irradiation
showing calcein (LIVE stain, green) disappearing due to the loss of
intracellular esterase activity with cell death. (b) Zoomed-in view with
bright field (inset) showing cells bursting during death with cytoplasm
leaking and, organelles and nuclei appearing. (c-d) LIVE and DEAD
channels after laser irradiation of 2 and 5 min, showing DNA-bound
ethidium bromide homodimer-1 (DEAD stain, red) appearing indicating
the loss of plasma membrane integrity (d) Zoomed-out view after laser
irradiation showing laser spot. (Click to play. Requires Adobe Reader 8.×
or higher)
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5.3.3 Ex Vivo Assessment of the Quantum Rattles
Photothermal Properties
In order to obtain a better understanding of the PTT performance and
behaviour of QRs in tissue, ex vivo experiments were performed on chicken
muscles from the thigh used as tissue phantoms (Figure 5.11). Although
the QRs show great promise at mediating localised cell death in vitro, the
therapeutic NIR extinction peak of the QRs at 672 nm is close to the limit
of the NIR bio-window. Therefore, scattering of the incident light could
impede the QR efficiency at inducing hyperthermia. The aim of this study
is to assess QRs efficiency at inducing hyperthermia in tissue before future
in vivo studies. The temperature increase induced by subcutaneously in-
jected QRs upon NIR irradiation was recorded using a mini-hypodermic
probe and compared to PBS and no injection controls (Figure 5.11a-c).
It should be noted that this ex vivo study primarily aims at looking at
the feasibility of an in vivo study by testing if enough NIR light can be
absorbed and subsequently converted to heat in a medium (as close as pos-
sible) comparable to living tissue. The chicken thighs are a test system for
NIR light absorption by the QRs in animal tissue. Results gathered from
the generated heat in the chicken thighs only give an indication of adequate
light absorption by the QRs, and do not prove that the QRs can mediate
hyperthermia in living tissues. In order to fully investigate QR-mediated
cell death an extensive in vivo study involving a tumour model should be
undertaken.
Upon irradiation with a 671 nm laser (38 W.cm-2), the QRs induce a tem-
perature increase of approximately 38 °C to the surrounding chicken tissue
in less than 1 min (Figure 5.11d). The PBS and no injection controls gen-
erate an increase in tissue temperature of approximately 10 °C and 11 °C,
respectively (Figure 5.11d). The heat increase observed in both controls can
be attributed to the laser power directly heating the tissue. This explan-
ation is in good qualitative agreement with theoretical and experimental
data published previously on light interaction with tissue.[242,243]
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Figure 5.11: The photothermal potential of Quantum Rattles ex vivo.
Temperature profiles monitored through a thermocouple probe inserted
under the skin of a chicken thigh after (a) no injection (Negative Control,
grey), (b) phosphate buffer injection (PBS, grey) and (c) Quantum
Rattles in PBS injection (QR, red). (d) Maximum temperature increase
recorded for QRs in PBS injections (QR, red) compared to no injections
(Negative Control, grey) and PBS alone injections (PBS, grey). A higher
temperature increase is observed upon irradiation with a 671 nm laser
(38 W.cm-2) for the QR injection compared to the two controls, which
show identical temperature profiles. Error bars represent the standard
deviations of triplicate experiments.
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QR-mediated therapy raises temperatures well above the damage threshold
needed to induce irreversible tissue damage.[244] At the same time, the
heating levels caused by both controls show average tissue heating levels
that are insufficient to induce irreversible tissue damage.[244] Furthermore,
the average tissue heating observed in the QR-treated chicken is comparable
to the average tumour heating previously reported in vivo, where mice were
treated with nanoshells intratumourly.[29] In the same mouse study, saline
controls showed equivalent heating to the temperature increase observed for
PBS and no injection controls in the chicken thigh ex vivo study presented
here. This ex vivo study demonstrates the great potential of the QR system
for in vivo PTT cancer treatment.
5.4 Conclusions
This chapter demonstrated the photothermal properties of the QR system
and showed their potential for cancer therapy and, more specifically, as
a PTT agent. The photothermal properties of the QR system were first
confirmed from a physical standpoint before being tested from a more biolo-
gical point of view by means of in vitro studies on a cancer cell line followed
by an ex vivo assessment using a chicken model.
The QRs converted incident NIR light into vibrational energy or heat, when
deposited on dry surfaces or in solution. The temperature profiles showed
that the degree of heating of the QR surroundings depends on the power
density of the incident NIR laser irradiation. Furthermore, the silica shell
of the QRs protects the encapsulated AuQDs from changes in morphology,
and, therefore any associated changes in optical properties. In vitro studies
showed the QR system induced localised cell death, where the killing effi-
ciency is dependent on the NIR irradiation dose. Only after 10 minutes of
NIR laser treatment, 97% of all cells in a treated area were killed. Further-
more, the cancer cell membranes rupture upon irradiation, suggesting that
the QRs initiate hyperthermia.[28] Finally, the subcutaneous injection of
QRs in chicken thighs, in combination with NIR light activation, induced
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a rise of approximately 38 °C in tissue temperature. This tissue heating is
well above the damage threshold required to induce irreversible damage in
tissue.[244]
To conclude, both in vitro and ex vivo biological assessments of the QR
potential for PTT showed results and performance that are similar to pre-
viously published NP-based PTT system and in particular gold nanoshells,
which are currently the most researched nanosystem for PTT.[29,136,153]
However, by comparison with other systems such as gold nanoshells, the
QRs offer the advantage of being natively multifunctional and ideally suited
for both diagnostic (NIR live imaging, c.f. Chapter 4) as well as combined
therapy (photo- and chemotherapy, c.f. Chapter 6). To date, this is the
first study demonstrating the efficient use of AuQDs for cancer treatment
via NIR phototherapy.
160
Chapter 6
Quantum Rattles for Drug
Delivery
6.1 Introduction
From its earliest beginnings, medical practice has strived to heal injuries
and cure diseases by introducing drugs and other therapies into the body.
Over the years, drug delivery methods have progressed from the primitive
chewing of leaves and roots of medicinal plants to, more recently, injections,
tablets and capsules.[245] These systemic drug delivery approaches that
distribute the medications throughout the body, are most commonly used
due to their ease of administration. However, systemic delivery may result
in suboptimal drug concentration in the target organ and, next to that, may
affect healthy tissue in the body. In order to efficiently achieve therapeutic
drug levels, targeted local drug delivery methods can be applied.[104, 105]
Such controlled drug delivery systems (DDS) are engineered to release drugs
in the target area over a period of time in a controlled manner.[246]
Controlled drug delivery technology is amongst the most promising applic-
ations for human health care and represents one of the most rapidly advan-
cing fields for biomedical materials sciences.[173,246,247] Controlled DDSs
offer various advantages compared to more traditional dosage forms.[104,
246,248,249] These advantages include:
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• Increased performance compared to current commercial drugs;
• Potential applications of new drug molecules that are currently not
used in the clinic due to problems, such as low drug solubility and
systemic toxicity;
• Reduced undesirable side effects;
• More precise and lower drug dosages and concomitant costs.
Chemotherapy, the treatment of cancer with drugs, is often accompanied
by severe side effects due to the cytotoxicity of the chemotherapy drug com-
bined with its non-specific distribution in the body.[105, 146] An obstacle
towards the development of more advanced chemotherapies with reduced
side effects concerns the limited availability of efficient biocompatible DDSs
for most hydrophobic anticancer drugs.[249] For example, the low solubility
of most anticancer drugs in aqueous media hampers their effective use via
intravenous injections.[249] In order to overcome the poor water solubility
of these anticancer molecules, the development of novel DDSs to carry the
hydrophobic agents without the use of toxic organic solvents has received
significant interest.[184,249] In particular, nanotechnology offers great po-
tential in designing DDSs for targeted delivery of therapeutic agents into
organs or cells.[105,250,251] Nanoengineered DDSs could overcome the lack
of specificity of conventional chemotherapeutic agents and reduce overall
cytotoxicity by using both passive and active targeting strategies and by
enhancing the local dosages of drugs into the tumours.[105,146,248]
Various organic and inorganic NPs that can circulate through the blood-
stream and target tumours, while carrying small payloads of anticancer
drugs, have been examined.[9, 102, 104, 252] For example, the high loading
capacity of liposomes allows the delivery of drugs to target sites in vivo,
minimising side effects and toxicity of the drug payloads.[173, 174] How-
ever, such organic systems suffer from poor thermal and chemical stability
as well as rapid elimination by the immune system. In contrast, inorganic
silica particles offer an biocompatible and stable alternative as a carrier for
therapeutic cancer drugs.[180,184,245]
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In this context, mesoporous silica nanomaterials are showing great promise
for delivering anticancer and other water-insoluble drugs into human can-
cer cells.[82, 104, 185, 253] The high surface area, tuneable pore diameter,
and uniform porous structure of mesoporous silica nanomaterials offer a
unique advantage for loading and releasing large quantities of biomedical
agents.[175–179] Furthermore, the favourable biocompatibility and ease of
functionalisation through silane chemistry of silica nanomaterials are be-
neficial for designing tumour-targeting vectors.[105, 175–177] Mesoporous
silica nanosystems with a hollow structure are of particular interest as they
show particularly high drug loading efficiency, due to their the intersti-
tial hollow space, which can selectively and efficiently accommodate drug
molecules.[104, 213, 254] Recently, hollow rattle-type nanosystems with a
mesoporous silica shell have shown promising results as drug delivery vec-
tors.[3, 98, 145, 189, 255–257] Not only can the inner material be chosen to
confer new functionalities to the system, such as diagnosis via MRI (in the
case of Fe3O4 NPs)[255] but their added available surface further enhances
their drug loading efficiency.[98] Such multifunctional nanostructured ma-
terials, which are able to combine targeted diagnosis and therapy in one
system can simultaneously image early tumour site, deliver polyvalent pay-
loads and kill cancer cells in a controlled manner.[30, 91,190]
The first parts of this thesis (c.f. Chapter 4 and Chapter 5) reported
on the QRs capabilities and potential for NIR imaging and photothermal
applications. This chapter moves on to investigate the potential use of the
QR systems for drug delivery in cancer treatment. By combining controlled
drug delivery with NIR imaging and photothermal capabilities, the QRs
can be demonstrated as highly multifunctional agents and thus extremely
suitable for combined cancer diagnosis and therapy. As a starting point, it
is hypothesised that the presence of multiple hydrophobic gold NPs inside
the cavity of the silica shell will enhance the drug loading capacity because
of the increase in reactive surface area and the favourable interaction of
gold with hydrophobic anticancer drugs. Moreover, it is hypothesised that
the mesoporous silica shell will act as a diffusion membrane that allows
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a sustained drug release. In this study, both the drug loading capacity
and drug release kinetics of the QRs were examined by using the small
hydrophobic anticancer drug doxorubicin (DOX) as a model drug. DOX
has been widely used as a model for small hydrophobic drugs because of
its potent therapeutic effect and its photonic properties, which can be used
to quantify the amount of DOX present.[248,252,258]
6.2 Materials and Methods
Materials : Doxorubicin (DOX) was purchased from Sigma-Aldrich, UK.
Solvents such as absolute ethanol were purchased from VWR, UK. Phos-
phate buffer (PBS, pH 7.4) was purchased from Invitrogen, UK.
6.2.1 Drug Loading
In order to investigate the drug loading efficiency of the QR system, DOX
was used as an anticancer drug model. The DOX drug loading efficiency
of the QRs was compared to hollow mesoporous silica particles (HSs) and
non-hollow Quantum Rattles (NQRs) as controls. The red fluorescence
of DOX was used to quantify the amount of DOX loaded in the three
types of particles. Stock solutions of QRs, HSs or NQRs were prepared by
dispersing them in MilliQ H2O at a concentration of 5 mg.mL-1. Six dif-
ferent stock solutions of DOX were prepared in MilliQ H2O ranging from
1 mg.mL-1to 31.3×10-3 mg.mL-1 in concentration. Samples for the drug
loading experiments were obtained by adding 10 µL of stock particle dis-
persions to 50 µL of stock DOX solutions and 40 µL of MilliQ H2O resulting
in a final particle concentration of 0.5 mg.mL-1 and a DOX concentration
range of 0.5 mg.mL-1 to 15.6×10-3 mg.mL-1. The samples were left to ro-
tate overnight in the dark at room temperature. Afterwards, the samples
were washed three times in MilliQ H2O at 14000 rpm.min-1and resuspended
in MilliQ H2O. The fluorescence emission of the loaded QR, HS or NQR
particles was monitored at 590 nm with an excitation wavelength set at
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470 nm using a microplate reader (SpectraMax M5). From the fluorescence
results, the amount of DOX was calculated using a DOX standard curve
constructed from a DOX dilution series ranging from 3.91×10-3 mg.mL-1to
2.56×10-6 mg.mL-1 in concentration.1 The loading efficiency was expressed
as the ratio of DOX loaded in the particles to the mass of particles. The
experiment was run in triplicate and the results are presented as averages
± standard deviation.
6.2.2 Drug Release
The anticancer drug model DOX, in addition to being used for testing drug
loading efficiency, also served as a model for investigating the release profile
of the QR system. The release profile of the QRs was compared to HSs and
NQRs as controls. The red fluorescence of DOX was used to quantify the
amount of DOX released by the three types of particles. Stock solutions
of QRs, HSs or NQRs were prepared by dispersing them in MilliQ H2O at
a concentration of 5 mg.mL-1. A stock solution of 1 mg.mL-1 of DOX was
prepared in MilliQ H2O. Samples for the drug loading experiments were ob-
tained by adding 10 µL of stock particle dispersions to 50 µL of stock DOX
solutions and 40 µL of MilliQ H2O resulting in a final particle concentra-
tion of 0.5 mg.mL-1 and DOX concentration of 0.5 mg.mL-1. The samples
were left to rotate overnight in the dark at room temperature. Afterwards,
the samples were washed three times in MilliQ H2O at 14000 rpm.min-1,
resuspended in PBS and left to rotate in the dark at room temperature. At
0.5, 1, 2, 4, 8, 12 and 24 h, the supernatants of the samples were collected
by centrifuging the samples at 14000 rpm.min-1for 5 min. The particles
were resuspended in PBS and the fluorescence emission of the collected
supernatant was monitored at 590 nm with an excitation wavelength set at
470 nm using a microplate reader (SpectraMax M5). From the fluorescence
1No point higher than 10 µM (5.44×10-3 mg.mL-1) was used to construct the standard
curve as above 10 µM of DOX, DOX molecules have been shown to self-associate
resulting in quenching.[258] Therefore, the linear behaviour of the fluorescence emis-
sion of DOX with regards to concentration can only be assumed for concentrations
lower than 10 µM.
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results, DOX release from the DOX-loaded particles was calculated using a
DOX standard curve constructed from a DOX dilution series ranging from
3.91×10-3 mg.mL-1to 2.56×10-6 mg.mL-1 in concentration.1 The DOX re-
lease profile shows the accumulated value of the mass of DOX released
by the particles over time. The experiment was run in triplicate and the
results are presented as averages ± standard deviation.
6.3 Results and Discussion
6.3.1 Drug Loading
The small molecule drug doxorubicin (DOX) was used to evaluate the QRs
potential as a drug carrier. The QRs show a significant increase in DOX
loading efficiency compared to the HS and NQRs, from DOX loading con-
centrations as low as 31.3×10-3 mg.mL-1 (Figure 6.1). At the highest load-
ing concentration of DOX (0.5 mg.mL-1), the QRs load up to 9 and 5 times
more DOX than the HS and NQRs, respectively, with a loading efficiency
of 87 mg.g-1.
In previous studies, the reported drug loading efficiencies for mesoporous
silica based nanosystems have varied widely.[91, 146, 213, 253, 255] For ex-
ample, Huang et al.[253] showed a DOX loading efficiency of 30.8 mg.g-1 for
multi-shelled mesoporous silica rattle-type NPs, whereas Zhu et al.[255]
and Chen et al.[213] reported DOX loading efficiencies of 302 mg.g-1 and
1222 mg.g-1, respectively, for Fe3O4@SiO2 rattle-type NPs and hollow rattle-
type mesoporous silica NPs. This wide variation might be due to the dif-
ferent methods used to obtain the loading efficiency. Most studies use the
absorption peak of DOX at 480 nm to quantify the loading efficiencies of
their systems.[91, 98, 213, 255, 259] These absorption-based methods tend
to obtain higher loading efficiency values compared to quantification ap-
proaches that use the fluorescence emission of DOX at 585 nm.[253] How-
ever, none of the reported absorbance- and fluorescence-based methods
directly quantify the loading efficiency from the DOX-loaded NPs, using
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Figure 6.1: Quantum Rattles loading efficiency of doxorubicin (DOX).
DOX loading efficiency of Quantum Rattles (QR, red) compared to
hollow mesoporous silica shells without gold (HS, blue) and non-hollow
Quantum Rattles (NQR, orange) showing up to 9 and 5 fold increased
loading efficiency for the QRs compared to the HSs and NQRs,
respectively. The higher surface area and hydrophobic environment
provided by the gold nanoparticles inside the cavity of the silica shell
drastically enhance the DOX loading efficiency of the system, starting
from concentrations as low of 31.3 µg.mL-1. Error bars represent the
standard deviation of triplicate experiments. Inset: Transmission electron
micrographs of QR, NQRs and HS. Scale bars: 50 nm.
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only that obtained from the residual supernatant. This indirect approach
is very sensitive to methodological factors, such as the purification process,
which can explain the many differences observed in loading efficiency values
for similar systems.
In the results reported here, however, the drug loading efficiency is calcu-
lated directly from the fluorescent response of DOX loaded inside the QRs.
By using this direct quantification approach, effects due to experimental
factors are limited when compared to indirect methods that calculate load-
ing efficiency through the non-loaded DOX remaining in the loading solu-
tion. However, luminescence self-quenching of the loaded DOX molecules
might occur within the QRs due to higher-order packing interactions, as
previously reported with DOX-loaded carbon nanotubes and graphene ox-
ide.[259,260] More specifically, the denser packing of DOX molecules inside
the QR cavity compared to DOX molecules in solutions result in a lower
fluorescence emission obtained from the DOX inside the QRs than from the
supernatant. This might be an explanation for the relatively low quantified
drug loading efficiency of the QRs.
It is difficult to directly compare the absolute value observed for the load-
ing efficiency of the QRs with drug delivery results of other mesoporous
silica-based nanosystems. However, it seems likely that the presence of the
hydrophobic AuNPs inside the hollow core of the QRs greatly enhances the
loading efficiency of the QR system compared to both hollow mesoporous
silica and non-hollow mesoporous silica particles filled with gold nanostruc-
tures. Due to the hydrophobic AuNPs hosted in the QRs central cavity,
the QRs offer a large hydrophobic surface in an isolated chamber. The hy-
drophobic surfaces created by the AuNPs within the QRs cavity have two
distinct effects. Firstly, the hydrophobic cavity environment increases the
diffusivity of anticancer drugs from the hydrophilic exterior environment
through the mesoporous silica shell. Secondly, the gold surfaces function-
alised with the hydrophobic thiol-ligand enhance the interaction with the
hydrophobic anticancer drugs, thus leading to greater loading and a reduc-
tion in the release rate of the drug. Finally, compared to existing Au@SiO2
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rattle-type systems, such as the one developed by Wang et al.,[91] the QR
system offers the advantage of a higher surface area of gold inside the cav-
ity.
6.3.2 Drug Release
The QRs ability to control drug release was evaluated using the small
anticancer drug molecule DOX (Figure 6.2). The QRs release 10 and 4
times more DOX than the HSs and NQRs, respectively, which is in good
qualitative agreement with the differences in the amount of loaded DOX
between each type of particle observed in the previous loading study (c.f.
section 6.3.1). More than 75% of the total DOX release occurs in the first
4 h for all particle types. However, for the HSs, the DOX release plateaus
already after 4 h, whereas the QRs and NQRs modulate DOX release up
to 12 h.
When comparing the drug release profile from the three types of particles,
two observations can be drawn:
• Addition of gold quantum dots (AuQDs) inside the mesopores seems
to modulate sustained release compared to empty mesopores and;
• A hollow cavity does not affect the release kinetics, but does affect
the loading.
The later observation seems counter-intuitive, as the thin silica shell of the
QRs is expected to be less of a diffusion barrier compared to the NQRs
solid mesoporous silica. However, the presence of AuQDs randomly dis-
tributed inside the mesostructure might make the length of the mesopores
less significant in the drug release kinetics. The modulated 12 h release
observed for both QRs and NQRs suggest that the mesopores are being
occupied by AuQDs. Similar to studies described by Torney et al. and
Vivero-Escoto et al.,[186,187] where AuNPs were used as hard caps for the
pores of mesoporous silica vectors, the AuQDs inside the QRs and NQRs
mesoporous structure seem to limit the outwards diffusion of the loaded
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Figure 6.2: Release of doxorubicin (DOX) from Quantum Rattles. Drug
release profile of Quantum Rattles (QR, red) compared to hollow
mesoporous silica shells without gold (HS, blue) and non-hollow Quantum
Rattles (NQR, orange) showing a 10 and 4 fold increase in the total DOX
released compared to the HSs and NQRs, respectively. The QRs appear
to modulate the release kinetics providing prolonged release for up to 12 h
compared to HSs where the DOX release plateaus after 4 h. Error bars
represent the standard deviation of triplicate experiments. Inset:
Transmission electron micrographs of QR, NQRs and HS. Scale bars: 50
nm.
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drugs. Therefore, the drug molecules have fewer pores available through
which they can evade the particle.
The QRs seem to modulate a more sustained release than HSs. Future work
on stimuli-responsive release should be undertaken to further improve on
the potential use of the QRs as controlled drug delivery agents. The ad-
dition of a polymer coating with stimuli-responsive properties (e.g. pH or
temperature responsive) can greatly improve the drug release kinetics of
the QRs. For example, as tumour tissues are more acidic than healthy tis-
sues,[183] an option to achieve a more site-selective controlled drug release
is to design a pH-responsive QR.[261] Furthermore, by coating the QRs
with a temperature-responsive coating, a NIR light-triggered anticancer
drug release could be added during photothermal treatment of a tumour,
thereby, efficiently combining chemo- and photothermal therapy.
6.4 Conclusions
The purpose of this chapter was to demonstrate the QRs potential for drug
delivery applications in cancer treatment. Compared to gold-silica rattle-
type particles obtained through other methods,[3, 91] the QRs possess the
advantage of not only encapsulating multiple AuNPs, thereby obtaining
a higher surface-to-volume ratio, but also of having the AuNPs surface
functionalised with hydrophobic ligands, which enhances the potential for
interactions with hydrophobic drug molecules. The results of this study
showed that the presence of the hydrophobic AuNPs inside the cavity of
the QR enhanced the QRs drug loading capacity. Furthermore, particles
incorporating AuQDs inside their silica shell showed a more sustained re-
lease profile compared to plain hollow silica particles, which suggests that
the AuQDs trapped inside the silica partly blocked off some of the drug
diffusion pathways. To conclude, the QRs display the potential to favour-
ably modulate the handling of a large drug payload for small hydrophobic
anticancer drugs compared to mesoporous silica carriers. Hence, this study
indicates new possibilities for enabling the design of stimuli-responsive QR
171
Chapter 6 Quantum Rattles for Drug Delivery
systems for localised cancer treatment by combining photothermal therapy
with triggered drug release.
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Conclusions and Future Work
Optimising nanosystems for cancer treatment is a non trivial undertaking
subject to many and varied considerations, which may sometimes require
the adoption of design compromises.[3, 21, 23, 82] In this thesis, a novel
gold-silica rattle-type system, the Quantum Rattle (QR) has been designed
and presented. The QRs possess emergent properties that arise from a
simple synergistic design in which the overall performance exceeds that of
the individual constituents. Furthermore, the QR performance efficacy is
accompanied by versatility, multifunctionality and scalability.
Making gold quantum dots (AuQDs) available for biomedicine has been a
longstanding research goal that promises to open opportunities for multi-
functional treatment and imaging options.[52] The QR synthetic approach,
as presented in this thesis, provides stable, water soluble, biocompatible
AuQDs that are effective in biological conditions by trapping them within
mesopores. The AuQDs endow the QRs with simultaneous heat generation
and NIR light emission capabilities when excited in the NIR bio-window.
Consequently, the therapeutic and imaging agents are linked in the QRs,
which provides an optimal combination for imaging of therapeutic effic-
acy. In addition, this combination avoids the various problems related to
differential biodistribution that are associated with multiple agents.
Following the introduction of AuQDs, their therapeutic and imaging po-
tential has been compromised by their lack of stability in aqueous solvent
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and the lack of bioavailability and toxicology necessary for their safe and
effective use.[75] Free AuQDs tend to merge rapidly into inactive gold
nanoparticles (AuNPs) with faster kinetics at higher temperatures, which
hampers their use for PTT. Furthermore, AuQDs with photonic proper-
ties in the NIR bio-window,[71, 79] tend to aggregate in biological buffers
and interact disruptively with biological structures both at the cellular and
biomolecular level. To circumvent such problems, AuQDs require a pro-
tecting, stabilising template that enables proficient biological interactions
while still retaining photonic properties.[75] The QRs address these issues
by entrapping AuQDs in the mesopores of a hydrophilic NP that is dispers-
ible in biological buffers and mediates interaction with biological systems.
At the same time, the QRs size range prolongs circulation half-life and is
suitable to passively target disease-associated vasculature.
Inclusion of AuQDs within hollow silica shells is sufficient to create a unified
platform for combining treatments involving chemotherapy, PTT and ima-
ging. The possibility of carrying the drug payload within the same particle
inducing the thermal ablation is a formidable additional advantage, as it
would insure their combined delivery in known and optimised proportions
and guarantee overlapping effects on the same target. Many other gold-
based PTT systems are attempting to achieve an adjuvant effect between
chemotherapy and PTT, but positive results are elusive due to imposition
of various necessary design constraints. In the case of the QRs, however,
the AuNPs within the silica shells act in unison to control the loading and
release of the drug payload, allowing increased payload concentration and
favourable release kinetics that can extend over a wider range than that of
the silica shells.
By integrating diverse elements of chemistry, material science, photonics
and biology, the system reported in this thesis has been developed into a
multifunctional hybrid system showing clear evidence of intrinsic and effi-
cient therapeutic and diagnostic potential in vitro. These promising results
should be followed by a thorough assessment of the QR performance for
cancer treatment in vivo. In this context, a study assessing the QR poten-
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tial for combined photothermal therapy and NIR live imaging in a mouse
model, has recently been funded by the Rosetrees Trust. QRs will be in-
tratumourly injected in live mice to examine their ability to act as contrast
agents for NIR imaging in parallel to their ability for inducing controlled
cell death (c.f. preliminary results in Appendix A.2). In addition, the QR
distribution upon systemic injection in the bloodstream will be examined
in a mice model to fully demonstrate and characterise the QR capacities for
passive targeting of tumours. In the same study, active targeting can also
be investigated. The QRs silica shell functionalisation by means of silane
chemistry (c.f. Chapter 4) opens the door to active targeting of tumours
with QRs. Thus, QR accumulation in tumours by active and passive tar-
geting can be compared with the objective of assessing and formulating the
best strategies for targeting tumours.
In parallel, further work on the use of QRs as drug delivery agents should be
undertaken with particular emphasis on examining the possibility of using
the QR platform for trigger-responsive, drug delivery vectors. Novel stud-
ies focusing on the coating of QRs with temperature- and pH-responsive
polymers have already commenced. The added temperature-responsiveness
could be combined with the QR intrinsic photothermal properties to con-
trol drug delivery with a NIR light-trigger. Additionally, given that tumour
tissues are more acidic than healthy tissues,[183] pH-responsive QRs could
possibly achieve a more site-selective controlled drug release.
Recently, a preliminary study using SQUID magnetometry demonstrated
the paramagnetic attributes of the QR system (c.f. preliminary results in
Appendix A.3). These very promising results pave the way towards the
incorporation of yet another native functionality into the QR platform.
Possessing magnetic properties, the QR system could offer the advantages
of both MRI and NIR imaging, combining high spatial and temporal resol-
ution (MRI) and high sensitivity (NIR imaging).[7] The QRs ability to be
used as MRI contrast agent should be investigated to assess the QR poten-
tial for multimodal imaging. Compared with existing multimodal imaging
systems that rely almost exclusively on Fe3O4NP-based nanosystems, the
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QRs would not require the addition of reliable coatings to promote favour-
able interactions with the host biological system.[7]
In summary, the QR system offers a relatively simple yet powerful plat-
form for developing a new and vast range of multimodal, multifunctional
systems to be used in the treatment and imaging of disease. However,
the range and scope of QR applications need not be confined solely to the
biological systems outlined in this thesis. Other potential uses of the QR
system should be investigated. For example, the highly catalytic nature of
AuQDs, which are trapped inside the QR silica shell, make QRs of special
interest for catalytic applications.[11, 99, 262, 263] The QRs can act as a
high performance nanoreactor with AuNPs and AuQDs readily available
in aqueous solvent for catalysis.
To conclude, the simple synthesis pathway developed during this PhD study
generated an efficient rattle-like particle system with a variety of highly
attractive, intrinsic properties for cancer treatment. However, the QRs
potential is not confined solely to applications in oncology. Overall, the
QR platform represents an emerging technology that seems destined for a
golden future.
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Appendices
A.1 Photonic Properties of ‘Thick’ Quantum
Rattles
Figure A.1: Photonic properties of thick Quantum Rattles (silica shell
thickness of ∼ 50 nm for a total diameter of ∼ 200 nm). (a) Extinction
spectra of thick Quantum Rattles (thick QR, red) showing the same
characteristic features as the thin QRs extinction spectra. Inset: zoomed
in on the near infrared region of interest showing an extinction peak
centred around 672 nm. (b) Photoluminescence spectra of thick QR
showing an excitation peak centred at 672 nm and an emission peak
centred at 827 nm. Both emission spectrum (λex = 672 nm, red) and
excitation spectrum (λem = 827 nm, grey) are identical to the thin QRs
photoluminescent spectra.
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A.2 NIR Imaging Potential of the Quantum
Rattles
NIR imaging of the Quantum Rattles (QRs) was carried out by Dr. Daniel
Stuckey and Dr. Josef Habib in Prof. Michael Schneider’s group at the Na-
tional Heart and Lung Institute at Imperial College London, UK. The tu-
mour inoculation and QR injections were performed by Dr. Adam Gormley
of Prof. Hamid Ghandehari’s group at the Utah Center for Nanomedicine
at the University of Utah, USA.
Figure A.2: NIR imaging of Quantum Rattles. DU145 bilateral prostate
tumours in NU/NU mice were injected with 500 µL of (a) Quantum
Rattles (QR, 20 mg.mL-1 in PBS) or (b) saline solution. The mice were
sacrificed 1 day after the intratumoural injections and the excised
tumours were fixed in 4% paraformaldehyde (PFA). QRs are localised by
their own photoluminescence within the tumours, accumulating in intense
epifluorescent spots, which are not observed in tumorous tissue injected
with saline solution. These results show the great potential of the strong
NIR absorption of the QRs for selective photothermal tumour ablation.
NIR imaging set-up: λex = 675 nm and λem = 840 nm.
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A.3 Magnetic Properties of the Quantum
Rattles
The SQUID measurements were performed by Dr. Sai Katla in Prof. Challa
Kumar’s group at the Center for Advanced Microstructures and Devices at
the Louisiana State University, USA.
Figure A.3: Magnetic properties of the Quantum Rattle. Magnetisation
curve of Quantum Rattles (QR, red dotted line) at 2 K showing
paramagnetic properties. These intrinsic QR paramagnetic characteristics
could enable efficient MRI imaging, thereby providing another imaging
modality to the QR system.
A.4 Statistical Analyses
The statistical analyses were performed using MatLab R2012a (MathWorks).
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A.4.1 In Vitro Cytotoxicity
MTT Assays
Fluorescein-functionalised Quantum Rattles:
Statistical analysis was performed on the MTT assay of cells cultured in
the presence of fluorescein-functionalised QRs (c.f. Figure 4.1). A one-way
ANOVA combined with a post-hoc Tukey-Kramer Multiple comparisons
test was used to statistically assess differences in cell viability at various
concentrations (’100%’, ’10%’, ’1%’ and ’0.1%’) between thick and thin
fluorescein-functionalised QRs (’thick_fQR’ and ’thin_fQR’, respectively),
thick and thin fluorescein-functionalised hollow mesoporous silica particles
(HSs) (’thick_fHS’ and ’thin_fHS’, respectively), medical grade PVC neg-
ative control (’Ctrl-’) and organo-tin PVC positive control (’Ctrl+’). These
differences were then deemed significant if the probability of the results oc-
curring by random chance was less than 5% (p < 0.05).
Listing A.1: Statistical significance calculation MatLab script for the
MTT assay of cells cultured in the presence of fluorescein-functionalised
Quantum Rattles.
1 close all;
2 clear all;
3
4 p1 = 0.05;
5
6 load MTT_fQR;
7 res = Res’;
8 groups={’Ctrl- 100%’ ’Ctrl- 10%’ ’Ctrl- 1%’ ’Ctrl- 0.1%’
’Ctrl+ 100%’ ’Ctrl+ 10%’ ’Ctrl+ 1%’ ’Ctrl+ 0.1%’ ’
thick HS 100%’ ’thick HS 10%’ ’thick HS 1%’ ’thick HS
0.1%’ ’thick QR 100%’ ’thick QR 10%’ ’thick QR 1%’ ’
thick QR 0.1%’ ’thin HS 100%’ ’thin HS 10%’ ’thin HS
1%’ ’thin HS 0.1%’ ’thin QR 100%’ ’thin QR 10%’ ’thin
QR 1%’ ’thin QR 0.1%’};
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9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
Figure A.4: Multicomparison test for the MTT assay of cells cultured in
the presence of fluorescein-functionalised Quantum Rattles.
Native Quantum Rattles:
Statistical analysis was performed on the MTT assay of cells cultured in
the presence of QRs (c.f. Figure 4.2). A one-way ANOVA combined with a
post-hoc Tukey-Kramer Multiple comparisons test was used to statistically
assess differences in cell viability at two time points (’1day’ and ’3days’)
between thick and thin QRs (’thick_QR’ and ’thin_QR’, respectively),
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thick and thin HSs (’thick_HS’ and ’thin_HS’, respectively), medical grade
PVC negative control (group ’Ctrl-’) and organo-tin PVC positive control
(’Ctrl+’). These differences were then deemed significant if the probability
of the results occurring by random chance was less than 5% (p < 0.05).
Listing A.2: Statistical significance calculation MatLab script for the
MTT assay of cells cultured in the presence of Quantum Rattles.
1 close all;
2 clear all;
3
4 p1 = 0.05;
5
6 load MTT_QR;
7 res = Res’;
8 groups={’Ctrl+ 1day’ ’Ctrl- 1day’ ’thick HS 1day’ ’thick
QR 1day’ ’thin HS 1day’ ’thin QR 1day’ ’Ctrl+ 3days’ ’
Ctrl- 3days’ ’thick HS 3days’ ’thick QR 3days’ ’thin
HS 3days’ ’thin QR 3days’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
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Figure A.5: Multicomparison test for the MTT assay of cells cultured in
the presence of Quantum Rattles.
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Total DNA Assays
Statistical analysis was performed on the tDNA assay of cells cultured
in the presence of QRs (c.f. Figure 4.3). A one-way ANOVA combined
with a post-hoc Tukey-Kramer Multiple comparisons test was used to stat-
istically assess differences in cell proliferation at two time points (’1day’
and ’3days’) between thick and thin QRs (’thick_QR’ and ’thin_QR’, re-
spectively), thick and thin HSs (’thick_HS’ and ’thin_HS’, respectively),
medical grade PVC negative control (’Ctrl-’) and organo-tin PVC posit-
ive control (’Ctrl+’). These differences were then deemed significant if the
probability of the results occurring by random chance was less than 5% (p
< 0.05).
Listing A.3: Statistical significance calculation MatLab script for the
tDNA assay of cells cultured in the presence of Quantum Rattles.
1 close all;
2 clear all;
3
4 p1 = 0.05;
5
6 load tDNA;
7 res = Res’;
8 groups={’Ctrl+ 1day’ ’Ctrl- 1day’ ’thick HS 1day’ ’thick
QR 1day’ ’thin HS 1day’ ’thin QR 1day’ ’Ctrl+ 3days’ ’
Ctrl- 3days’ ’thick HS 3days’ ’thick QR 3days’ ’thin
HS 3days’ ’thin QR 3days’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
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Figure A.6: Multicomparison test for the tDNA assay of cells cultured
in the presence of Quantum Rattles.
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A.4.2 LIVE/DEAD Quantification Study
LIVE/DEAD quantification study for the HeLa cell population inside the
NIR laser spot:
Statistical analysis was performed on the LIVE/DEAD assay quantifica-
tion results of the cell population inside the laser spot (c.f. Figure 5.9). A
one-way ANOVA combined with a post-hoc Tukey-Kramer Multiple com-
parisons test was used to statistically assess differences in cell death at
different NIR irradiation time treatment between the QRs (’0min’ ’2min’
’5min’ ’8min’ ’10min’ ’15min’, depending on the NIR irradiation time),
HS control (’HS’) and no particle control (’blank’). These differences were
then deemed significant if the probability of the results occurring by ran-
dom chance was less than 1% (p < 0.01).
Listing A.4: Statistical significance calculation MatLab script for the
LIVE/DEAD study of the cell population inside the laser spot, which has
been incubated with Quantum Rattles and treated with NIR light.
1 close all;
2 clear all;
3
4 p1 = 0.01;
5
6 load Keff;
7 res = Res’;
8 groups={’blank’ ’HS’ ’0min’ ’2min’ ’5min’ ’8min’ ’10min’
’15min’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
LIVE/DEAD quantification study for the HeLa cell population outside the
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Figure A.7: Multicomparison test for the LIVE/DEAD study of the cell
population inside the laser spot, which has been incubated with Quantum
Rattles and treated with NIR light.
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NIR laser spot:
Statistical analysis was performed on the LIVE/DEAD assay results of the
cell population adjacent to the laser spot (c.f. Figure 5.10). A one-way
ANOVA combined with a post-hoc Tukey-Kramer Multiple comparisons
test was used to statistically assess differences in cell death at different
NIR irradiation time treatment between the QRs (’0min’ ’2min’ ’5min’
’8min’ ’10min’ ’15min’, depending on the NIR irradiation time), HS control
(’HS’) and no particle control (’blank’). These differences were then deemed
significant if the probability of the results occurring by random chance was
less than 1% (p < 0.01).
Listing A.5: Statistical significance calculation MatLab script for the
LIVE/DEAD study of the cell population adjacent to the laser spot,
which has been incubated with Quantum Rattles and treated with NIR
light.
1 close all;
2 clear all;
3
4 p1 = 0.01;
5
6 load Keff_OUT;
7 res = Res’;
8 groups={’blank’ ’HS’ ’0min’ ’2min’ ’5min’ ’8min’ ’10min’
’15min’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
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Figure A.8: Multicomparison test for the LIVE/DEAD study of the cell
population adjacent to the laser spot, which has been incubated with
Quantum Rattles and treated with NIR light.
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A.4.3 Ex Vivo Assessment of the Quantum Rattles
Photothermal Properties Study
Statistical analysis was performed on the ex vivo assessment of the Quantum
Rattles photothermal properties study (c.f. Figure 5.11). A one-way AN-
OVA combined with a post-hoc Tukey-Kramer Multiple comparisons test
was used to statistically assess differences in the maximum temperature
increase between the QRs (’QR’), PBS control (’PBS) and no injection
control (’Ctrl-’). These differences were then deemed significant if the
probability of the results occurring by random chance was less than 1%
(p < 0.01).
Listing A.6: Statistical significance calculation MatLab script for the ex
vivo assessment of the Quantum Rattles photothermal properties study.
1 close all;
2 clear all;
3
4 p1 = 0.01;
5
6 load ExVivo;
7 res = Res’;
8 groups={’Ctrl-’ ’PBS’ ’QR’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
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Figure A.9: Multicomparison test for the ex vivo assessment of the
Quantum Rattles photothermal properties study.
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A.4.4 Drug Delivery Study
Doxorubicin loading efficiency study:
Statistical analysis was performed on the doxorubicin (DOX) loading ef-
ficiency study (c.f. Figure 6.1). A one-way ANOVA combined with a
post-hoc Tukey-Kramer Multiple comparisons test was used to statistically
assess differences in DOX loading efficiency between the QRs (’QR’), HSs
(’HS’) and non-hollow Quantum Rattles (NQRs) (’NQR’). These differ-
ences were then deemed significant if the probability of the results occurring
by random chance was less than 5% (p < 0.05).
Listing A.7: Statistical significance calculation MatLab script for the
Quantum Rattles doxorubicin loading efficiency study.
1 close all;
2 clear all;
3
4 p1 = 0.05;
5
6 load DOXload;
7 res = Res’;
8 groups={’HS 0.5 mg/mL’ ’HS 0.25 mg/mL’ ’HS 0.125 mg/mL’ ’
HS 0.0625 mg/mL’ ’HS 0.03125 mg/mL’ ’HS 0.015625 mg/mL
’ ’NQR 0.5 mg/mL’ ’NQR 0.25 mg/mL’ ’NQR 0.125 mg/mL’ ’
NQR 0.0625 mg/mL’ ’NQR 0.03125 mg/mL’ ’NQR 0.015625 mg
/mL’ ’QR 0.5 mg/mL’ ’QR 0.25 mg/mL’ ’QR 0.125 mg/mL’ ’
QR 0.0625 mg/mL’ ’QR 0.03125 mg/mL’ ’QR 0.015625 mg/mL
’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
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Figure A.10: Multicomparison test for the Quantum Rattles
doxorubicin loading efficiency study.
Doxorubicin release study:
Statistical analysis was performed on the DOX release study (c.f. Fig-
ure 6.2). A one-way ANOVA combined with a post-hoc Tukey-Kramer Mul-
tiple comparisons test was used to statistically assess differences in DOX
release kinetics between the QRs (’QR’) HSs (’HS’) and NQRs (’NQR’).
These differences were then deemed significant if the probability of the
results occurring by random chance was less than 5% (p < 0.05).
Listing A.8: Statistical significance calculation MatLab script for the
Quantum Rattles doxorubicin release study.
1 close all;
2 clear all;
3
4 p1 = 0.05;
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5
6 load DOXrelease;
7 res = Res’;
8 groups={’HS 0.5h’ ’NQR 0.5h’ ’QR 0.5h’ ’HS 1h’ ’NQR 1h’ ’
QR 1h’ ’HS 2h’ ’NQR 2h’ ’QR 2h’ ’HS 4h’ ’NQR 4h’ ’QR
4h’ ’HS 8h’ ’NQR 8h’ ’QR 8h’ ’HS 12h’ ’NQR 12h’ ’QR 12
h’ ’HS 24h’ ’NQR 24h’ ’QR 24h’};
9 [p2,t,st] = anova1(res,groups);
10
11 figure;
12 [c,m,h,nms] = multcompare(st, ’alpha’, p1, ’ctype’, ’hsd’
);
13 [nms num2cell(m)]
Figure A.11: Multicomparison test for the Quantum Rattles
doxorubicin release study.
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A.5 Thermal Camera Movies - Real-Time
Temperature Acquisition
Movie A.1: Hollow mesoporous silica particles photothermal properties.
Movie showing the real-time acquisition by a thermal camera of the
temperature profile of a coverslip with hollow mesoporous silica particles
(HSs) drop-deposited on its surface. No heat increase is observed when a
671 nm laser is irradiated on the HS. (Click to play. Requires Adobe
Reader 8.× or higher)
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A.5 Thermal Camera Movies - Real-Time Temperature Acquisition
Movie A.2: Quantum Rattles photothermal properties. Movie showing
the real-time acquisition by a thermal camera of the temperature profile
of a coverslip with Quantum Rattles (QRs) drop-deposited on its surface.
A temperature increase of ∼ 1.5 °C is observed upon irradiation by a 671
nm laser of the QR sample. (Click to play. Requires Adobe Reader 8.× or
higher)
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A.6 LIVE/DEAD Assay Quantification -
Killing Efficiency
After the raw fluorescent images of the LIVE/DEAD assays (c.f. section
5.2.2) were cropped to the laser spot (1 mm disk) or the adjacent area to
the laser spot (0.3 mm thick ring around laser spot) they were segmented
using MatLab R2012a (MathWorks) to obtain binary images representing
the surface of live and dead cells, respectively. Images were loaded as
IMxy, where x = g or r refers to either the LIVE (green, g) or DEAD
(red, r) images and y = 1 - 8 refers to the different conditions (1: Cell
only control, 2: HS control, 3 - 8: QRs with 0, 2, 5, 8, 10 or 15 min laser
irradiation). Both thresholds for the red (Tr) and green (Tg) images series
are set manually by examining the histograms figure (1) and (2) in the
script.
Listing A.9: LIVE/DEAD assay quantification. Segmentation script for
the fluorescent images obtained from the LIVE/DEAD study and
percentage cell death computation.
1 %% Segmentation
2
3 close all,
4
5 % Thresholds values defined iteratively
6 Tg = 80;
7 Tr = 10;
8
9 % Convert rgb images to grayscale
10 Gg1 = rgb2gray(IMg1);
11 Gg2 = rgb2gray(IMg2);
12 Gg3 = rgb2gray(IMg3);
13 Gg4 = rgb2gray(IMg4);
14 Gg5 = rgb2gray(IMg5);
15 Gg6 = rgb2gray(IMg6);
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16 Gg7 = rgb2gray(IMg7);
17 Gg8 = rgb2gray(IMg8);
18
19 Gr1 = rgb2gray(IMr1);
20 Gr2 = rgb2gray(IMr2);
21 Gr3 = rgb2gray(IMr3);
22 Gr4 = rgb2gray(IMr4);
23 Gr5 = rgb2gray(IMr5);
24 Gr6 = rgb2gray(IMr6);
25 Gr7 = rgb2gray(IMr7);
26 Gr8 = rgb2gray(IMr8);
27
28
29
30 % Definition of red, green and blue colourmaps for image
display
31 % column_ramp = [0:1/255:1]’;
32 % redmap = [column_ramp,zeros(256,1),zeros(256,1)];
33 % greenmap = [zeros(256,1),column_ramp,zeros(256,1)];
34 % bluemap = [zeros(256,1),zeros(256,1),column_ramp];
35 % figure;
36 % subplot(1,2,1);colormap(greenmap);imagesc(Gg5);
37 % subplot(1,2,2);colormap(redmap);imagesc(Gr5);
38
39 % Matrices conversion for histograms display. Histograms
were used to set Tr and Tg.
40 Gg1 = double(Gg1);
41 gg1 = Gg1(:);
42 Gg2 = double(Gg2);
43 gg2 = Gg2(:);
44 Gg3 = double(Gg3);
45 gg3 = Gg3(:);
46 Gg4 = double(Gg4);
47 gg4 = Gg4(:);
48 Gg5 = double(Gg5);
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49 gg5 = Gg5(:);
50 Gg6 = double(Gg6);
51 gg6 = Gg6(:);
52 Gg7 = double(Gg7);
53 gg7 = Gg7(:);
54 Gg8 = double(Gg8);
55 gg8 = Gg8(:);
56
57 Gr1 = double(Gr1);
58 gr1 = Gr1(:);
59 Gr2 = double(Gr2);
60 gr2 = Gr2(:);
61 Gr3 = double(Gr3);
62 gr3 = Gr3(:);
63 Gr4 = double(Gr4);
64 gr4 = Gr4(:);
65 Gr5 = double(Gr5);
66 gr5 = Gr5(:);
67 Gr6 = double(Gr6);
68 gr6 = Gr6(:);
69 Gr7 = double(Gr7);
70 gr7 = Gr7(:);
71 Gr8 = double(Gr8);
72 gr8 = Gr8(:);
73
74 % figure(1);
75 % subplot(2,8,1); image(IMg1);title(’1’);
76 % subplot(2,8,2); image(IMg2);title(’2’);
77 % subplot(2,8,3); image(IMg3);title(’3’);
78 % subplot(2,8,4); image(IMg4);title(’4’);
79 % subplot(2,8,5); image(IMg5);title(’5’);
80 % subplot(2,8,6); image(IMg6);title(’6’);
81 % subplot(2,8,7); image(IMg7);title(’7’);
82 % subplot(2,8,8); image(IMg8);title(’8’);
83 % subplot(2,8,9); hist(gg1,100);title(’9’);
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84 % subplot(2,8,10); hist(gg2,100);title(’10’);
85 % subplot(2,8,11); hist(gg3,100);title(’11’);
86 % subplot(2,8,12); hist(gg4,100);title(’12’);
87 % subplot(2,8,13); hist(gg5,100);title(’13’);
88 % subplot(2,8,14); hist(gg6,100);title(’14’);
89 % subplot(2,8,15); hist(gg7,100);title(’15’);
90 % subplot(2,8,16); hist(gg8,100);title(’16’);
91 %
92 % figure(2);
93 % subplot(2,8,1); image(IMr1);title(’1’);
94 % subplot(2,8,2); image(IMr2);title(’2’);
95 % subplot(2,8,3); image(IMr3);title(’3’);
96 % subplot(2,8,4); image(IMr4);title(’4’);
97 % subplot(2,8,5); image(IMr5);title(’5’);
98 % subplot(2,8,6); image(IMr6);title(’6’);
99 % subplot(2,8,7); image(IMr7);title(’7’);
100 % subplot(2,8,8); image(IMr8);title(’8’);
101 % subplot(2,8,9); hist(gr1,100);title(’9’);
102 % subplot(2,8,10); hist(gr2,100);title(’10’);
103 % subplot(2,8,11); hist(gr3,100);title(’11’);
104 % subplot(2,8,12); hist(gr4,100);title(’12’);
105 % subplot(2,8,13); hist(gr5,100);title(’13’);
106 % subplot(2,8,14); hist(gr6,100);title(’14’);
107 % subplot(2,8,15); hist(gr7,100);title(’15’);
108 % subplot(2,8,16); hist(gr8,100);title(’16’);
109
110 % Thresholding
111 gg1bin = (Gg1 > Tg);
112 gg2bin = (Gg2 > Tg);
113 gg3bin = (Gg3 > Tg);
114 gg4bin = (Gg4 > Tg);
115 gg5bin = (Gg5 > Tg);
116 gg6bin = (Gg6 > Tg);
117 gg7bin = (Gg7 > Tg);
118 gg8bin = (Gg8 > Tg);
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119
120 gr1bin = (Gr1 > Tr);
121 gr2bin = (Gr2 > Tr);
122 gr3bin = (Gr3 > Tr);
123 gr4bin = (Gr4 > Tr);
124 gr5bin = (Gr5 > Tr);
125 gr6bin = (Gr6 > Tr);
126 gr7bin = (Gr7 > Tr);
127 gr8bin = (Gr8 > Tr);
128
129 % Quantification of the LIVE and DEAD coefficient
130 LIVE1 = sum(gg1bin(:));
131 LIVE2 = sum(gg2bin(:));
132 LIVE3 = sum(gg3bin(:));
133 LIVE4 = sum(gg4bin(:));
134 LIVE5 = sum(gg5bin(:));
135 LIVE6 = sum(gg6bin(:));
136 LIVE7 = sum(gg7bin(:));
137 LIVE8 = sum(gg8bin(:));
138
139 DEAD1 = sum(gr1bin(:));
140 DEAD2 = sum(gr2bin(:));
141 DEAD3 = sum(gr3bin(:));
142 DEAD4 = sum(gr4bin(:));
143 DEAD5 = sum(gr5bin(:));
144 DEAD6 = sum(gr6bin(:));
145 DEAD7 = sum(gr7bin(:));
146 DEAD8 = sum(gr8bin(:));
147
148 % Figure of the segementation results
149 figure(’Color’,[0 0 0]); colormap(gray(256));
150 subplot(4,8,1); imagesc(IMg1);title(’Blank’,’fontsize’
,12,’Color’,[1 1 1]);axis (’image’,’off’);
151 subplot(4,8,2); imagesc(IMg2);title(’HS’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
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152 subplot(4,8,3); imagesc(IMg3);title(’0m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
153 subplot(4,8,4); imagesc(IMg4);title(’2m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
154 subplot(4,8,5); imagesc(IMg5);title(’5m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
155 subplot(4,8,6); imagesc(IMg6);title(’8m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
156 subplot(4,8,7); imagesc(IMg7);title(’10m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
157 subplot(4,8,8); imagesc(IMg8);title(’15m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
158 subplot(4,8,9); imagesc(gg1bin);axis (’image’,’off’);
159 subplot(4,8,10); imagesc(gg2bin);axis (’image’,’off’);
160 subplot(4,8,11); imagesc(gg3bin);axis (’image’,’off’);
161 subplot(4,8,12); imagesc(gg4bin);axis (’image’,’off’);
162 subplot(4,8,13); imagesc(gg5bin);axis (’image’,’off’);
163 subplot(4,8,14); imagesc(gg6bin);axis (’image’,’off’);
164 subplot(4,8,15); imagesc(gg7bin);axis (’image’,’off’);
165 subplot(4,8,16); imagesc(gg8bin);axis (’image’,’off’);
166 subplot(4,8,17); imagesc(IMr1);axis (’image’,’off’);
167 subplot(4,8,18); imagesc(IMr2);axis (’image’,’off’);
168 subplot(4,8,19); imagesc(IMr3);axis (’image’,’off’);
169 subplot(4,8,20); imagesc(IMr4);axis (’image’,’off’);
170 subplot(4,8,21); imagesc(IMr5);axis (’image’,’off’);
171 subplot(4,8,22); imagesc(IMr6);axis (’image’,’off’);
172 subplot(4,8,23); imagesc(IMr7);axis (’image’,’off’);
173 subplot(4,8,24); imagesc(IMr8);axis (’image’,’off’);
174 subplot(4,8,25); imagesc(gr1bin);axis (’image’,’off’);
175 subplot(4,8,26); imagesc(gr2bin);axis (’image’,’off’);
176 subplot(4,8,27); imagesc(gr3bin);axis (’image’,’off’);
177 subplot(4,8,28); imagesc(gr4bin);axis (’image’,’off’);
178 subplot(4,8,29); imagesc(gr5bin);axis (’image’,’off’);
179 subplot(4,8,30); imagesc(gr6bin);axis (’image’,’off’);
180 subplot(4,8,31); imagesc(gr7bin);axis (’image’,’off’);
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181 subplot(4,8,32); imagesc(gr8bin);axis (’image’,’off’);
182
183 IM1 = IMg1 + IMr1;
184 IM2 = IMg2 + IMr2;
185 IM3 = IMg3 + IMr3;
186 IM4 = IMg4 + IMr4;
187 IM5 = IMg5 + IMr5;
188 IM6 = IMg6 + IMr6;
189 IM7 = IMg7 + IMr7;
190 IM8 = IMg8 + IMr8;
191
192 % Figure of the cropped and merged image
193 figure(’Color’,[0 0 0]); colormap(gray(256));
194 subplot(3,3,7); imagesc(IM1);title(’Blank’,’fontsize’,12,
’Color’,[1 1 1]);axis (’image’,’off’);
195 subplot(3,3,8); imagesc(IM2);title(’HS’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
196 subplot(3,3,1); imagesc(IM3);title(’0m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
197 subplot(3,3,2); imagesc(IM4);title(’2m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
198 subplot(3,3,3); imagesc(IM5);title(’5m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
199 subplot(3,3,4); imagesc(IM6);title(’8m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
200 subplot(3,3,5); imagesc(IM7);title(’10m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
201 subplot(3,3,6); imagesc(IM8);title(’15m’,’fontsize’,12,’
Color’,[1 1 1]);axis (’image’,’off’);
202
203 S = [[1 LIVE1 DEAD1];[2 LIVE2 DEAD2];[3 LIVE3 DEAD3];[4
LIVE4 DEAD4];[5 LIVE5 DEAD5];[6 LIVE6 DEAD6];[7 LIVE7
DEAD7];[8 LIVE8 DEAD8]];
204
205 LIVE = [LIVE1 LIVE2 LIVE3 LIVE4 LIVE5 LIVE6 LIVE7 LIVE8];
204
A.6 LIVE/DEAD Assay Quantification - Killing Efficiency
206 DEAD = [DEAD1 DEAD2 DEAD3 DEAD4 DEAD5 DEAD6 DEAD7 DEAD8];
207
208 %Killing efficiency calculation
209 Keff = [DEAD1/(DEAD1+LIVE1) DEAD2/(DEAD2+LIVE2) DEAD3/(
DEAD3+LIVE3) DEAD4/(DEAD4+LIVE4) DEAD5/(DEAD5+LIVE5)
DEAD6/(DEAD6+LIVE6) DEAD7/(DEAD7+LIVE7) DEAD8/(DEAD8+
LIVE8)];
210
211 %Displays results in the command window of MatLab
212 Tg,Tr,
213 S,
214 Keff = Keff(:)
205

Bibliography
[1] Kelly, K. L, Coronado, E, Zhao, L. L, & Schatz, G. C. (2003) The
Optical Properties of Metal Nanoparticles: The Influence of Size,
Shape, and Dielectric Environment. Journal of Physical Chemistry
B 107, 668–677.
[2] Zhu, M, Aikens, C, Hollander, F, Schatz, G, & Jin, R. (2008) Cor-
relating the crystal structure of a thiol-protected Au25 cluster and
optical properties. Journal of the American Chemical Society 130,
5883–5885.
[3] Liu, J, Qiao, S. Z, Chen, J. S, Lou, X. W. D, Xing, X, & Lu, G.
Q. M. (2011) Yolk/shell nanoparticles: new platforms for nanoreact-
ors, drug delivery and lithium-ion batteries. Chemical communica-
tions (Cambridge, England) 47, 12578–12591.
[4] Lee, J, Park, J. C, & Song, H. (2008) A Nanoreactor Framework
of a Au@SiO2 Yolk/Shell Structure for Catalytic Reduction of p-
Nitrophenol. Advanced Materials 20, 1523–1528.
[5] Wu, S.-H, Tseng, C.-T, Lin, Y.-S, Lin, C.-H, Hung, Y, & Mou, C.-Y.
(2010) Catalytic nano-rattle of Au@hollow silica: towards a poison-
resistant nanocatalyst. Journal of Materials Chemistry 21, 789–794.
[6] Dreaden, E. C, Mackey, M. A, Huang, X, Kang, B, & El-Sayed, M. A.
(2011) Beating cancer in multiple ways using nanogold. Chemical
Society Reviews 40, 3391–3404.
[7] Huang, Y, He, S, Cao, W, Cai, K, & Liang, X.-J. (2012) Biomedical
nanomaterials for imaging-guided cancer therapy. Nanoscale 4, 6135–
6149.
207
Bibliography
[8] Weissleder, R. (2001) A clearer vision for in vivo imaging. Nature
Biotechnology 19, 316–317.
[9] Faraji, A. H &Wipf, P. (2009) Nanoparticles in cellular drug delivery.
Bioorganic & Medicinal Chemistry 17, 2950–2962.
[10] Alivisatos, A. P. (1996) Semiconductor Clusters, Nanocrystals, and
Quantum Dots. Science (New York, NY) 271, 933–937.
[11] Daniel, M & Astruc, D. (2004) Gold nanoparticles: Assembly, supra-
molecular chemistry, quantum-size-related properties, and applica-
tions toward biology, catalysis, and nanotechnology. Chemical Re-
views 104, 293–346.
[12] Nealon, G. L, Donnio, B, Greget, R, Kappler, J.-P, Terazzi, E, &
Gallani, J.-L. (2012) Magnetism in gold nanoparticles. Nanoscale 4,
5244–5258.
[13] Yu, M, Files, B, Arepalli, S, & Ruoff, R. (2000) Tensile loading of
ropes of single wall carbon nanotubes and their mechanical proper-
ties. Physical Review Letters 84, 5552–5555.
[14] Baron, R, Willner, B, & Willner, I. (2007) Biomolecule-nanoparticle
hybrids as functional units for nanobiotechnology. Chemical Com-
munications pp. 323–332.
[15] Ghadiali, J. E & Stevens, M. M. (2008) Enzyme-responsive nan-
oparticle systems. Advanced materials (Deerfield Beach, Fla.) 20,
4359–4363.
[16] Ghadiali, J. E, Cohen, B. E, & Stevens, M. M. (2010) Protein kinase-
actuated resonance energy transfer in quantum dot-peptide conjug-
ates. ACS Nano 4, 4915–4919.
[17] Lowe, S. B, Dick, J. A. G, Cohen, B. E, & Stevens, M. M. (2011)
Multiplex Sensing of Protease and Kinase Enzyme Activity via Or-
thogonal Coupling of Quantum Dot-Peptide Conjugates. ACS Nano
6, 851–857.
208
Bibliography
[18] Gupta, S, Andresen, H, Ghadiali, J. E, & Stevens, M. M. (2010)
Kinase-Actuated Immunoaggregation of Peptide-Conjugated Gold
Nanoparticles. Small 6, 1509–1513.
[19] Ghadiali, J. E, Lowe, S. B, & Stevens, M. M. (2011) Quantum-
Dot-Based FRET Detection of Histone Acetyltransferase Activity.
Angewandte Chemie 123, 3479–3482.
[20] Aili, D, Mager, M, Roche, D, & Stevens, M. M. (2011) Hybrid
nanoparticle-liposome detection of phospholipase activity. Nano Let-
ters 11, 1401–1405.
[21] Sailor, M. J & Park, J.-H. (2012) Hybrid nanoparticles for detection
and treatment of cancer. Advanced materials (Deerfield Beach, Fla.)
24, 3779–3802.
[22] Jemal, A, Siegel, R, Xu, J, & Ward, E. (2010) Cancer statistics,
2010. CA: a cancer journal for clinicians 60, 277–300.
[23] Llevot, A & Astruc, D. (2012) Applications of vectorized gold nan-
oparticles to the diagnosis and therapy of cancer. Chemical Society
Reviews 41, 242–257.
[24] Ferrari, M. (2005) Cancer nanotechnology: opportunities and chal-
lenges. Nature Reviews Cancer 5, 161–171.
[25] Minelli, C, Lowe, S. B, & Stevens, M. M. (2010) Engineering Nano-
composite Materials for Cancer Therapy. Small 6, 2336–2357.
[26] Cai, W, Gao, T, Hong, H, & Sun, J. (2008) Applications of gold
nanoparticles in cancer nanotechnology. Nanotechnology Science and
Applications 1, 17–32.
[27] Pissuwan, D, Valenzuela, S. M, & Cortie, M. B. (2006) Therapeutic
possibilities of plasmonically heated gold nanoparticles. Trends in
Biotechnology 24, 62–67.
[28] Kennedy, L. C, Bickford, L. R, Lewinski, N. A, Coughlin, A. J, Hu,
Y, Day, E. S, West, J. L, & Drezek, R. A. (2011) A new era for cancer
209
Bibliography
treatment: gold-nanoparticle-mediated thermal therapies. Small 7,
169–183.
[29] Hirsch, L. R, Stafford, R. J, Bankson, J. A, Sershen, S. R, Rivera, B,
Price, R. E, Hazle, J. D, Halas, N. J, & West, J. L. (2003) Nanoshell-
mediated near-infrared thermal therapy of tumors under magnetic
resonance guidance. Proceedings of the National Academy of Sciences
of the United States of America 100, 13549–13554.
[30] Park, J.-H, von Maltzahn, G, Xu, M. J, Fogal, V, Kotamraju, V. R,
Ruoslahti, E, Bhatia, S. N, & Sailor, M. J. (2010) Cooperative nan-
omaterial system to sensitize, target, and treat tumors. Proceedings
of the National Academy of Sciences of the United States of America
107, 981–986.
[31] Park, J.-H, von Maltzahn, G, Ruoslahti, E, Bhatia, S. N, & Sailor,
M. J. (2008) Micellar hybrid nanoparticles for simultaneous mag-
netofluorescent imaging and drug delivery. Angewandte Chemie-
International Edition 47, 7284–7288.
[32] Tkachenko, A, Xie, H, Coleman, D, Glomm, W, Ryan, J, Ander-
son, M, Franzen, S, & Feldheim, D. (2003) Multifunctional gold
nanoparticle-peptide complexes for nuclear targeting. Journal of the
American Chemical Society 125, 4700–4701.
[33] Boisselier, E & Astruc, D. (2009) Gold nanoparticles in nanomedi-
cine: preparations, imaging, diagnostics, therapies and toxicity.
Chemical Society Reviews 38, 1759–1782.
[34] Laromaine, A, Koh, L, Murugesan, M, Ulijn, R. V, & Stevens,
M. M. (2007) Protease-triggered dispersion of nanoparticle assem-
blies. Journal of the American Chemical Society 129, 4156–4157.
[35] Love, J, Estroff, L, Kriebel, J, Nuzzo, R, & Whitesides, G. (2005)
Self-assembled monolayers of thiolates on metals as a form of nano-
technology. Chemical Reviews 105, 1103–1169.
[36] Piner, R, Zhu, J, Xu, F, Hong, S, & Mirkin, C. (1999) "Dip-pen"
nanolithography. Science (New York, NY) 283, 661–663.
210
Bibliography
[37] Templeton, A, Wuelfing, M, & Murray, R. (2000) Monolayer protec-
ted cluster molecules. Accounts Of Chemical Research 33, 27–36.
[38] Brust, M, Walker, M, Bethell, D, Schiffrin, D, & Whyman, R.
(1994) Synthesis of Thiol-Derivatized Gold Nanoparticles in a 2-
Phase Liquid-Liquid System. Journal of the Chemical Society-
Chemical Communications pp. 801–802.
[39] Niemeyer, C. (2001) Nanoparticles, proteins, and nucleic acids:
Biotechnology meets materials science. Angewandte Chemie-
International Edition 40, 4128–4158.
[40] Empedocles, S, Neuhauser, R, Shimizu, K, & Bawendi, M. (1999)
Photoluminescence from single semiconductor nanostructures. Ad-
vanced Materials 11, 1243–1256.
[41] Link, S & El-Sayed, M. (2000) Shape and size dependence of radiat-
ive, non-radiative and photothermal properties of gold nanocrystals.
International Reviews in Physical Chemistry 19, 409–453.
[42] Faraday, M. (1857) The Bakerian lecture: experimental relations of
gold (and other metals) to light. Philosophical Transactions of the
Royal Society of London 147, 145–181.
[43] Turkevich, J, Stevenson, P.C., & Hillier, J. (1951) A study of the
nucleation and growth processes in the synthesis of colloidal gold.
Discuss. Faraday Soc. 11, 55–75.
[44] Frens, G. (1973) Controlled nucleation for the regulation of the
particle size in monodisperse gold suspensions. Nature 241, 20–22.
[45] Brust, M, Fink, J, Bethell, D, Schiffrin, D. J, & Kiely, C. (1995)
Synthesis and reactions of functionalised gold nanoparticles. Journal
of the Chemical Society-Chemical Communications pp. 1655–1656.
[46] Jana, N. R & Peng, X. (2003) Single-phase and gram-scale routes
toward nearly monodisperse Au and other noble metal nanocrystals.
Journal of the American Chemical Society 125, 14280–14281.
211
Bibliography
[47] Rowe, M. P, Plass, K. E, Kim, K, Kurdak, C, Zellers, E. T, &
Matzger, A. J. (2004) Single-phase synthesis of functionalized gold
nanoparticles. Chemistry of Materials 16, 3513–3517.
[48] Zheng, N, Fan, J, & Stucky, G. D. (2006) One-Step One-Phase
Synthesis of Monodisperse Noble-Metallic Nanoparticles and Their
Colloidal Crystals. Journal of the American Chemical Society 128,
6550–6551.
[49] Scholl, J. A, Koh, A. L, & Dionne, J. A. (2012) Quantum plasmon
resonances of individual metallic nanoparticles. Nature 483, 421–427.
[50] Hu, M, Chen, J, Li, Z.-Y, Au, L, Hartland, G. V, Li, X, Marquez, M,
& Xia, Y. (2006) Gold nanostructures: engineering their plasmonic
properties for biomedical applications. Chemical Society Reviews 35,
1084–1094.
[51] Mie, G. (1908) Beiträge zur optik trüber medien, speziell kolloidaler
metallösungen. Annalen der Physik 25, 377–445.
[52] Qian, H, Zhu, M, Wu, Z, & Jin, R. (2012) Quantum sized gold
nanoclusters with atomic precision. Accounts Of Chemical Research
45, 1470–1479.
[53] Hutter, E & Fendler, J. H. (2004) Exploitation of localized surface
plasmon resonance. Advanced materials (Deerfield Beach, Fla.) 16,
1685–1706.
[54] Link, S & El-Sayed, M. A. (1999) Size and Temperature Dependence
of the Plasmon Absorption of Colloidal Gold Nanoparticles. Journal
of Physical Chemistry B 103, 4212–4217.
[55] Khlebtsov, B, Zharov, V, Melnikov, A, Tuchin, V, & Khlebtsov, N.
(2006) Optical amplification of photothermal therapy with gold nan-
oparticles and nanoclusters. Nanotechnology 17, 5167–5179.
[56] Perner, M, Bost, P, Lemmer, U, vonPlessen, G, Feldmann, J, Becker,
U, Mennig, M, Schmitt, M, & Schmidt, H. (1997) Optically induced
damping of the surface plasmon resonance in gold colloids. Physical
Review Letters 78, 2192–2195.
212
Bibliography
[57] Goettmann, F, Moores, A, Boissière, C, Le Floch, P, & Sanchez, C.
(2005) A Selective Chemical Sensor Based on the Plasmonic Response
of Phosphinine-Stabilized Gold Nanoparticles Hosted on Periodically
Organized Mesoporous Silica Thin Layers. Small 1, 636–639.
[58] Liu, X, Atwater, M, Wang, J, & Huo, Q. (2007) Extinction coeffi-
cient of gold nanoparticles with different sizes and different capping
ligands. Colloids and Surfaces, B: Biointerfaces 58, 3–7.
[59] Hostetler, M, Wingate, J, Zhong, C, Harris, J, Vachet, R, Clark,
M, Londono, J, Green, S, Stokes, J, Wignall, G, Glish, G, Porter,
M, Evans, N, & Murray, R. (1998) Alkanethiolate gold cluster mo-
lecules with core diameters from 1.5 to 5.2 nm: Core and monolayer
properties as a function of core size. Langmuir 14, 17–30.
[60] Genzel, L, Martin, T. P, & Kreibig, U. (1975) Dielectric function and
plasma resonances of small metal particles. Zeitschrift für Physik B
Condensed Matter and Quanta 21, 339–346.
[61] Peng, S, McMahon, J. M, Schatz, G. C, Gray, S. K, & Sun, Y. (2010)
Reversing the size-dependence of surface plasmon resonances. Pro-
ceedings of the National Academy of Sciences of the United States of
America 107, 14530–14534.
[62] Bakr, O. M, Amendola, V, Aikens, C. M, Wenseleers, W, Li, R,
Dal Negro, L, Schatz, G. C, & Stellacci, F. (2009) Silver nanoparticles
with broad multiband linear optical absorption. Angewandte Chemie-
International Edition 48, 5921–5926.
[63] Schaaff, T. G, Knight, G, Shafigullin, M. N, Borkman, R. F, &
Whetten, R. L. (1998) Isolation and selected properties of a 10.4
kDa gold: glutathione cluster compound. Journal of Physical Chem-
istry B 102, 10643–10646.
[64] Kubo, R, Kawabata, A, & Kobayashi, S. (1984) Electronic properties
of small particles. Annual Review of Materials Science 14, 49–66.
[65] Schaaff, T. G, Shafigullin, M. N, Khoury, J. T, Vezmar, I, Whetten,
R. L, Cullen, W. G, First, P. N, GutierrezWing, C, Ascensio, J,
213
Bibliography
& JoseYacaman, M. J. (1997) Isolation of smaller nanocrystal au
molecules: Robust quantum effects in optical spectra. Journal of
Physical Chemistry B 101, 7885–7891.
[66] Whetten, R. L, Khoury, J. T, Alvarez, M. M, Murthy, S, Vezmar,
I, Wang, Z. L, Stephens, P. W, Cleveland, C. L, Luedtke, W. D, &
Landman, U. (1996) Nanocrystal gold molecules. Advanced materials
(Deerfield Beach, Fla.) 8, 428–433.
[67] Link, S, Beeby, A, FitzGerald, S, El-Sayed, M. A, Schaaff, T. G,
& Whetten, R. L. (2002) Visible to Infrared Luminescence from a
28-Atom Gold Cluster. Journal of Physical Chemistry B 106, 3410–
3415.
[68] Zhu, M, Lanni, E, Garg, N, Bier, M. E, & Jin, R. (2008) Kinetic-
ally controlled, high-yield synthesis of Au25 clusters. Journal of the
American Chemical Society 130, 1138–1139.
[69] Wu, Z, Suhan, J, & Jin, R. (2009) One-pot synthesis of atomic-
ally monodisperse, thiol-functionalized Au25 nanoclusters. Journal
of Materials Chemistry 19, 622–626.
[70] Jin, R, Qian, H, Wu, Z, Zhu, Y, Zhu, M, Mohanty, A, & Garg, N.
(2010) Size Focusing: A Methodology for Synthesizing Atomically
Precise Gold Nanoclusters. Journal of Physical Chemistry Letters 1,
2903–2910.
[71] Park, S & Lee, D. (2012) Synthesis and Electrochemical and Spec-
troscopic Characterization of Biicosahedral Au 25Clusters. Langmuir
28, 7049–7054.
[72] Shichibu, Y, Negishi, Y, Tsukuda, T, & Teranishi, T. (2005) Large-
scale synthesis of thiolated Au25 clusters via ligand exchange reac-
tions of phosphine-stabilized Au11 clusters. Journal of the American
Chemical Society 127, 13464–13465.
[73] Shibu, E. S, Muhammed, M. A. H, Tsukuda, T, & Pradeep, T.
(2008) Ligand Exchange of Au25SG18 Leading to Functionalized
214
Bibliography
Gold Clusters: Spectroscopy, Kinetics, and Luminescence. Journal
of Physical Chemistry C 112, 12168–12176.
[74] Jin, R. (2010) Quantum sized, thiolate-protected gold nanoclusters.
Nanoscale 2, 343–362.
[75] Wu, X, He, X, Wang, K, Xie, C, Zhou, B, & Qing, Z. (2010) Ul-
trasmall near-infrared gold nanoclusters for tumor fluorescence ima-
ging in vivo. Nanoscale 2, 2244–2249.
[76] Zheng, J, Petty, J. T, & Dickson, R. M. (2003) High Quantum Yield
Blue Emission from Water-Soluble Au 8Nanodots. Journal of the
American Chemical Society 125, 7780–7781.
[77] Wu, Z & Jin, R. (2010) On the ligand’s role in the fluorescence of
gold nanoclusters. Nano Letters 10, 2568–2573.
[78] Bigioni, T. P, Whetten, R. L, & Dag, Ö. (2000) Near-infrared lumin-
escence from small gold nanocrystals. Journal of Physical Chemistry
B 104, 6983–6986.
[79] Yang, Y & Chen, S. (2003) Surface Manipulation of the Electronic
Energy of Subnanometer-Sized Gold Clusters: An Electrochemical
and Spectroscopic Investigation. Nano Letters 3, 75–79.
[80] Donnio, B, Derory, A, Terazzi, E, Drillon, M, Guillon, D, & Gallani,
J.-L. (2010) Very slow high-temperature relaxation of the remnant
magnetic moment in 2 nm mesomorphic gold nanoparticles. Soft
Matter 6, 965–970.
[81] Davis, M. E, Chen, Z. G, & Shin, D. M. (2008) Nanoparticle thera-
peutics: an emerging treatment modality for cancer. Nature Reviews
Drug Discovery 7, 771–782.
[82] Lee, J. E, Lee, N, Kim, T, Kim, J, & Hyeon, T. (2011) Multifunc-
tional mesoporous silica nanocomposite nanoparticles for theranostic
applications. Accounts Of Chemical Research 44, 893–902.
[83] Wang, S, Zhang, M, & Zhang, W. (2011) Yolk-Shell Catalyst of Single
215
Bibliography
Au Nanoparticle Encapsulated within Hollow Mesoporous Silica Mi-
crospheres. ACS Catalysis 1, 207–211.
[84] Zhang, W. M, Hu, J. S, Guo, Y. G, Zheng, S. F, Zhong, L. S,
Song, W. G, & Wan, L. J. (2008) Tin-Nanoparticles Encapsulated in
Elastic Hollow Carbon Spheres for High-Performance Anode Material
in Lithium-Ion Batteries. Advanced Materials 20, 1160–1165.
[85] Qian, J, Liu, P, Xiao, Y, Jiang, Y, Cao, Y, Ai, X, & Yang, H.
(2009) TiO2-Coated Multilayered SnO2 Hollow Microspheres for
Dye-Sensitized Solar Cells. Advanced Materials 21, 3663–3667.
[86] Li, L, Tang, F, Liu, H, Liu, T, Hao, N, Chen, D, Teng, X, & He, J.
(2010) In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel
for Liver Cancer Therapy with Low Toxicity and High Efficacy. ACS
Nano 4, 6874–6882.
[87] Geng, B, Liu, J, Zhao, Y, & Wang, C. (2010) A Room-Temperature
Chemical Route to Homogeneous Core-Shell Cu2O Structures and
Their Application in Biosensors. CrystEngComm 13, 697–701.
[88] Roca, M & Haes, A. J. (2008) Silica-Void-Gold Nanoparticles:
Temporally Stable Surface-Enhanced Raman Scattering Substrates.
Journal of the American Chemical Society 130, 14273–14279.
[89] Link, S & El-Sayed, M. A. (2003) Optical properties and ultrafast dy-
namics of metallic nanocrystals. Annual review of physical chemistry
54, 331–366.
[90] Zhan, Q, Qian, J, Li, X, & He, S. (2010) A Study of Mesopor-
ous Silica-Encapsulated Gold Nanorods as Enhanced Light Scattering
Probes for Cancer Cell Imaging. Nanotechnology 21, 055704–055716.
[91] Wang, T.-T, Chai, F, Wang, C.-G, Li, L, Liu, H.-Y, Zhang, L.-Y, Su,
Z.-M, & Liao, Y. (2011) Fluorescent hollow/rattle-type mesoporous
Au@SiO2 nanocapsules for drug delivery and fluorescence imaging of
cancer cells. Journal of Colloid and Interface Science 358, 109–115.
[92] Melancon, M. P, Zhou, M, & Li, C. (2011) Cancer theranostics with
216
Bibliography
near-infrared light-activatable multimodal nanoparticles. Accounts
Of Chemical Research 44, 947–956.
[93] Kamata, K, Lu, Y, & Xia, Y. (2003) Synthesis and Characterization
of Monodispersed Core-Shell Spherical Colloids with Movable Cores.
Journal of the American Chemical Society 125, 2384–2385.
[94] Zhao, Y & Jiang, L. (2009) Hollow Micro/Nanomaterials with Mul-
tilevel Interior Structures. Advanced Materials 21, 3621–3638.
[95] Lou, X. W. D, Archer, L. A, & Yang, Z. (2008) Hollow Micro-
/Nanostructures: Synthesis and Applications. Advanced Materials
20, 3987–4019.
[96] Wu, X. J & Xu, D. (2010) Soft Template Synthesis of Yolk/Silica
Shell particles. Advanced Materials 22, 1516–1520.
[97] Liu, J, Qiao, S. Z, Budi Hartono, S, & Lu, G. Q. M. (2010) Mon-
odisperse Yolk-Shell Nanoparticles with a Hierarchical Porous Struc-
ture for Delivery Vehicles and Nanoreactors. Angewandte Chemie-
International Edition 49, 4981–4985.
[98] Chen, Y, Chen, H, Zeng, D, Tian, Y, Chen, F, Feng, J, & Shi, J.
(2010) Core/shell structured hollow mesoporous nanocapsules: a po-
tential platform for simultaneous cell imaging and anticancer drug
delivery. ACS Nano 4, 6001–6013.
[99] Park, J. C & Song, H. (2010) Metal@Silica Yolk-Shell Nanostructures
as Versatile Bifunctional Nanocatalysts. Nano Research 4, 33–49.
[100] Liu, J, Fan, F, Feng, Z, Zhang, L, Bai, S, Yang, Q, & Li, C.
(2008) From Hollow Nanosphere to Hollow Microsphere: Mild Buffer
Provides Easy Access to Tunable Silica Structure. Journal of Physical
Chemistry C 112, 16445–16451.
[101] Liu, J, Bai, S, Zhong, H, Li, C, & Yang, Q. (2010) Tunable Assembly
of Organosilica Hollow Nanospheres. Journal of Physical Chemistry
C 114, 953–961.
217
Bibliography
[102] Duncan, R. (2003) The dawning era of polymer therapeutics. Nature
Reviews Drug Discovery 2, 347–360.
[103] Langer, R. (1998) Drug delivery and targeting. Nature 392, 5–10.
[104] Vallet-Regi, M, Balas, F, & Arcos, D. (2007) Mesoporous materi-
als for drug delivery. Angewandte Chemie-International Edition 46,
7548–7558.
[105] Cho, K, Wang, X, Nie, S, Chen, Z. G, & Shin, D. M. (2008) Thera-
peutic nanoparticles for drug delivery in cancer. Clinical cancer re-
search : an official journal of the American Association for Cancer
Research 14, 1310–1316.
[106] Allen, T. M. (2002) Ligand-targeted therapeutics in anticancer ther-
apy. Nature Reviews Cancer 2, 750–763.
[107] Jain, R. K. (1998) The next frontier of molecular medicine: delivery
of therapeutics. Nature Medicine 4, 655–657.
[108] Serda, R. E, Mack, A, Pulikkathara, M, Zaske, A. M, Chiappini, C,
Fakhoury, J. R, Webb, D, Godin, B, Conyers, J. L, Liu, X. W, Bank-
son, J. A, & Ferrari, M. (2010) Cellular Association and Assembly
of a Multistage Delivery System. Small 6, 1329–1340.
[109] Melancon, M. P, Lu, W, Yang, Z, Zhang, R, Cheng, Z, Elliot, A. M,
Stafford, J, Olson, T, Zhang, J. Z, & Li, C. (2008) In vitro and in
vivo targeting of hollow gold nanoshells directed at epidermal growth
factor receptor for photothermal ablation therapy. Molecular Cancer
Therapeutics 7, 1730–1739.
[110] Lu, W, Xiong, C, Zhang, G, Huang, Q, Zhang, R, Zhang, J. Z, &
Li, C. (2009) Targeted Photothermal Ablation of Murine Melano-
mas with Melanocyte-Stimulating Hormone Analog-Conjugated Hol-
low Gold Nanospheres. Clinical Cancer Research 15, 876–886.
[111] Choi, C. H. J, Alabi, C. A, Webster, P, & Davis, M. E. (2010) Mech-
anism of active targeting in solid tumors with transferrin-containing
gold nanoparticles. Proceedings of the National Academy of Sciences
of the United States of America 107, 1235–1240.
218
Bibliography
[112] Pirollo, K. F & Chang, E. H. (2008) Does a targeting ligand influence
nanoparticle tumor localization or uptake? Trends in Biotechnology
26, 552–558.
[113] O’Neal, D. P, Hirsch, L. R, Halas, N. J, Payne, J. D, & West, J. L.
(2004) Photo-thermal tumor ablation in mice using near infrared-
absorbing nanoparticles. Cancer Letters 209, 171–176.
[114] Matsumura, Y & Maeda, H. (1986) A new concept for macromolecu-
lar therapeutics in cancer chemotherapy: mechanism of tumoritropic
accumulation of proteins and the antitumor agent smancs. Cancer
Research 46, 6387–6392.
[115] He, X, Wang, K, & Cheng, Z. (2010) In vivo near-infrared fluor-
escence imaging of cancer with nanoparticle-based probes. Wiley
Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2,
349–366.
[116] Luo, S, Zhang, E, Su, Y, Cheng, T, & Shi, C. (2011) A review of NIR
dyes in cancer targeting and imaging. Biomaterials 32, 7127–7138.
[117] Mahmoudi, M, Serpooshan, V, & Laurent, S. (2011) Engineered
nanoparticles for biomolecular imaging. Nanoscale 3, 3007–3026.
[118] Willmann, J. K, van Bruggen, N, Dinkelborg, L. M, & Gambhir, S. S.
(2008) Molecular imaging in drug development. Nature Reviews Drug
Discovery 7, 591–607.
[119] Aswathy, R. G, Yoshida, Y, Maekawa, T, & Kumar, D. S. (2010)
Near-infrared quantum dots for deep tissue imaging. Analytical and
Bioanalytical Chemistry 397, 1417–1435.
[120] Hilderbrand, S. A & Weissleder, R. (2010) Near-infrared fluores-
cence: application to in vivo molecular imaging. Current Opinion In
Chemical Biology 14, 71–79.
[121] Sipkins, D. A, Cheresh, D. A, Kazemi, M. R, Nevin, L. M, Bednarski,
M. D, & Li, K. C. P. (1998) Detection of tumor angiogenesis in vivo
by avß3-targeted magnetic resonance imaging. Nature Medicine 4,
623–626.
219
Bibliography
[122] Paulus, M. J, Gleason, S. S, Kennel, S. J, Hunsicker, P. R, & John-
son, D. K. (2000) High resolution X-ray computed tomography: an
emerging tool for small animal cancer research. Neoplasia 2, 62–70.
[123] de Wit, M, Bumann, D, Beyer, W, Herbst, K, Clausen, M, & Hoss-
feld, D. K. (1997) Whole-body positron emission tomography (PET)
for diagnosis of residual mass in patients with lymphoma. Annals of
oncology 8 Suppl 1, 57–60.
[124] Warner, E, Plewes, D. B, Shumak, R. S, Catzavelos, G. C, Di Pros-
pero, L. S, Yaffe, M. J, Goel, V, Ramsay, E, Chart, P. L, Cole, D. E,
Taylor, G. A, Cutrara, M, Samuels, T. H, Murphy, J. P, Murphy,
J. M, & Narod, S. A. (2001) Comparison of breast magnetic res-
onance imaging, mammography, and ultrasound for surveillance of
women at high risk for hereditary breast cancer. Journal of Clinical
Oncology 19, 3524–3531.
[125] Badr, C. E & Tannous, B. A. (2011) Bioluminescence imaging: pro-
gress and applications. Trends in Biotechnology 29, 624–633.
[126] Sadikot, R. T & Blackwell, T. S. (2005) Bioluminescence Imaging.
Proceedings of the American Thoracic Society 2, 537–540.
[127] Hoffman, R. M. (2005) The multiple uses of fluorescent proteins to
visualize cancer in vivo. Nature Reviews Cancer 5, 796–806.
[128] Condeelis, J & Segall, J. E. (2003) Intravital imaging of cell move-
ment in tumours. Nature Reviews Cancer 3, 921–930.
[129] Jain, P. K, Huang, X, El-Sayed, I. H, & El-Sayed, M. A. (2008)
Noble metals on the nanoscale: optical and photothermal properties
and some applications in imaging, sensing, biology, and medicine.
Accounts Of Chemical Research 41, 1578–1586.
[130] Smith, A. M, Mancini, M. C, & Nie, S. (2009) Bioimaging: Second
window for in vivo imaging. Nature Nanotechnology 4, 710–711.
[131] Mahmood, U & Weissleder, R. (2003) Near-infrared optical imaging
of proteases in cancer. Molecular Cancer Therapeutics 2, 489–496.
220
Bibliography
[132] Sevick-Muraca, E. M. (2012) Translation of Near-Infrared Fluores-
cence Imaging Technologies: Emerging Clinical Applications. Annual
Review of Medicine 63, 217–231.
[133] Frangioni, J. (2003) In vivo near-infrared fluorescence imaging. Cur-
rent Opinion In Chemical Biology 7, 626–634.
[134] Xing, Y & Rao, J. (2008) Quantum dot bioconjugates for in vitro
diagnostics and in vivo imaging. Cancer Biomarkers 4, 307–319.
[135] Gao, X, Cui, Y, Levenson, R. M, Chung, L. W. K, & Nie, S. (2004)
In vivo cancer targeting and imaging with semiconductor quantum
dots. Nature Biotechnology 22, 969–976.
[136] Bardhan, R, Chen, W, Perez-Torres, C, Bartels, M, Huschka, R. M,
Zhao, L. L, Morosan, E, Pautler, R. G, Joshi, A, & Halas, N. J.
(2009) Nanoshells with Targeted Simultaneous Enhancement of Mag-
netic and Optical Imaging and Photothermal Therapeutic Response.
Advanced Functional Materials 19, 3901–3909.
[137] Smith, A. M, Gao, X, & Nie, S. (2004) Quantum dot nanocrys-
tals for in vivo molecular and cellular imaging. Photochemistry and
Photobiology 80, 377–385.
[138] Zheng, Y, Gao, S, & Ying, J. Y. (2007) Synthesis and Cell-Imaging
Applications of Glutathione-Capped CdTe Quantum Dots. Advanced
Materials 19, 376–380.
[139] Huang, X, El-Sayed, I. H, Qian, W, & El-Sayed, M. A. (2006) Cancer
cell imaging and photothermal therapy in the near-infrared region by
using gold nanorods. Journal of the American Chemical Society 128,
2115–2120.
[140] Lin, C.-A. J, Yang, T.-Y, Lee, C.-H, Huang, S. H, Sperling, R. A,
Zanella, M, Li, J. K, Shen, J.-L, Wang, H.-H, Yeh, H.-I, Parak, W. J,
& Chang, W. H. (2009) Synthesis, Characterization, and Bioconjug-
ation of Fluorescent Gold Nanoclusters toward Biological Labeling
Applications. ACS Nano 3, 395–401.
221
Bibliography
[141] Yu, J, Choi, S, Richards, C. I, Antoku, Y, & Dickson, R. M. (2008)
Live Cell Surface Labeling with Fluorescent Ag Nanocluster Conjug-
ates . Photochemistry and Photobiology 84, 1435–1439.
[142] Chevrier, D. M, Chatt, A, & Zhang, P. (2012) Properties and ap-
plications of protein-stabilized fluorescent gold nanoclusters: short
review. Journal of Nanophotonics 6, 064504–1–064504–16.
[143] Kircher, M. F, Mahmood, U, King, R. S, Weissleder, R, & Josephson,
L. (2003) A multimodal nanoparticle for preoperative magnetic res-
onance imaging and intraoperative optical brain tumor delineation.
Cancer Research 63, 8122–8125.
[144] Bardhan, R, Lal, S, Joshi, A, & Halas, N. J. (2011) Theranostic
nanoshells: from probe design to imaging and treatment of cancer.
Accounts Of Chemical Research 44, 936–946.
[145] Zhang, L, Wang, T, Yang, L, Liu, C, Wang, C, Liu, H, Wang,
Y. A, & Su, Z. (2012) General Route to Multifunctional Uniform
Yolk/Mesoporous Silica Shell Nanocapsules: A Platform for Sim-
ultaneous Cancer-Targeted Imaging and Magnetically Guided Drug
Delivery. Chemistry-A European Journal 18, 12512–12521.
[146] Zhang, F, Braun, G. B, Pallaoro, A, Zhang, Y, Shi, Y, Cui, D,
Moskovits, M, Zhao, D, & Stucky, G. D. (2012) Mesoporous Mul-
tifunctional Upconversion Luminescent and Magnetic “Nanorattle”
Materials for Targeted Chemotherapy. Nano Letters 12, 61–67.
[147] Ma, M, Chen, H, Chen, Y, Wang, X, Chen, F, Cui, X, & Shi,
J. (2012) Au capped magnetic core/mesoporous silica shell nano-
particles for combined photothermo-/chemo-therapy and multimodal
imaging. Biomaterials 33, 989–998.
[148] Huang, X, Jain, P. K, El-Sayed, I. H, & El-Sayed, M. A. (2007)
Plasmonic photothermal therapy (PPTT) using gold nanoparticles.
Lasers in Medical Science 23, 217–228.
[149] Cavaliere, R, Ciocatto, E. C, Giovanella, B. C, Heidelberger, C, John-
son, R. O, Margottini, M, Mondovi, B, Moricca, G, & Rossi Fanelli,
222
Bibliography
A. (1967) Selective heat sensitivity of cancer cells. Biochemical and
clinical studies. Cancer 20, 1351–1381.
[150] Overgaard, J, Gonzalez, D. G, Hulshof, M, Arcangeli, G, Dahl, O,
Mella, O, & Bentzen, S. M. (1996) Hyperthermia as an adjuvant
to radiation therapy of recurrent or metastatic malignant melanoma.
A multicentre randomized trial by the European Society for Hyper-
thermic Oncology. International Journal of Hyperthermia 12, 3–20.
[151] Cobley, C. M, Chen, J, Cho, E. C, Wang, L. V, & Xia, Y. (2010) Gold
nanostructures: a class of multifunctional materials for biomedical
applications. Chemical Society Reviews 40, 44–56.
[152] Averitt, R, Sarkar, D, & Halas, N. (1997) Plasmon Resonance Shifts
of Au-Coated Au2S Nanoshells: Insight into Multicomponent Nano-
particle Growth. Physical Review Letters 78, 4217–4220.
[153] Loo, C, Lowery, A, Halas, N, West, J, & Drezek, R. (2005) Immun-
otargeted Nanoshells for Integrated Cancer Imaging and Therapy.
Nano Letters 5, 709–711.
[154] Na, H. B, Song, I. C, & Hyeon, T. (2009) Inorganic Nanoparticles
for MRI Contrast Agents. Advanced Materials 21, 2133–2148.
[155] Xu, S.-L & Cui, H. (2007) Luminol chemiluminescence catalysed by
colloidal platinum nanoparticles. Luminescence 22, 77–87.
[156] Chen, J, Wang, D, Xi, J, Au, L, Siekkinen, A, Warsen, A, Li, Z.-Y,
Zhang, H, Xia, Y, & Li, X. (2007) Immuno Gold Nanocages with
Tailored Optical Properties for Targeted Photothermal Destruction
of Cancer Cells. Nano Letters 7, 1318–1322.
[157] Huang, X, Neretina, S, & El-Sayed, M. A. (2009) Gold Nanorods:
From Synthesis and Properties to Biological and Biomedical Applic-
ations. Advanced Materials 21, 4880–4910.
[158] El-Sayed, I, Huang, X, & El-Sayed, M. (2006) Selective Laser Photo-
Thermal Therapy of Epithelial Carcinoma Using Anti-Egfr Antibody
Conjugated Gold Nanoparticles. Cancer Letters 239, 129–135.
223
Bibliography
[159] Li, J.-L, Wang, L, Liu, X.-Y, Zhang, Z.-P, Guo, H.-C, Liu, W.-M,
& Tang, S.-H. (2009) In vitro cancer cell imaging and therapy using
transferrin-conjugated gold nanoparticles. Cancer Letters 274, 319–
326.
[160] Hirsch, F. R, Franklin, W. A, Gazdar, A. F, & Bunn, P. A. (2001)
Early detection of lung cancer: clinical perspectives of recent ad-
vances in biology and radiology. Clinical cancer research : an official
journal of the American Association for Cancer Research 7, 5–22.
[161] Sosnovik, D. E, Nahrendorf, M, & Weissleder, R. (2008) Magnetic
nanoparticles for MR imaging: agents, techniques and cardiovascular
applications. Basic Research in Cardiology 103, 122–130.
[162] Wunderbaldinger, P, Josephson, L, & Weissleder, R. (2002) Cross-
linked Iron Oxides (Clio): a New Platform for the Development of
Targeted Mr Contrast Agents. Academic Radiology 9, S304–S306.
[163] Sun, Y. (2002) Shape-Controlled Synthesis of Gold and Silver Nan-
oparticles. Science (New York, NY) 298, 2176–2179.
[164] Cole, J. R, Mirin, N. A, Knight, M. W, Goodrich, G. P, & Halas,
N. J. (2009) Photothermal Efficiencies of Nanoshells and Nanorods
for Clinical Therapeutic Applications. Journal of Physical Chemistry
C 113, 12090–12094.
[165] Parak, W, Gerion, D, Pellegrino, T, Zanchet, D, Micheel, C, Willi-
ams, S, Boudreau, R, Le Gros, M, Larabell, C, & Alivisatos, A. (2003)
Biological applications of colloidal nanocrystals. Nanotechnology 14,
R15–R27.
[166] Jain, P. K, Lee, K. S, El-Sayed, I. H, & El-Sayed, M. A. (2006) Calcu-
lated Absorption and Scattering Properties of Gold Nanoparticles of
Different Size, Shape, and Composition: Applications in Biological
Imaging and Biomedicine. Journal of Physical Chemistry B 110,
7238–7248.
[167] von Maltzahn, G, Park, J. H, Agrawal, A, Bandaru, N. K, Das, S. K,
Sailor, M. J, & Bhatia, S. N. (2009) Computationally Guided Photo-
224
Bibliography
thermal Tumor Therapy Using Long-Circulating Gold Nanorod An-
tennas. Cancer Research 69, 3892–3900.
[168] Schwartz, J. A, Shetty, A. M, Price, R. E, Stafford, R. J, Wang, J. C,
Uthamanthil, R. K, Pham, K, McNichols, R. J, Coleman, C. L, &
Payne, J. D. (2009) Feasibility study of particle-assisted laser ablation
of brain tumors in orthotopic canine model. Cancer Research 69,
1659–1667.
[169] Eichler, A. F & Loeﬄer, J. S. (2007) Multidisciplinary management
of brain metastases. Oncologist 12, 884–898.
[170] Lasa-Saracibar, B, Estella-Hermoso de Mendoza, A, Guada, M, Dios-
Vieitez, C, & Blanco-Prieto, M. J. (2012) Lipid nanoparticles for
cancer therapy: state of the art and future prospects. Expert opinion
on drug delivery 9, 1245–1261.
[171] Li, K. C. P, Pandit, S. D, Guccione, S, & Bednarski, M. D. (2004)
Molecular imaging applications in nanomedicine. Biomedical mi-
crodevices 6, 113–116.
[172] Minelli, C, Kikuta, A, Tsud, N, Ball, M, & Yamamoto, A. (2008) A
micro-fluidic study of whole blood behaviour on PMMA topograph-
ical nanostructures. Journal of Nanobiotechnology 6, 3–13.
[173] Torchilin, V. P. (2005) Recent advances with liposomes as pharma-
ceutical carriers. Nature Reviews Drug Discovery 4, 145–160.
[174] Torchilin, V. P. (1996) Liposomes as delivery agents for medical
imaging. Molecular medicine today 2, 242–249.
[175] Li, J, Liu, J, Wang, D, Guo, R, Li, X, & Qi, W. (2010) Interfacially
controlled synthesis of hollow mesoporous silica spheres with radially
oriented pore structures. Langmuir 26, 12267–12272.
[176] An, K & Hyeon, T. (2009) Synthesis and biomedical applications of
hollow nanostructures. Nano Today 4, 359–373.
[177] Zhao, Y, Sun, X, Zhang, G, Trewyn, B. G, Slowing, I. I, & Lin, V. S.-
Y. (2011) Interaction of mesoporous silica nanoparticles with human
225
Bibliography
red blood cell membranes: size and surface effects. ACS Nano 5,
1366–1375.
[178] Song, S.-W, Hidajat, K, & Kawi, S. (2005) Functionalized SBA-15
materials as carriers for controlled drug delivery: influence of surface
properties on matrix-drug interactions. Langmuir 21, 9568–9575.
[179] Muñoz, B, Ramila, A, Perez-Pariente, J, Díaz, I, & Vallet-Regi, M.
(2003) MCM-41 Organic Modification as Drug Delivery Rate Regu-
lator. Chemistry of Materials 15, 500–503.
[180] Trewyn, B. G, Slowing, I. I, Giri, S, Chen, H.-T, & Lin, V. S.-Y.
(2007) Synthesis and Functionalization of a Mesoporous Silica Nano-
particle Based on the Sol–Gel Process and Applications in Controlled
Release. Accounts Of Chemical Research 40, 846–853.
[181] Beck, J. S, Vartuli, J. C, Roth, W. J, Leonowicz, M. E, Kresge, C. T,
Schmitt, K. D, Chu, C. T, Olson, D. H, Sheppard, E. W, McCullen,
S. B, Higgins, J. B, & L, S. J. (1992) A New Family of Mesoporous
Molecular Sieves Prepared with Liquid Crystal Templates. Journal
of the American Chemical Society 114, 10834–10843.
[182] Yu, T, Malugin, A, & Ghandehari, H. (2011) Impact of Silica Nan-
oparticle Design on Cellular Toxicity and Hemolytic Activity. ACS
Nano 5, 5717–5728.
[183] He, Q & Shi, J. (2011) Mesoporous silica nanoparticle based nano
drug delivery systems: synthesis, controlled drug release and delivery,
pharmacokinetics and biocompatibility. Journal of Materials Chem-
istry 21, 5845–5855.
[184] Slowing, I. I, Trewyn, B. G, Giri, S, & Lin, V. S. Y. (2007) Mesopor-
ous Silica Nanoparticles for Drug Delivery and Biosensing Applica-
tions. Advanced Functional Materials 17, 1225–1236.
[185] Vallet-Regi, M, Ramila, A, del Real, R, & Perez-Pariente, J. (2001)
A New Property of MCM-41: Drug Delivery System. Chemistry of
Materials 13, 308–311.
226
Bibliography
[186] Torney, F, Trewyn, B. G, Lin, V. S.-Y, & Wang, K. (2007) Meso-
porous silica nanoparticles deliver DNA and chemicals into plants.
Nature Nanotechnology 2, 295–300.
[187] Vivero-Escoto, J. L, Slowing, I. I, Wu, C.-W, & Lin, V. S.-Y. (2009)
Photoinduced Intracellular Controlled Release Drug Delivery in Hu-
man Cells by Gold-Capped Mesoporous Silica Nanosphere. Journal
of the American Chemical Society 131, 3462–3463.
[188] Slowing, I. I, Vivero-Escoto, J. L, Wu, C. W, & Lin, V. S. Y. (2008)
Mesoporous silica nanoparticles as controlled release drug delivery
and gene transfection carriers. Advanced drug delivery reviews 60,
1278–1288.
[189] Liu, H, Chen, D, Li, L, Liu, T, Tan, L, Wu, X, & Tang, F. (2011)
Multifunctional Gold Nanoshells on Silica Nanorattles: A Platform
for the Combination of Photothermal Therapy and Chemotherapy
with Low Systemic Toxicity. Angewandte Chemie-International Edi-
tion 50, 891–895.
[190] Liu, H, Liu, T, Wu, X, Li, L, Tan, L, Chen, D, & Tang, F. (2012)
Targeting gold nanoshells on silica nanorattles: a drug cocktail to
fight breast tumors via a single irradiation with near-infrared laser
light. Advanced materials (Deerfield Beach, Fla.) 24, 755–761.
[191] Williams, D. B & Carter, C. B. (2009) Transmission Electron Micro-
scopy: A Textbook for Materials Science. (Springer).
[192] Prasad, V, Semwogerere, D, & Weeks, E. R. (2007) Confocal micro-
scopy of colloids. Journal of Physics: Condensed Matter 19, 113102–
113127.
[193] Lohela, M & Werb, Z. (2010) Intravital imaging of stromal cell dy-
namics in tumors. Current Opinion in Genetics & Development 20,
72–78.
[194] Boassa, D, Solan, J. L, Papas, A, Thornton, P, Lampe, P. D, &
Sosinsky, G. E. (2010) Trafficking and Recycling of the Connexin43
Gap Junction Protein during Mitosis. Traffic 11, 1471–1486.
227
Bibliography
[195] Li, Z, Wen, L, Shao, L, & Chen, J. (2004) Fabrication of porous hol-
low silica nanoparticles and their applications in drug release control.
Journal of Controlled Release 98, 245–254.
[196] Chen, Z, Cui, Z.-M, Niu, F, Jiang, L, & Song, W. G. (2010) Pd
Nanoparticles in Silica Hollow Spheres with Mesoporous Walls: a
Nanoreactor with Extremely High Activity. Chemical communica-
tions (Cambridge, England) 46, 6524–6526.
[197] Ding, S, Chen, J. S, Qi, G, Duan, X, Wang, Z, Giannelis, E. P,
Archer, L. A, & Lou, X. W. (2011) Formation of SnO2 Hollow Nano-
spheres Inside Mesoporous Silica Nanoreactors. Journal of the Amer-
ican Chemical Society 133, 21–23.
[198] De, M, Ghosh, P. S, & Rotello, V. M. (2008) Applications of Nano-
particles in Biology. Advanced Materials 20, 4225–4241.
[199] Blas, H, Save, M, Pasetto, P, Boissière, C, Sanchez, C, & Charleux,
B. (2008) Elaboration of Monodisperse Spherical Hollow Particles
with Ordered Mesoporous Silica Shells via Dual Latex/Surfactant
Templating: Radial Orientation of Mesopore Channels. Langmuir
24, 13132–13137.
[200] Feng, Z, Li, Y, Niu, D, Li, L, Zhao, W, Chen, H, Li, L, Gao, J,
Ruan, M, & Shi, J. (2008) A facile route to hollow nanospheres
of mesoporous silica with tunable size. Chemical communications
(Cambridge, England) pp. 2629–2631.
[201] Sun, Q, Kooyman, P. J, Grossmann, J. G, Bomans, P. H. H, Frederik,
P. M, Magusin, P. C. M. M, Beelen, T. P. M, van Santen, R. A, &
Sommerdijk, N. A. J. M. (2003) The Formation of Well-Defined
Hollow Silica Spheres with Multilamellar Shell Structure. Advanced
Materials 15, 1097–1100.
[202] Zhu, Y, Shi, J, Shen, W, Chen, H, Dong, X, & Ruan, M. (2005)
Preparation of novel hollow mesoporous silica spheres and their
sustained-release property. Nanotechnology 16, 2633–2638.
228
Bibliography
[203] Tan, B & Rankin, S. E. (2005) Dual latex/surfactant templating
of hollow spherical silica particles with ordered mesoporous shells.
Langmuir 21, 8180–8187.
[204] Wu, X, Tian, Y, Cui, Y, Wei, L, Wang, Q, & Chen, Y. (2007)
Raspberry-like silica hollow spheres: hierarchical structures by dual
latex-surfactant templating route. Journal of Physical Chemistry C
111, 9704–9708.
[205] Fowler, C. E, Khushalani, D, Lebeau, B, & Mann, S. (2001) Nano-
scale materials with mesostructured interiors. Advanced materials
(Deerfield Beach, Fla.) 13, 649–652.
[206] Li, Z. Z, Xu, S. A, Wen, L. X, Liu, F, Liu, A. Q, Wang, Q, Sun,
H. Y, Yu, W, & Chen, J. F. (2006) Controlled release of avermectin
from porous hollow silica nanoparticles: influence of shell thickness
on loading efficiency, UV-shielding property and release. Journal of
Controlled Release 111, 81–88.
[207] Park, S. J, Kim, Y. J, & Park, S. J. (2008) Size-dependent shape
evolution of silica nanoparticles into hollow structures. Langmuir 24,
12134–12137.
[208] Woehrle, G. H, Warner, M. G, & Hutchison, J. E. (2002) Lig-
and Exchange Reactions Yield Subnanometer, Thiol-Stabilized Gold
Particles with Defined Optical Transitions. Journal of Physical
Chemistry B 106, 9979–9981.
[209] Weare, W. W, Reed, S. M, Warner, M. G, & Hutchison, J. E. (2000)
Improved synthesis of small (d core= 1.5 nm) phosphine-stabilized
gold nanoparticles. Journal of the American Chemical Society 122,
12890–12891.
[210] Woehrle, G. H, Brown, L. O, & Hutchison, J. E. (2005) Thiol-
functionalized, 1.5-nm gold nanoparticles through ligand exchange
reactions: scope and mechanism of ligand exchange. Journal of the
American Chemical Society 127, 2172–2183.
229
Bibliography
[211] Donkers, R. L, Lee, D, & Murray, R. (2004) Synthesis and isolation
of the molecule-like cluster Au38 (PhCH2CH2S) 24. Langmuir 20,
1945–1952.
[212] Blas, H, Save, M, Boissière, C, Sanchez, C, & Charleux, B. (2011)
Surface-Initiated Nitroxide-Mediated Polymerization from Ordered
Mesoporous Silica. Macromolecules 44, 2577–2588.
[213] Chen, Y, Chen, H, Guo, L, He, Q, Chen, F, Zhou, J, Feng, J, &
Shi, J. (2010) Hollow/rattle-type mesoporous nanostructures by a
structural difference-based selective etching strategy. ACS Nano 4,
529–539.
[214] Yang, S, Zhou, C, Liu, J, Yu, M, & Zheng, J. (2012) One-Step Interfa-
cial Synthesis and Assembly of Ultrathin Luminescent AuNPs/Silica
Membranes. Advanced Materials 24, 3218–3222.
[215] Aikens, C. M. (2011) Electronic Structure of Ligand-Passivated Gold
and Silver Nanoclusters. Journal of Physical Chemistry Letters 2,
99–104.
[216] Yang, P, Quan, Z, Hou, Z, Li, C, Kang, X, Cheng, Z, & Lin, J. (2009)
A magnetic, luminescent and mesoporous core–shell structured com-
posite material as drug carrier. Biomaterials 30, 4786–4795.
[217] Bass, J. D, Grosso, D, Boissière, C, Belamie, E, Coradin, T, & Sanc-
hez, C. (2007) Stability of mesoporous oxide and mixed metal oxide
materials under biologically relevant conditions. Chemistry of Ma-
terials 19, 4349–4356.
[218] Soo Choi, H, Liu, W, Misra, P, Tanaka, E, Zimmer, J. P, Itty Ipe,
B, Bawendi, M. G, & Frangioni, J. V. (2007) Renal clearance of
quantum dots. Nature Biotechnology 25, 1165–1170.
[219] Cai, W & Chen, X. (2008) Preparation of peptide-conjugated
quantum dots for tumor vasculature-targeted imaging. Nature Pro-
tocols 3, 89–96.
[220] Michalet, X. (2005) Quantum Dots for Live Cells, in Vivo Imaging,
and Diagnostics. Science (New York, NY) 307, 538–544.
230
Bibliography
[221] Rahbari, R, Sheahan, T, Modes, V, Collier, P, Macfarlane, C, &
Badge, R. M. (2009) A novel L1 retrotransposon marker for HeLa
cell line identification. BioTechniques 46, 277–284.
[222] Sieuwerts, A. M, Klijn, J. G. M, Peters, H. A, & Foekens, J. A.
(1995) The MTT Tetrazolium Salt Assay Scrutinized: How to Use
this Assay Reliably to Measure Metabolic Activity of Cell Cultures in
vitro for the Assessment of Growth Characteristics, IC 5 0-Values and
Cell Survival. European Journal of Clinical Chemistry and Clinical
Biochemistry 33, 813–824.
[223] Wallin, R. F & Arscott, E. F. (1998) A practical guide to ISO 10993-
5: Cytotoxicity. Medical device & diagnostic industry 20, 96.
[224] Hedegaard, M, Matthäus, C, Hassing, S, Krafft, C, Diem, M, & Popp,
J. (2011) Spectral unmixing and clustering algorithms for assessment
of single cells by Raman microscopic imaging. Theoretical Chemistry
Accounts 130, 1249–1260.
[225] Kircher, M. F, de la Zerda, A, Jokerst, J. V, Zavaleta, C. L, Kempen,
P. J, Mittra, E, Pitter, K, Huang, R, Campos, C, Habte, F, Sinclair,
R, Brennan, C. W, Mellinghoff, I. K, Holland, E. C, & Gambhir, S. S.
(2012) A brain tumor molecular imaging strategy using a new triple-
modality MRI-photoacoustic-Raman nanoparticle. Nature Medicine
18, 829–834.
[226] Conner, S. D & Schmid, S. L. (2003) Regulated portals of entry into
the cell. Nature 422, 37–44.
[227] Wang, J, Byrne, J. D, Napier, M. E, & DeSimone, J. M. (2011) More
effective nanomedicines through particle design. Small 7, 1919–1931.
[228] Petros, R. A & DeSimone, J. M. (2010) Strategies in the design
of nanoparticles for therapeutic applications. Nature Reviews Drug
Discovery 9, 615–627.
[229] Rejman, J, Oberle, V, Zuhorn, I. S, & Hoekstra, D. (2004) Size-
dependent internalization of particles via the pathways of clathrin-
231
Bibliography
and caveolae-mediated endocytosis. Biochemical Journal 377, 159–
169.
[230] Bathori, G, Cervenak, L, & Karadi, I. (2004) Caveolae - An Al-
ternative Endocytotic Pathway for Targeted Drug Delivery. Critical
Reviews in Therapeutic Drug Carrier Systems 21, 67–96.
[231] Hall, E. J. (2006) Intensity-modulated radiation therapy, protons,
and the risk of second cancers. International Journal of Radiation
Oncology, Biology, Physics 65, 1–7.
[232] Zietman, A. L, DeSilvio, M. L, Slater, J. D, Rossi, C. J, Miller, D. W,
Adams, J. A, & Shipley, W. U. (2005) Comparison of conventional-
dose vs high-dose conformal radiation therapy in clinically local-
ized adenocarcinoma of the prostate: a randomized controlled trial.
Journal of the American Medical Association 294, 1233–1239.
[233] Li, L, Guan, Y, Liu, H, Hao, N, Liu, T, Meng, X, Fu, C, Li, Y,
Qu, Q, Zhang, Y, Ji, S, Chen, L, Chen, D, & Tang, F. (2011) Silica
nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-
tropic therapy. ACS Nano 5, 7462–7470.
[234] Sapareto, S. A & Dewey, W. C. (1984) Thermal dose determina-
tion in cancer therapy. International Journal of Radiation Oncology,
Biology, Physics 10, 787–800.
[235] Song, C. W. (1984) Effect of local hyperthermia on blood flow and
microenvironment: a review. Cancer Research 44, 4721s–4730s.
[236] Halperin, E. C, Perez, C. A, Brady, L. W, & Wazer, D. E. (2007)
Perez and Brady’s Principles and Practice of Radiation Oncology.
(Wolters Kluwer Health/Lippincott Williams & Wilkins.).
[237] Zharov, V. P, Letfullin, R. R, & Galitovskaya, E. N. (2005)
Microbubbles-overlapping mode for laser killing of cancer cells with
absorbing nanoparticle clusters. Journal of Physics D: Applied Phys-
ics 38, 2571–2581.
[238] Yavuz, M. S, Cheng, Y, Chen, J, Cobley, C. M, Zhang, Q, Rycenga,
M, Xie, J, Kim, C, Song, K. H, Schwartz, A. G, Wang, L. V, & Xia,
232
Bibliography
Y. (2009) Gold nanocages covered by smart polymers for controlled
release with near-infrared light. Nature Materials 8, 935–939.
[239] Kurita, H, Takami, A, & Koda, S. (1998) Size reduction of gold
particles in aqueous solution by pulsed laser irradiation. Applied
Physics Letters 72, 789–791.
[240] Takami, A, Kurita, H, & Koda, S. (1999) Laser-induced size reduction
of noble metal particles. Journal of Physical Chemistry B 103, 1226–
1232.
[241] Chen, Y.-S, Frey, W, Kim, S, Homan, K, Kruizinga, P, Sokolov, K,
& Emelianov, S. (2010) Enhanced thermal stability of silica-coated
gold nanorods for photoacoustic imaging and image-guided therapy.
Optics Express 18, 8867–8878.
[242] Van Gemert, M. J. C, Jacques, S. L, Sterenborg, H. J. C. M, &
Star, W. M. (1989) Skin optics. IEEE Transactions on Biomedical
Engineering 36, 1146–1154.
[243] Flock, S. T, Patterson, M. S, Wilson, B. C, & Wyman, D. R. (1989)
Monte Carlo modeling of light propagation in highly scattering tis-
sues. I. Model predictions and comparison with diffusion theory.
IEEE Transactions on Biomedical Engineering 36, 1162–1168.
[244] Welch, A. J & van Gemert, M. J. C. (2011) Optical-Thermal Response
of Laser-Irradiated Tissue. (Springer).
[245] Barbé, C, Bartlett, J, Kong, L, Finnie, K, Lin, H. Q, Larkin, M,
Calleja, S, Bush, A, & Calleja, G. (2004) Silica Particles: A Novel
Drug-Delivery System. Advanced materials (Deerfield Beach, Fla.)
16, 1959–1966.
[246] Vallet-Regi, M. (2006) Ordered mesoporous materials in the context
of drug delivery systems and bone tissue engineering. Chemistry-A
European Journal 12, 5934–5943.
[247] Lee, K. Y, Peters, M. C, & Mooney, D. J. (2001) Controlled drug
delivery from polymers by mechanical signals. Advanced materials
(Deerfield Beach, Fla.) 13, 837–839.
233
Bibliography
[248] Gao, F, Li, L, Liu, T, Hao, N, Liu, H, Tan, L, Li, H, Huang, X, Peng,
B, Yan, C, Yang, L, Wu, X, Chen, D, & Tang, F. (2012) Doxorubicin
loaded silica nanorattles actively seek tumors with improved anti-
tumor effects. Nanoscale 4, 3365–3372.
[249] Lu, J, Liong, M, Zink, J. I, & Tamanoi, F. (2007) Mesoporous
Silica Nanoparticles as a Delivery System for Hydrophobic Antic-
ancer Drugs. Small 3, 1341–1346.
[250] Farokhzad, O. C, Karp, J. M, & Langer, R. (2006) Nanoparticle–
aptamer bioconjugates for cancer targeting. Expert opinion on drug
delivery 3, 311–324.
[251] Cuenca, A. G, Jiang, H, Hochwald, S. N, Delano, M, Cance, W. G,
& Grobmyer, S. R. (2006) Emerging implications of nanotechnology
on cancer diagnostics and therapeutics. Cancer 107, 459–466.
[252] Markman, M. (2006) Pegylated liposomal doxorubicin in the treat-
ment of cancers of the breast and ovary. Expert opinion on pharma-
cotherapy 7, 1469–1474.
[253] Huang, C.-C, Huang, W, & Yeh, C.-S. (2011) Shell-by-shell synthesis
of multi-shelled mesoporous silica nanospheres for optical imaging
and drug delivery. Biomaterials 32, 556–564.
[254] Zhu, Y, Shi, J, Shen, W, Dong, X, Feng, J, Ruan, M, & Li, Y. (2005)
Stimuli-Responsive Controlled Drug Release from a Hollow Meso-
porous Silica Sphere/Polyelectrolyte Multilayer Core-Shell Structure.
Angewandte Chemie 117, 5213–5217.
[255] Zhu, Y, Ikoma, T, Hanagata, N, & Kaskel, S. (2010) Rattle-type
Fe(3)O(4)@SiO(2) hollow mesoporous spheres as carriers for drug
delivery. Small 6, 471–478.
[256] Liu, J, Qiao, S. Z, Hu, Q. H, & Lu, G. Q. (2011) Magnetic nano-
composites with mesoporous structures: synthesis and applications.
Small 7, 425–443.
[257] Wu, H, Liu, G, Zhang, S, Shi, J, Zhang, L, Chen, Y, Chen, F, &
Chen, H. (2011) Biocompatibility, MR imaging and targeted drug
234
Bibliography
delivery of a rattle-type magnetic mesoporous silica nanosphere sys-
tem conjugated with PEG and cancer-cell-specific ligands. Journal
of Materials Chemistry 21, 3037–3045.
[258] Karukstis, K. K, Thompson, E. H, Whiles, J. A, & Rosenfeld, R. J.
(1998) Deciphering the fluorescence signature of daunomycin and
doxorubicin. Biophysical chemistry 73, 249–263.
[259] Liu, Z, Sun, X, Nakayama-Ratchford, N, & Dai, H. (2007) Supra-
molecular chemistry on water-soluble carbon nanotubes for drug load-
ing and delivery. ACS Nano 1, 50–56.
[260] Liu, Z, Robinson, J. T, Sun, X, & Dai, H. (2008) PEGylated nano-
graphene oxide for delivery of water-insoluble cancer drugs. Journal
of the American Chemical Society 130, 10876–10877.
[261] Xing, L, Zheng, H, Cao, Y, & Che, S. (2012) Coordination poly-
mer coated mesoporous silica nanoparticles for pH-responsive drug
release. Advanced materials (Deerfield Beach, Fla.) 24, 6433–6437.
[262] Gorin, D. J, Sherry, B. D, & Toste, F. D. (2008) Ligand effects in
homogeneous Au catalysis. Chemical Reviews 108, 3351–3378.
[263] Gorin, D. J & Toste, F. D. (2007) Relativistic effects in homogeneous
gold catalysis. Nature 446, 395–403.
235
